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The Molecular Basis Of Membrane Interactions Of Peripheral Membrane Proteins
Abstract
Biological membranes are constantly being remodeled with high spatial and temporal accuracy, which is
essential during various cellular processes, including cell trafficking, cell signaling, and the generation and
maintenance of organelles. Critical to these cellular processes is the Bin/Amphiphysin/Rvs (BAR) domain
superfamily, whose crescent-shaped scaffold allows them to sense and induce membrane curvature.
Membrane curvature generation can occur through one or more of at least four mechanisms that are not
mutually exclusive, including scaffolding, hydrophobic insertion, oligomerization, and crowding. One BAR
domain class, N-BAR, contains an N-terminal amphipathic helix. The amphipathic helix (AH) motif is a
common protein folding motif. Many AHs are disordered in solution and will adopt an α-helical structure
upon membrane association.
α-Synuclein is an intrinsically disordered protein in solution but will form a uniquely long AH upon
association with anionic membranes. It is known that α-synuclein significantly expands the membrane
proportionally to α-synuclein’s membrane binding density. Firstly, we hypothesized that membraneexpanding proteins might adjust their binding in response to lateral membrane tension. To test this
hypothesis, we used model membranes in the form of Giant Unilamellar Vesicles. Membrane tension was
altered by osmotic stress and via micropipette aspiration. I reveal that α-synuclein can change its
membrane binding density in response to osmotic membrane tension changes. Our observations reveal a
mechanism by which different types of peripheral membrane proteins might change their binding during
processes such as endo- and exocytosis that involve membrane tension changes.
Secondly, I develop a model for the molecular basis of F-BAR protein, FBP17, as a plasma membrane
tension sensor. Since the molecular protein density is intricately connected to membrane tension, I
assess FBP17’s curvature sensing and generation ability on both tensionless and tense membranes. I
demonstrate that at high protein densities FBP17 can form an immobile protein coat on the membrane,
which may prevent curvature generation. Furthermore, I show that cholesterol can facilitate FBP17’s
curvature generation capacity and that it can accentuate FBP17’s role as a tension sensing protein.
Thirdly, I ask to what extent molecular properties of the H0 helix of N-BAR endophilin affect membrane
targeting behavior. Five different endophilin isoforms, grouped into A and B subclasses, have been
described to differ in their subcellular localization and function. I determine that the presence of anionic
phospholipids is critical for all H0 helices partitioning into membranes. Membrane partitioning is found to
be sensitive to variations in membrane complexity. The different H0 helix subfamilies display different
membrane binding preferences that are influenced by both electrostatic interactions and hydrophobic
contributions.
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ABSTRACT
THE MOLECULAR BASIS OF MEMBRANE INTERACTIONS OF PERIPHERAL
MEMBRANE PROTEINS
Jaclyn A. Robustelli
Tobias Baumgart
Biological membranes are constantly being remodeled with high spatial and
temporal accuracy, which is essential during various cellular processes, including cell
trafficking, cell signaling, and the generation and maintenance of organelles. Critical to
these cellular processes is the Bin/Amphiphysin/Rvs (BAR) domain superfamily, whose
crescent-shaped scaffold allows them to sense and induce membrane curvature. Membrane
curvature generation can occur through one or more of at least four mechanisms that are
not mutually exclusive, including scaffolding, hydrophobic insertion, oligomerization, and
crowding. One BAR domain class, N-BAR, contains an N-terminal amphipathic helix.
The amphipathic helix (AH) motif is a common protein folding motif. Many AHs are
disordered in solution and will adopt an α-helical structure upon membrane association.
α-Synuclein is an intrinsically disordered protein in solution but will form a
uniquely long AH upon association with anionic membranes. It is known that α-synuclein
significantly expands the membrane proportionally to α-synuclein’s membrane binding
density. Firstly, we hypothesized that membrane-expanding proteins might adjust their
binding in response to lateral membrane tension. To test this hypothesis, we used model
membranes in the form of Giant Unilamellar Vesicles. Membrane tension was altered by
osmotic stress and via micropipette aspiration. I reveal that α-synuclein can change its
vii

membrane binding density in response to osmotic membrane tension changes. Our
observations reveal a mechanism by which different types of peripheral membrane proteins
might change their binding during processes such as endo- and exocytosis that involve
membrane tension changes.
Secondly, I develop a model for the molecular basis of F-BAR protein, FBP17, as
a plasma membrane tension sensor. Since the molecular protein density is intricately
connected to membrane tension, I assess FBP17’s curvature sensing and generation ability
on both tensionless and tense membranes. I demonstrate that at high protein densities
FBP17 can form an immobile protein coat on the membrane, which may prevent curvature
generation. Furthermore, I show that cholesterol can facilitate FBP17’s curvature
generation capacity and that it can accentuate FBP17’s role as a tension sensing protein.
Thirdly, I ask to what extent molecular properties of the H0 helix of N-BAR
endophilin affect membrane targeting behavior. Five different endophilin isoforms,
grouped into A and B subclasses, have been described to differ in their subcellular
localization and function. I determine that the presence of anionic phospholipids is critical
for all H0 helices partitioning into membranes. Membrane partitioning is found to be
sensitive to variations in membrane complexity. The different H0 helix subfamilies display
different membrane binding preferences that are influenced by both electrostatic
interactions and hydrophobic contributions.
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Chapter 1: Introduction
1.1

Cellular Membrane Curvature
The structural basis of the cellular membrane consists of a dynamic phospholipid

bilayer integrated with numerous integral and transmembrane proteins and receptors as
well as glycoproteins and glycolipids supported by the cytoskeletal network and the
extracellular matrix.1, 2 The key role of the plasma membrane is to compartmentalize the
components of the crowded cellular milieu to allow for complex biochemical reactions to
occur in addition to form a semi-permeable barrier from the harsh environment.1, 2 The
plasma membrane acts in harmony with the rest of the cellular machinery by transmitting
mechanical and biochemical signals in order to maintain and control cell trafficking,
motility, division, and other cellular processes essential to life.3
Generation of cellular membrane curvature is a highly regulated process.4 Proteins
that can sense and generate membrane curvature, such as the BAR (Bin/Amphiphysin/Rvs)
domain superfamily, are essential for cell survival. Membrane curvature sensing refers to
a protein’s ability to bind onto membranes, and once bound, these proteins can alter
membrane shape, which is known as curvature generation or membrane remodeling.5, 6
Curvature generation plays a role in the morphological maintenance and remodeling of all
membranous organelles as well as signaling downstream processes after the binding of
proteins.7 Membrane-bound organelles have varying degrees of curvatures due to varied
and complex membrane compositions from the relatively flat plasma membrane to the
highly curved and narrow tubular-like structures of the endoplasmic reticulum and Golgi
apparatus.7 The plasma membrane has a low degree of curvature, with most mammalian
1

cells having a diameter ranging from 10–100 microns, varying based on cell type.8
However, the plasma membrane does have intricate microstructures, such as invaginations
and protrusions usually accompanied by the cytoskeletal network, which increases its local
curvature.8 The shape of membranes is modulated by its natural lipid asymmetry and
spatial organization of the phospholipid bilayer.9

Additionally, membrane shape is

controlled by the precise tuning of its interactions with various cell components and the
external environment.9
1.2

Endocytosis

1.2.1

Clathrin-Mediated Endocytosis
Endocytosis is a highly regulated cellular process. It is the primary pathway for

cargo and/or pathogens to enter the cell, including both clathrin-dependent and independent
pathways.10 Clathrin-mediated endocytosis (CME) is generally regarded as the canonical
pathway where cargo is packaged into vesicles with the aid of a clathrin coat and numerous
accessory proteins, including BAR domain proteins, which will be discussed in more detail
later in this chapter.11,

12

Endocytosis is fundamental to neurotransmission, signal

transduction, and the regulation of plasma membrane activities, and it is thus essential to
higher eukaryotic life.
CME, depicted in Figure 1.1, begins with a nucleation module that defines the site
on the plasma membrane where different adaptor proteins along with clathrin will bind.12
A membrane invagination, or pit, will begin to bud once F-BAR protein FCHO, EGFR
pathway substrate 15 (EPS15), and intersectins bind to PI(4,5)P2 lipids on the membrane.12
These proteins in turn recruit adaptor protein 2 (AP2) and clathrin followed by the selection
2

of specific cargo while the membrane pit enlarges.12 Clathrin triskelia coat the budding
vesicle recruited by AP2 and stabilizes the highly curved budding vesicle. Critical to this
stabilization of the budding neck is the recruitment of N-BAR and F-BAR domaincontaining proteins, specifically endophilin, sorting nexin 9 (SNX9), amphiphysin, and
FBP17.12 The Src Homology 3 (SH3) domains of these BAR proteins in turn aid in the
recruitment of dynamin and synaptojanin for vesicle scission and uncoating, respectively.12

Figure 1.1. The five proposed modules of clathrin-mediated endocytosis.
This figure was adapted from McMahon et al.12 1) The nucleation module depicts the
site on the plasma membrane where the budding vesicle will form. 2) Cargo is selected
by adaptor protein 2 (AP2) and other accessory molecules, and clathrin begins to
accumulate at the bud. 3) Clathrin triskelia form a cage-like structure to support and
stabilize the vesicle. BAR domain proteins are also recruited to the neck of the bud and
subsequently recruit other downstream proteins, such as dynamin and synaptojanin. 4)
The vesicle undergoes membrane scission with the GTPase dynamin.

5) The

endocytosed vesicle then undergoes an uncoating process with the aid of synaptojanin.
1.2.2

Clathrin-Independent Endocytosis
There are many clathrin-independent (CI) pathways that are characterized by the

absence of a clathrin coat that serve as internalization pathways for cargo, which introduces
3

additional ways that pathogens can enter the cell. Therefore, the biomedical relevance of
elucidating the internalization mechanisms could lead the way to improved therapeutic
strategies. These pathways, including caveolae-mediated, dynamin-dependent and
independent, and ultrafast endocytosis are likely involved in the regulation of cell
membrane area, tension, and migration.13-16
One such emerging CI pathway is fast endophilin-mediated endocytosis (FEME),
where endophilin is the main mediator.17 Recently, it has been shown that F-BARs FBP17
and CIP4 prime the membrane for FEME by recruitment of 5’-lipid phosphatase SHIP2
and lamellipodin.18 This discovery highlights the multifaceted role BAR domain proteins
play in curvature sensing and generation within cellular trafficking and signifies the
importance of elucidating the mechanisms in which these proteins function in cellular
processes.
1.3

Mechanisms of Membrane Remodeling

Figure 1.2. Proposed membrane curvature generation and sensing mechanisms by
proteins.
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BAR proteins can sense membrane curvature and remodel membranes by at least one
of the four mechanisms: 1) Scaffolding, or imprinting of the protein’s intrinsic
curvature onto the underlying membrane; 2) hydrophobic insertion, or wedging, of
hydrophobic residues and/or amphipathic helices; 3) oligomerization, or protein lattice
formation; and 4) macromolecular crowding. This figure was adapted from Baumgart
et al.5
1.3.1

Scaffolding and Amphipathic Helix Insertion
BAR proteins can sense and generate curvature by one of at least four mechanisms

that are not mutually exclusive as depicted in Figure 1.2. Scaffolding involves imprinting
the protein’s intrinsic shape of its membrane binding surface onto the underlying
membrane while hydrophobic insertion involves wedging domains, such as an amphipathic
helix, into the bilayer.5 The BAR domain, consisting of a homo-dimer with sub-nanomolar
affinity, acts as a scaffold that results in membrane curvature generation.19, 20 N-BAR
proteins contain an N-terminal H0 amphipathic helix that has been shown to wedge into
the membrane surface and contribute to membrane curvature generation.20-22 One such NBAR protein, endophilin, contains an additional insert helix, termed H1I, that can also act
as a molecular wedge.23 The H0 helix has previously been described as the sufficient
domain for amphipathic wedging-induced membrane curvature21, 22, 24, while Chen et al.
showed that the H0 helix does not contribute to the molecular curvature generation capacity
of endophilin.25 The contribution of the BAR dimer scaffold and amphipathic helix
insertion remains a controversial topic. Therefore, more studies are necessary to access the

5

biophysical role of the H0 helix since it has been directly shown not to be a major
contributor of curvature generation.
1.3.2

Protein Oligomerization
Oligomerization can amplify membrane curvature sensing and generation by the

association of several proteins into a higher order lattice-like formation.5 Cryo-electron
microscopy (cryo-EM) studies have revealed that both N-BAR proteins, such as
endophilin,26 and F-BAR proteins, such as FBP17 and CIP4,27 can organize into stable
lattices on membrane tubules due to strong tip-to-tip interactions. Interestingly, FBP17 has
the ability to generate filamentous structures even without the presence of membranes.27
In agreement to the cryo-EM studies, molecular dynamics simulations suggest that BAR
domain proteins assemble into linear aggregates after membrane binding.28-30 However,
increases in membrane tension can disassemble this lattice formation.30 Nevertheless, the
cryo-EM experiments mentioned above are far from a natural cellular environment with
liposomes containing an unnaturally high negative charge (50 – 85%). There are doubts
whether these ridge structures would form in cells and how relevant these structures are if
they cannot develop. More quantitative studies are needed to explore the contribution of
the amplification effect of protein oligomerization to the membrane curvature generation
capacity of membrane bending proteins both in vitro and in cells.
1.3.3

Macromolecular Crowding
The cellular milieu is characterized by a complex and crowded environment,

including the cell membrane surface.31

Local crowding of membrane proteins can

contribute to membrane bending due to steric forces leading to an increase in lateral
6

pressure.5 Stachowiak et al. proposed that a crowded protein environment is an additional
general mechanism for membrane curvature generation.32 The amino-terminal homology
region of epsin1 (ENTH domain) binds to PI(4,5)P2 lipids and contains a helix (helix0) that
hydrophobically inserts into the membrane.32 The authors used Ni-NTA lipids and a 6xHis
tagged epsin1 ENTH domain without the helix0, which showed indistinguishable tubule
morphologies as with wild-type ENTH with helix0 and PI(4,5)P2 domain containingmembranes.32 The study concluded that curvature generation was controlled by protein
coverage rather than helix insertion.32 Furthermore, Chen et al. revealed that the protein
crowding effect is coregulated by both protein coverage and membrane tension and
determined that macromolecular crowding is a much weaker mechanism when compared
to the membrane curvature generation capacity inherent to BAR proteins.33
1.4

Peptide-Membrane Interactions

1.4.1

Amphipathic Helices
The amphipathic helix (AH) motif is a common domain in numerous proteins and

peptides. The amphipathic helix is defined by having two opposing faces, a polar and
nonpolar side.34

Every AH has its unique physicochemical values, such as its

hydrophobicity, net charge, and hydrophobic moment, or the measure of amphiphilicity.34
These unique parameters determine specific membrane interactions. Through long-range
electrostatic interactions, an unfolded AH will accumulate at the surface of anionic
membranes and begin to bind (Figure 1.3).35 In this entropy-driven binding process by the
hydrophobic effect, the AH is transferred to the membrane by insertion of hydrophobic
residues between lipid acyl chains and water releasement (Figure 1.3).35 Then the AH
7

partitions into the membrane and undergoes a conformational change with α-helical
secondary structure (Figure 1.3). The unfolded AH transitions to an α-helix due to a more
favorable peptide bond formation in the hydrophobic membrane environment.35 This
process is also known as partitioning-folding coupling, where the overall free energy of
partitioning of the α-helical AH is significantly lower than the disordered AH.36

Figure 1.3. General mechanism for the molecular recognition of an amphipathic helix
(AH) to the membrane.
An initial electrostatic interaction between basic residues of the amphipathic helix and
an anionic membrane attracts the AH to the membrane surface. The AH is adsorbed
onto the underlying membrane and undergoes a favorable conformational change. This
figure was adapted from Seelig.35
1.5

Peripheral Membrane Proteins

1.5.1

BAR proteins
Numerous important membrane trafficking phenomena, such as endo- and

exocytosis, rely on the action of protein families that couple with membrane curvature. The
class of BAR (Bin/Amphiphysin/ Rvs) domain containing proteins is particularly important
for membrane shape and curvature modulation. BAR domain proteins are considered key
players in clathrin-mediated endocytosis.37 These crescent-shaped α-helical homodimers
8

tend to oligomerize on the membrane and subsequently deform it into shapes with positive
(convex) or negative (concave) curvature.5 These proteins control membrane shape by
amphipathic helix insertion and by serving as a scaffold to regulate endocytic membrane
remodeling and curvature induction through higher-order and long-range interactions.5
Additionally, many BAR domain proteins contain a Src Homology 3 (SH3) domain, which
has been shown to coordinate and recruit other accessory and regulatory proteins.38, 39
BAR domain proteins are essential for the cell to carry out many dynamic shape
changes of membranes.37 Dysfunctional BAR proteins are linked to numerous
neurodegenerative, cardiovascular, and neoplastic diseases.40-43 These proteins play a
critical role in membrane trafficking and cellular movement. Therefore, we are highly
interested in discovering the molecular mechanisms that these proteins use to generate
membrane curvature and thus affect membrane shape transitions. In Chapter 5, I evaluate
one subclass of the BAR domain superfamily (N-BAR) to determine differences in
membrane curvature sensing mechanisms to aid in evaluating the potential functional
redundancy of structurally similar proteins.
1.5.2

N-BAR: Endophilin
A unique subclass within the BAR domain superfamily consists of the N-terminal

amphipathic helix-BAR, or N-BAR, proteins. Endophilin is a widely studied N-BAR
domain containing protein that induces positive curvature, or bending of the membrane
away from the sides of the protein, and is recruited in clathrin-mediated endocytosis and
other membrane trafficking processes.44 The structure of endophilin includes an N-terminal
BAR domain, a variable linker region, and a C-terminal SH3 domain.2 Within the N-BAR
9

domain, endophilin has two amphipathic helices (H0 and H1I) that insert into the bilayer
when associated with the membrane.44-46 There are several reports that debate the function
of the H0 helix on membrane curvature sensing and generation. The H0 helix of endophilin
is necessary for the promotion of binding to the membrane but not membrane curvature
generation23, while the H0 helix has been shown through molecular dynamics (MD)
simulations to induce membrane curvature only if present at high densities.25, 47 Further,
the H0 helix of N-BARs may be involved in the oligomerization of these BAR-domain
containing proteins, since deletion of the H0 helix disrupts lattice formation according to
both cryo-EM and coarse-grained MD simulations.26, 48
1.5.3

F-BAR: FBP17
F-BAR proteins are another class of the BAR domain superfamily that induces

positive curvature. The N-terminal Fes/CIP4 homology (FCH) domain followed by a
coiled-coil domain is considered the F-BAR domain.41 In contrast to N-BARs, F-BARs
generally have an elongated BAR domain with a shallower degree of curvature and are
implicated as critical regulators of membrane dynamic changes.41 The molecular
mechanism of membrane shape deformation and regulation has not yet been elucidated for
F-BAR proteins and will be one focus of this thesis. The formin-binding protein 17
(FBP17) is our target for providing key mechanistic insights because it is known to couple
membrane curvature generation with cytoskeletal function.49 The cellular cytoskeleton is
often a critically important modulator of membrane curvature and tension.49 FBP17
accomplishes this coupling through its C-terminal SH3 domain that recruits, binds, and
activates Wiskott-Aldrich syndrome protein/ Neural Wiskott-Aldrich syndrome
10

(WASP/N-WASP) protein, which are crucial factors in actin nucleation and
polymerization.50 In Chapter 4, I will discuss FBP17 and N-WASP interactions to enhance
our understanding of curvature-induced actin polymerization. Furthermore, we assess
FBP17’s membrane curvature sensing and generation ability with different membrane
compositions under negligible and applied membrane tension to understand FBP17’s role
as a tension sensing protein.
1.5.4

Intrinsically disordered protein: α-Synuclein
α-Synuclein is an intrinsically disordered protein (IDP) that forms a uniquely long

N-terminal amphipathic helix upon binding to acidic membranes.51 Its aggregation into
amyloidogenic fibrils is a hallmark of Parkinson’s disease, a neurodegenerative movement
disorder characterized by the loss of dopaminergic neurons.52 α-Synuclein is localized in
the cytosol as well as presynaptic terminals, and its function remains a mystery despite
being highly studied.52 α-Synuclein has been implicated in numerous cellular pathways,
such as synaptic vesicle trafficking and recycling, dopamine synthesis and transport,
maintaining neuronal plasticity as well as having a role as a protein-folding chaperone.52
It is hypothesized that α-synuclein membrane curvature sensing is a critical native function
of the protein.53 Congruently, α-synuclein-membrane catalyzed aggregation has also been
observed.54-56 The plasma membrane presents a large reservoir for α-synuclein interactions,
specifically in neurons, as it is found in high concentrations at synaptic boutons (40 M).57
Therefore, the mechanism in which α-synuclein senses membrane curvature can be a
critical component in both its native function and its neuropathology. In Chapter 3, I will
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evaluate the membrane curvature sensing behavior of α-synuclein and its biophysical
function.
1.6

Biophysical Properties of Membranes

1.6.1

Cellular Membrane Tension
Membrane tension is a dynamic biophysical parameter that responds to mechanical

cues by generating a force to deform membranes that propagates a biochemical signal
throughout the whole cell.58, 59 It is defined as the in-plane force necessary for surface
expansion.59 Regulation of membrane tension has been implicated to play a significant
role in maintaining membrane homeostasis and the dynamic shape changes within a cell’s
life cycle.58 Fluctuations in membrane tension have been previously linked to membrane
trafficking through the regulation of endo- and exocytosis, the cytoskeletal network, and
the maintenance of cell polarity during movement.60-65 High membrane tension can prevent
key proteins involved in membrane remodeling from binding to the membrane and is linked
to a decrease in endocytosis rate.58, 60 Meanwhile, an increase in membrane tension has
been shown to trigger the process of exocytosis.58, 60
Lateral tensions in living cells have been previously measured ranging from several
pN/m to tens of mN/m.66-68 Moreover, all cell types respond to perturbations in membrane
tension69, signifying the complexity and importance of tightly controlling this parameter.
However, the role of plasma membrane tension in cells is still not yet well understood,
specifically, how it is sensed and regulated throughout the entire cell. A common theme
throughout this thesis will be to understand the influence of membrane tension through the
biophysical studies of various peripheral membrane proteins.
12

1.6.2

Lipid Asymmetry
Membrane asymmetry influences membrane shape, stability, and charge in addition

to many other membrane properties.70 The phospholipid bilayer has a thickness of 4-5 nm
and contains hundreds of different lipid species with a continuous surface area of hundreds
of square microns.71 Different organelles and cell states have different lipid distributions.72
The inner leaflet of the plasma membrane contains many highly anionic lipids including
rare phosphoinositides (PI), which are critical for many cellular signaling pathways.71 This
trans-bilayer asymmetry is crucial to maintaining autonomous cell function. For example,
phosphatidylserine (PS) (a negatively charged lipid found mainly in the inner leaflet of the
plasma membrane) externalization to the outer leaflet can signal for apoptosis, adhesion,
and blood coagulation depending on cell type.70 Lipid disorder is controlled by the lateral
distribution of lipids in addition to the chain length and degree of saturation of the fatty
acid tail.71 It remains an unresolved issue whether the lateral distribution of phospholipids
in each leaflet is either randomly distributed or organized into microdomains, which is a
key component to understanding cellular signaling.
1.7

Organelle Recognition by Peripheral Proteins

1.7.1

Physicochemical Parameters
Many cellular processes are initiated through reversable protein association at the

membrane-bound organelle surface.73 Proteins must transverse the crowded cellular milieu
and recognize its specific binding compartment.73 There are a few general strategies
employed by proteins in order to distinguish one membrane-bound organelle from the rest.
First, some proteins have a specific lipid binding domain, such as the phox homology (PX)
13

domain, a phosphoinositide-binding domain.73

Phosphoinositide lipids are tightly

regulated signaling molecules that constitute less than 1% of membrane lipids.74 Secondly,
there is kinetic trapping.73 A protein will visit all membrane-bound compartments through
a weak anchor, and the desorption rate will decrease upon proper compartment binding.73
Lastly, a protein can recognize one or more physicochemical parameters of the membrane,
such as its curvature, electrostatics, or lipid packing.73
As mentioned previously, different membrane-bound organelles have different
lipid distributions and thereby have very different properties and subsequent binding
partners. The endoplasmic reticulum (ER) and cis Golgi apparatus, organelles of the early
secretory pathway, have a greater amount of unsaturated and zwitterionic lipids than the
plasma membrane.73 Therefore, early secretory pathway binding partners are guided by
lipid packing defects rather than electrostatic interactions.73 For example, the amphipathic
lipid packing sensor (ALPS) motif is another sensor of membrane curvature. The ALPS
motif is enriched in bulky hydrophobic residues on its nonpolar face and uncharged polar
residues (serine and threonine) on its opposite polar face.34 The ALPS motif favors the
packing defects found in the ER and cis Golgi since its curvature sensing is solely due to
insertion of bulky residues.34 Meanwhile, the plasma membrane and late endosomal
membrane are comprised of saturated lipids and a higher PS and PI(4,5)P2 content, and
hence binding is guided by electrostatics.73 However, recent advances in lipidomics
suggest that the inner leaflet of the PM contains a higher amount of unsaturated lipids than
previously characterized.75 One example where binding is guided by electrostatics is the
BAR domain scaffold, which is enriched in basic residues and has a strong affinity to the
14

negatively charged plasma membrane.73 In Chapter 6, I determine the physicochemical
parameters of the H0 helix of endophilin and evaluate how these parameters relate to its
membrane binding preferences.
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Chapter 2: Materials and Methods
2.1

Materials
The following lipids were obtained from Avanti Polar Lipids (Alabaster, AL): brain

sphingomyelin (SM; porcine), (S,S) sn-(3-olyeloyl-2-hydroxy)-glycerol-1-phospho-sn-1’(3’-olyeol-2’-hydroxy)-glycerol (BMP), cholesterol (ovine), 1,2-dioleyol-sn-glycerol
(DG), 1,2-diolyeolyl-sn-glycero-3-phosphocholine (DOPC), 1,2-diolyeolyl-sn-glycero-3phosphoethanolamine (DOPE), 1,2-diolyeolyl-sn-glycero-3-phospho-L-serine (DOPS),
heart cardiolipin (CL, bovine), total ganglioside extract (brain, porcine-ammonium salt)
(GM1), 1,2-dioleyol-sn-glycero-3-phosphate (PA), L-α-phosphatidylinositol (soy PI), and
L-α-phosphatidylinositol-4,5-bisphosphate) ammonium salt (Brain, Porcine, PI(4,5)P2).
Alexa Fluor® 488 C-5 maleimide (AF488), Alexa Fluor® 594 C-5 maleimide
(AF594), N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)-1,2dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (BODIPY™FL DHPE), 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium
salt (Texas Red™ DHPE = TRTM-DHPE), and Cholera toxin subunit B – Alexa Fluor® 488
conjugate were obtained from Life Technologies (Grand Island, NY).
H0-peptides with phenylalanine to tryptophan mutations (in bold) were custom
synthesized from Biomatik (Wilmington, DE) in trifluoroacetate (TFA) salt form with a
free N-terminus and an amidated C-terminus. The modified C-terminus alters the charge
of the end of the peptide, resulting in a peptide that more closely mimics its native protein
environment. The sequences are as follows:
H0 A1: MSVAGLKKQWHKATQKVSEKVGGA;
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H0 A2: MSVAGLKKQWYKASQLVSEKVGGA;
H0 A3: MSVAGLKKQWHKASQLFSEKISGA;
H0 B1: MNIMDFNVKKLAADAGTWLSRAVQFTEEKLGQA;
H0 B2: MDFNMKKLASDAGIWFTRAVQFTEEKFGQA.
Ammonium sulfate, ampicillin, kanamycin, calcium chloride (CaCl2), casein,
chloroform, 1,4-dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA), glucose,
glutathione (reduced), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES),
magnesium chloride (MgCl2), methanol, phosphate buffered saline (PBS) 1X powder pH
7.4, sodium chloride (NaCl), sodium phosphate monobasic (NaH2PO4), sucrose, tris(2carboxyethyl)phosphine hydrochloride (TCEP-HCl), tris(hydroxymethyl)aminomethane
(Tris) were purchased from Fisher Scientific (Rochester, NY).

Imidazole,

phenylmethylsulfonyl fluoride (PMSF), and polyvinyl alcohol 98% hydrolyzed MW
146,000-180,000 (PVA) were obtained from Sigma-Aldrich (St. Louis, MO). Thin wall
capillaries with 1 mm and 1.5 mm outer diameters were from World Precision Instruments
(Sarasota, FL). Coomassie plus (Bradford) Assay Kit, Modified Lowry Protein Assay Kit,
and bovine serum albumin (BSA) standards were obtained from Pierce/Thermo Scientific
(Rockford, IL). Complete Mini EDTA-free protease inhibitor cocktail, DNase I, Triton X100 were from Roche (Indianapolis, IN). β-mercaptoethanol was from BioRad (Hercules,
CA). Anhydrous DMSO was from Molecular Probes/Invitrogen. UltraPure agarose was
obtained from Invitrogen/ Thermo Scientific). Silica microspheres (5 μm diameter) were
from Polysciences, Inc (Warrington, PA).

2,2,2-trifluoroethanol (TFE) was from

Oakwood Chemicals (West Columbia, SC). Cut Smart buffer, Phusion High Fidelity DNA
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polymerase, SspI – HF, and T4 DNA polymerase were obtained from New England
Biolabs (Ipswich, MA). Deoxynucleoside triphosphate (dNTPs) were obtained from GEAmersham Bioscience (Marlborough, MA). Isopropyl β-d-1-thiogalactopyranoside
dioxane free (IPTG) was from Lab Scientific Biokemix, Inc (Davers, MA). BL21(DE3)RIL competent cells and XL1-Blue competent cells were from Stratagene (San Diego, CA).
All reagents were used without additional purification.
2.2

Model Membrane Preparation

2.2.1

Giant Unilamellar Vesicles (GUV)
All lipids except brain PI(4,5)P2 were stored in chloroform at ˗20°C. Brain

PI(4,5)P2 was stored in 75% v/v chloroform, 25% v/v methanol at ˗20°C. Lipid stocks
were brought to room temperature in a desiccator. Various molar percentages with desired
lipids and/or lipid dye were mixed, and the lipid compositions are specified through this
thesis.
Giant unilamellar vesicles (GUVs) were prepared by the standard method of
electroformation.76 Two indium tin oxide (ITO) (Delta Technologies, Ltd) glass slides with
4-8 ohms resistance were prepared by spreading 40 μL of a 1 mM lipid mixture in
chloroform or chloroform: methanol (3:1) mixture for compositions with PI(4,5)P2 on each
ITO slide with the addition of low heat ~30-40°C. The ITO slides with a lipid film were
then vacuum dried for at least two hours (and up to 24 hours) to remove any remaining
organic solvent. A chamber was then formed by the addition of two 0.8 mm thick rubber
spacers and the lipid film was rehydrated with 500 μL of a filtered (with 0.22 μm MillexGP syringe filter, Millipore Sigma) 0.3 M sucrose solution. An electric field of 10 Hz and
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2-4 V was applied to the chamber for at 1.25-2 hours. The GUVs were stored at room
temperature and used within 3-4 days.
In order to generate vesicles with a high salt content, we used gel-assisted GUV
formation.77 A 5% (w/w) PVA (high MW 146,000-180,000) solution in ultrapure water
was initially prepared while heating at 90°C. This solution is ready to use after it has fully
dissolved and cooled to room temperature. Glass coverslips (FisherbrandTM) were plasma
cleaned (Harrick Plasma, Ithaca, NY) on medium intensity for 10 minutes. After the glass
cover slips were removed from the plasma cleaner, 75-100 μL of 5% PVA was immediately
spread onto the glass. The PVA-coated glass was dried in an oven set at 50°C for exactly
30 minutes. Then, 40 μL of a 1 mM lipid mixture was spread onto the PVA-coated glass
surface, and the lipid film was dried for 1-2 hours in a vacuum desiccator. The lipid film
was then hydrated in 200 μL of buffer at room temperature for ~1 hour. GUVs were stored
at room temperature and used within 3 days after preparation.
2.2.2

Large Unilamellar Vesicles (LUV)
Large unilamellar vesicles (LUVs) were prepared by standard extrusion

techniques.78 Lipid mixtures prepared in either chloroform or chloroform: methanol (3:1)
mixture for compositions with brain PI(4,5)P2 were added to a small round bottom flask
and then gently dried with ultra-high purity nitrogen gas (Airgas) followed by vacuum
drying for at least two hours to remove the remaining organic solvent. Lipids were
rehydrated with buffer (specified for each experiment in the subsequent chapters).
For all experiments, except in transmission electron microscopy (TEM) assays,
involving LUVs, the following method was used to prepare the lipid vesicles. Rehydrated
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lipid suspensions were vortexed for 30s-1min, followed by sonication in a water bath for
45 minutes, and then by 3 freeze/thaw cycles with liquid nitrogen and warm water (~42°C).
Subsequently, the lipid dispersions were briefly vortexed again (< 30s) and then extruded
through a single polycarbonate membrane of a specified pore size (Whatman/GE
Healthcare Biosciences, Piscataway, NJ) 9-11 times. For LUVs used in transmission
electron microscopy assays, the rehydrated lipids were incubated for 1 hour with occasional
vortexing. The resulting lipid dispersion was extruded (without sonication and
freeze/thawing) 11-15 times through a single polycarbonate membrane (Whatman/GE
Healthcare Biosciences, Piscataway, NJ) of 400 nm. All prepared LUVs were stored at
4°C and used within 1-2 days. For CD spectroscopy measurements, LUVs were used after
at least one hour (and within 24 hours) after extrusion.
2.2.3

Supported Lipid Bilayers (SLB) on Silica Microspheres
Supported lipids bilayers on silica microspheres are an advantageous biomimetic

system that allows for a controllable shape and a narrower size distribution over
liposomes.79 1-2 μL of silica microspheres (5 μm diameter) were transferred into a 0.6 mL
microcentrifuge tube with 50 μL buffer (150 mM NaCl, 20 mM HEPES, 1 mM TCEP pH
7.4). Microspheres were centrifuged at 1,400 g for 30 seconds and the buffer was decanted.
The microspheres were then washed three times with fresh buffer. The microspheres were
then aliquoted equally into 5 different tubes, followed by centrifugation (1,400 g for 30
seconds) and decanting. The microspheres were plasma cleaned on medium intensity for
5 minutes. Immediately after plasma cleaning, 15 μL LUVs (0.5 mg/ mL) were added and
incubated with the microsphere for 30 minutes. Excess/unfused vesicles were removed by
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centrifuging at 1,000 g for 30 seconds. SLB microspheres were washed with fresh buffer
3 times with subsequent centrifugation (1,000 g for 30 seconds) and decanting. SLB
microspheres were used within 24 hours and were stored at room temperature.
2.3

Protein Purification and Quantification

2.3.1

α-Synuclein
α-Synuclein with single cysteine mutations (S9C, E130C) and N-terminal

acetyltransferase b (Nat b) plasmids were obtained from the Rhoades lab (University of
Pennsylvania, Department of Chemistry).

N-terminal-acetylated α-synuclein single

cysteine mutant was expressed, purified, and labeled with Alexa Fluor® 488 as described
in references.80, 81
N-terminal acetylated α-synuclein was expressed in BL21(DE3) RIL CodonPlus
competent bacterial cells with the addition of α-synuclein and Nat b plasmids
simultaneously and grown at 37°C with shaking in a rotary shaker at 250 rpm (500 mL
growth). Protein expression was induced by 1 mM IPTG after OD600 (optical density)
reached 0.6 and was grown for 4 hours at 37°C. Bacterial cells were spun at 4,600 g at 4°C
for 20 minutes.
The pellet was resuspended in 25 mL lysis buffer (40 mM NaOH, 20 mM Tris pH
8.0, 1 mM EDTA, 1 mM PMSF, 0.1% Triton X-100, and ½ tablet of Complete Mini
EDTA-free protease inhibitor cocktail) and incubated at 37°C for 40 minutes. Then, 200
U of DNase I in addition to MgCl2 and CaCl2 were added to reach a final concentration of
10 mM each. The protein lysate was set in a rotary shaker at 250 rpm at 37°C for 1 hour.
Then, 2 mM EDTA was added to the resuspension, mixed, and centrifuged at 16,900 g for
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15 minutes at 4°C. Following centrifugation, the protein was always kept on ice when
possible.
The protein was salted out by means of ammonium sulfate in two steps: i) 0.116 g
ammonium sulfate / mL of supernatant was added while stirring at 4°C for 1 hour, then
centrifuged at 20,000 g for 30 minutes; ii) 0.244 g ammonium sulfate/ mL of supernatant
(from centrifugation step i) was added while stirring at 4°C for 1 hour then centrifuged at
20,000 g for 30 minutes. The pellet was then resolubilized in 25 mL of 20 mM NaCl, 25
mM Tris pH 8, 1 mM EDTA and 1 mM PMSF and stirred for 30 minutes at 4°C. The
lysate (25 mL) was dialyzed using 3.5 K MWCO dialysis tubing (Thermo Scientific)
against 20 mM NaCl, 25 mM Tris pH 8, 1 mM EDTA (1 L) overnight (8-12 hours).

Figure 2.1. Representative anion exchange and size exclusion chromatographs of αsynuclein.
α-Synuclein was purified on an ÄKTATM pure system (GE Life Sciences, now Cytiva)
using a) a HiTrap Q FF (anion exchange) column followed by b) a HiLoad Superdex
200 (size exclusion) column. The dashed box indicates the volume at which αsynuclein eluted.
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The dialyzed protein was filtered through 0.22 µm (Millex, Millipore) filter. The
protein was applied to a HiTrap Q FF (anion exchange) column (GE Healthcare,
Marlborough, MA) with buffer A as 20 mM NaCl, 25 mM Tris pH 8, 1 mM EDTA and
buffer B as 1 M NaCl, 25 mM Tris pH 8, 1 mM EDTA (Figure 2.1a). The protein was
further purified using a HiLoad Superdex 200 PG column (GE Healthcare, Marlborough,
MA) equilibrated with buffer: 100 mM NaCl, 25 mM Tris pH 8, 1 mM EDTA, 0.5 mM
TCEP (Figure 2.1b). α-Synuclein was concentrated using Amicon® Ultra Centrifugal
filters with 3,000 MWCO.
α-Synuclein was labeled with Alexa Fluor® 488 (see section 2.3.6). Labeled αsynuclein was stored in small aliquots (20-50 μL) at ˗80°C. Frozen protein samples were
thawed on ice and used on the same day. Protein concentrations were determined using a
Lowry assay, (see section 2.3.8) a colorimetric assay that forms a complex between copper
ions and peptide bonds.82 The Bradford reagent primarily measures arginine content83 and
α-synuclein does not contain any native arginine residues.
2.3.2

Endophilin N-BAR
A pGEX-6P-1 vector (N-terminal GST tag) encoding the N-terminal amphipathic

helix and BAR domain of rat endophilin A1 (residues 1-247, MW 28.2 kilodaltons, pI 5.87)
sequence 1-247) with single site mutations C108A and E241C was purified.25 The fusion
protein was expressed in BL21(DE3) RIL CodonPlus competent bacterial cells. Bacterial
cultures were grown in a rotary shaker at 250 rpm with a temperature set at 37°C. Protein
expression was induced with 1 mM IPTG after OD600 reached 0.6 and subsequently grown
for 16 hours at 18°C. The bacterial pellet was resuspended in 300 mM NaCl, 20 mM Tris
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pH 8, 2 mM DTT. The cells were lysed by sonication (Qsonica Q700) with 50 Amps for
5 minutes (1 second on, 2 seconds off). The lysed cells were then centrifuged at 20,000 g
for an hour at 4°C.
The lysate supernatant was applied to a GSTrap FF affinity column (GE Healthcare,
Marlborough, MA). The protein was eluted with 150 mM NaCl, 20 mM glutathione, 20
mM Tris pH 8, 1 mM DTT. Endophilin N-BAR and the GST fusion tag are connected by
a PreScission protease cleavage site. Generally, 125-250 ng of PreScission protease was
added to the eluted protein (~10-15 mL) and incubated overnight at 4°C (~8-10 hours) with
constant 360° rotation at 30 rpm. The digested protein was then applied to a HiTrap Q HP
column (anion exchange) (Figure 2.2a) followed by a sizing HiLoad Superdex 200 PG
column (Figure 2.2b). The protein was eluted with 150 mM NaCl, 20 mM HEPES, 1 mM
TCEP pH 7.4. Endophilin N-BAR was concentrated using Amicon® Ultra Centrifugal
filters with 10,000 MWCO. Protein was aliquoted and stored at ˗80°C.

Figure 2.2. Representative anion exchange and size exclusion chromatographs of
endophilin N-BAR.
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Endophilin N-BAR was purified on an ÄKTATM pure system using a) a HiTrap Q FF
(anion exchange) column followed by b) a HiLoad Superdex 200 (size exclusion)
column. The dashed box indicates the volume at which endophilin N-BAR eluted.
2.3.3

FBP17s
A pGEX-6P-1 vector (N-terminal GST tag) with PreScission protease cleavage site

encoding the EFC/F-BAR domain full-length of human formin-binding protein 17
(FBP17s) (residues 1-556, MW 64.6 kilodaltons, pI 5.17) without the intrinsically
disordered region was purified. Growth and purification were similar to endophilin NBAR with minor differences noted below. The fusion protein was expressed in BL21(DE3)
RIL CodonPlus competent bacterial cells. Cells were grown in a rotary shaker at 250 rpm
with a temperature set at 37°C. Protein expression was induced with 1 mM IPTG after
OD600 reached 0.7-0.8; cells were subsequently grown for 16 hours at 18°C. The bacterial
pellet was resuspended in 300 mM NaCl, 20 mM Tris pH 8, 2 mM DTT. The cells were
lysed by sonication with 50 Amps for 5 minutes (1 second on, 2 seconds off). The lysed
cells were then centrifuged at 20,000 g for one hour at 4°C.

Figure 2.3. Representative size exclusion chromatograph of FBP17s.
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FBP17s was purified on an ÄKTATM pure system using a HiLoad Superdex 200 (size
exclusion) column. The dashed box indicates the volume at which FBP17s eluted.
The supernatant was applied to a GSTrap FF affinity column. The protein was
eluted with 150 mM NaCl, 20 mM glutathione, 20 mM Tris pH 8, and then the GST fusion
protein was cleaved overnight with PreScission protease (125 ng). The digested protein
was concentrated using Amicon® Ultra Centrifugal filters with 30,000 MWCO and then
was directly applied to a HiLoad Superdex 200 PG column (Figure 2.3). The isoelectric
point of FBP17s is 5.17, however, this protein does not bind to the anion exchange column.
FBP17s was eluted from the sizing column with 150 mM NaCl, 20 mM HEPES, 1 mM
TCEP pH 7.4. FBP17s was concentrated using Amicon® Ultra Centrifugal filters with
30,000 MWCO. Protein was aliquoted and stored at ˗80°C.
2.3.4

N-WASP
Full length-human Neural-Wiskott-Aldrich syndrome protein (N-WASP) (residues

1-505, MW 54.8 kilodaltons, pI 8.05) with N-terminal 6x His-tag and TEV cleavage site
was purified. The protein was expressed in BL21(DE3) RIL CodonPlus competent
bacterial cells. Cells were grown in a rotary shaker at 250 rpm with a temperature set at
37°C. Protein expression was induced with 1 mM IPTG after OD600 reached 0.8-0.9 and
subsequently grown for 16 hours at 18°C. The bacterial pellet was resuspended in 200 mM
NaCl, 20 mM HEPES, 10 mM imidazole, 1 mM TCEP, pH 8. The cells were lysed by
sonication with 50 Amps for 5 minutes (1 second on, 4 seconds off). The lysed cells were
then centrifuged at 20,000 g for an hour at 4°C.
26

Figure 2.4. Representative size exclusion chromatograph of N-WASP.
N-WASP was purified on an ÄKTATM pure system using a HiLoad Superdex 200 (size
exclusion) column. The dashed box indicates the volume at which N-WASP eluted.
The supernatant was manually applied to a HisTrap FF column (GE Healthcare,
Marlborough, MA) with elution buffer 100 mM NaCl, 20 mM HEPES, 400 mM imidazole,
1 mM TCEP, pH 8. The 6x His-tag was then cleaved by the addition of 1:100 TEV protease
to N-WASP followed by dialysis at 4°C for 16 hours using 6-8 K dialysis (Thermo
Scientific) tubing against buffer 100 mM NaCl, 20 mM HEPES, 1 mM TCEP, pH 8. The
digested product was then reapplied to the HisTrap FF column to remove the TEV protease
from the protein of interest (N-WASP is contained in the flow through). The protein was
then applied to a HiLoad Superdex 200 PG column (Figure 2.4). The protein was eluted
with 150 mM NaCl, 20 mM HEPES, 1 mM TCEP pH 7.4. N-WASP was concentrated
using Amicon® Ultra Centrifugal filters with 10,000 MWCO. Protein was aliquoted and
stored at ˗80°C.
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2.3.5

SNX9
Full length-human sorting-nexin 9 (SNX9) (residues 1-595, MW 66.6 kilodaltons,

pI 5.40) with N-terminal 6x His-tag was purified.

The protein was expressed in

BL21(DE3) RIL CodonPlus competent bacterial cells. Cells were grown in a rotary shaker
at 250 rpm with a temperature set at 37°C. Protein expression was induced with 1 mM
IPTG after OD600 reached 0.6 and subsequently grown for 16 hours at 18°C. The bacterial
pellet was resuspended in 200 mM NaCl, 20 mM HEPES, 10 mM imidazole, 1 mM TCEP,
pH 8. The cells were lysed by sonication with 50 Amps for 5 minutes (1 second on, 4
seconds off). The lysed cells were then centrifuged at 20,000 g for an hour at 4°C.
The supernatant was manually applied to a HisTrap FF column with elution buffer
500 mM NaCl, 25 mM Tris pH 8.2, 300 mM imidazole, 5 mM β-mercaptoethanol. The
protein was then applied to a HiLoad Superdex 200 PG column (Figure 2.5). The protein
was eluted with 150 mM NaCl, 20 mM HEPES, 1 mM TCEP pH 7.4. SNX9 was
concentrated using Amicon® Ultra Centrifugal filters with 30,000 MWCO. Protein was
aliquoted and stored at ˗80°C.

Figure 2.5. Representative size exclusion chromatograph of SNX9.
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SNX9 was purified on an ÄKTATM pure system using a HiLoad Superdex 200 (size
exclusion) column. The dashed box indicates the volume at which SNX9 eluted.
2.3.6

Cysteine Labeling with Alexa Fluor® C-5 Maleimide Dyes
Alexa Fluor® dyes were usually dissolved in DMSO and stored at ˗20°C except in

the case for labeling α-synuclein, in which anhydrous DMSO was used to dissolve the dye
and then the dye was immediately stored in ultra-high purity nitrogen gas at ˗80°C. Proteins
were labeled with a molar excess (5x) of Alexa Fluor® 488 C5 maleimide or 594 C5
maleimide and were incubated at 4°C with constant 360° rotation at 30 rpm for ~8 hours.
The labeled protein was then applied to 3x-HiTrap Desalting column (GE Healthcare,
Marlborough, MA) to remove excess dye using 150 mM NaCl, 20 mM HEPES, 1 mM
TCEP pH 7.4 for all proteins except α-synuclein, which was eluted with 50 mM NaCl, 20
mM Tris pH 7.4 (Figure 2.6). After the protein was labeled, the protein was aliquoted and
stored at ˗80°C. Protein dye concentration was determined by UV-Vis spectroscopy, using
either an Agilent 8453 UV-visible spectrometer or a Thermo Scientific NanoDropTM.

Figure 2.6. Representative HiTrap desalting column chromatograph.
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Proteins labeled with Alexa Fluor® dyes were purified using 3x-HiTrap desalting
columns to remove excess dye. The dashed box indicates the volume at which the
labeled protein is eluted.
2.3.7

Bradford Assay
Pierce™ Coomassie Plus (Bradford) Assay kit was used to determine protein

concentrations of BAR domain proteins and N-WASP. 2 mg/mL BSA was used to prepare
standard solutions with a concentration range of 0 to 0.4 mg/ml. 50 µL of each standard
solution was added to 1 mL Bradford reagent, mixed well, and incubated for 10 minutes.
The absorbance was taken at 595 nm and was used to create a standard curve (Figure 2.7).
A new standard curve was obtained each time a protein concentration determination was
necessary.
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Figure 2.7. Bradford assay standard curve using BSA standards.
The absorbance of 50 μL of each standard solution in 1 mL Bradford reagent was taken
at 595 nm after incubating for at least 10 minutes. The data were fit with a linear
regression. The unknown protein concentration, x, was calculated from the BSA linear
standard curve (y = 1.77x).
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2.3.8

Lowry Assay
Pierce™ Modified Lowry Protein Assay kit was used to determine the protein

concentration of α-synuclein. 2 mg/mL bovine serum albumin (BSA) was used to prepare
standard solutions of BSA with a concentration range of 0 to 0.4 mg/ml. 100 µL of each
standard solution was added to 1 mL Lowry reagent, vortexed, and incubated for exactly
10 minutes. A 1X Folin-Ciocalteu phenol reagent solution was freshly prepared, and 100
µL was added to each standard solution, vortexed, and incubated for 30 minutes. The
absorbance was taken at 750 nm and was used to create a standard curve (Figure 2.8). A
new standard curve was obtained each time an α-synuclein concentration determination
was necessary.
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Figure 2.8. Modified Lowry assay standard curve using BSA standards.
The absorbance of 100 µL of each standard solution was taken at 750 nm. The data
were fit with a linear regression. The unknown protein concentration, x, was calculated
from the BSA linear standard curve (y =2.13x).

31

2.3.9

Protein Preparation for Experimental Use
All proteins were prepared for use by first thawing on ice from ˗80°C storage and

then ultracentrifuged (Thermo Scientific Sorvall MX Plus 120 Micro-Ultracentrifuge) for
6-15 minutes at 94,000 rpm at 4°C. Protein and dye concentrations were measured after
ultracentrifugation, and then the degree of labeling (labeling efficiency – LE) was
determined using the formula: moles of dye/ moles of protein.
It is of the upmost importance to ensure reproducibility of protein-membrane
interactions including: i) the proper handling and notation (i.e. age of the protein from
thawing, ultracentrifugation, age of vesicles, etc.) of materials; and ii) that precise and
consistent (same technique and method from person to person) protein and dye
concentration estimation methods are employed.
2.4

Membrane Protein Density Calibration
The measured fluorescence intensity can be converted to protein density on the

membrane.84,

85

The calibration curve was generated using two different model

membranes: GUVs and SLB microspheres. BODIPYTM-DHPE incorporated vesicles
(mol% ranging from 0.1-0.7) and DOPC (100% - BODIPY%) were prepared. BODIPYTMDHPE in the membrane is correlated to the protein number density on the membrane when
proteins are labeled with Alexa Fluor® 488. The prepared GUVs do not always result in
consistently homogenous vesicles for each mol% dye, and thus the brightness of the dye
from each vesicle can vary. Therefore, a large data set for each concentration needs to be
imaged to get an accurate average of BODIPY brightness. Meanwhile SLB microspheres
can result in multilamellar vesicles and incomplete vesicle fusion86, which can lead to
32

variations in calibration values when comparing to a GUV-generated calibration curve.
However, three advantages of using SLB microspheres include i) a larger number of SLB
microspheres can be imaged in a significantly shorter time frame than GUVs; ii) dye
brightness is more homogenous for SLB microspheres than GUVs; and iii) incompletely
fused SLB microspheres can be excluded when the defects are visible by confocal
microscopy.
Vesicles (and microspheres) were selected from the transmitted light channel
instead of the fluorescence channel and therefore were selected without user-bias. A large
data set of 100 GUVs (or microspheres) for each concentration of BODIPYTM-DHPE
labeled vesicles were imaged under constant imaging settings. The protein density on the
membrane was obtained from the linear relationship between number density of dye
molecules and lipid dye fluorescence (Figure 2.9a). The same method above can be applied
to measuring Alexa Fluor® 594 labeled proteins by using Texas RedTM-DHPE (Figure
2.9b). The average lipid headgroup area was estimated to be 0.7 nm2 and the quantum
yield difference of BODIPY/AF488 was previously determined to be 0.5. 42 The relation
between fluorescence intensity (F.I) and protein density (ρ in the unit of μm-2 and with a
labeling efficiency, LE) is determined from the slope/ lipid head group area (Figure 2.9):
F.I/LE=2.99 × ρ at 800V PMT for Alexa Fluor® 488 and F.I/LE=2.31 × ρ at 800V PMT
for Alexa Fluor® 594. Additionally, conversion of different PMT values for Alexa Fluor®
488 include: intensity (PMT=800V)/intensity (PMT=700V) = 2.59, intensity (PMT=900V)
/intensity (PMT=800V) = 1.92; intensity (PMT=1000V)/ intensity (PMT=900V) = 2.06.
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Figure 2.9. Representative membrane protein density calibration curves for BODIPYTMDHPE and Texas RedTM-DHPE.
An imaging chamber, with casein (2.5 mg/ml casein, 20 mM Tris, 2 mM EDTA, pH 8)
passivation, was prepared using GUVs or SLB microspheres with composition a)
BODIPYTM-DHPE or b) Texas RedTM-DHPE dye and DOPC with dye% (0.1-0.7)/
DOPC (100% - dye%). Final buffer conditions were 117 mM sucrose, 117 mM
glucose, and 50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP, pH 7.4. GUVs/microspheres
were imaged under PMT = 800V and laser power intensity ranged from 0.1 – 0.8%.
Laser power intensity was adjusted to avoid pixel saturation. The average fluorescence
intensity in arbitrary units for a 16-bit image was plotted as a function of percent dye
and fitted with a linear regression. The average lipid head group area is 0.7 nm2. Using
the slope/ average lipid head group area, we can determine the density (ρ) of protein
(µm-2) as the fluorescence intensity (F.I.)/ LE: 2.99 × ρ for Alexa Fluor® 488 and 2.31
× ρ for Alexa Fluor® 594. Conversion of different PMT values for Alexa Fluor® 488
include: intensity (PMT=800V)/intensity (PMT=700V) = 2.59, intensity (PMT=900V)
/intensity (PMT=800V) = 1.92; intensity (PMT=1000V)/ intensity (PMT=900V) =
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2.06. For BODIPYTM-DHPE, error bars are SEM, n = 100. For Texas RedTM-DHPE
dye, error bars are SEM, n = 25.
2.5

Single GUV Transfer Assay

Figure 2.10. Schematic of an aspirated vesicle during a single GUV transfer assay to
evaluate protein association.
a) A schematic representation of a pipette-aspirated GUV, where Rv is the radius of the
GUV, Rp is the radius of the pipette, Lp is the projection length of the aspirated GUV,
and ΔP is the aspiration pressure, which is related to the lateral membrane tension, .
b) Sequence of a GUV transfer where red = a GUV dispersion and green = protein
solution: 1) GUV aspiration; 2) GUV protection with capillary cover; 3) transfer of
GUV from GUV dispersion into protein solution; 4) removal of protecting capillary to
initiate protein binding.
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An assay was previously developed to study protein-membrane interactions.87 A
chamber (consisting of two cover slips separated 2 mm apart) with a GUV dispersion (red
dye) and a separate protein solution (green dye) was freshly prepared (Figure 2.10b). Both
solutions were prepared from a 1:1:1 ratio of 0.35 M sucrose: 0.35 M glucose: 150 mM
NaCl, 20 mM HEPES, 1 mM TCEP, pH 7.4. A GUV was aspirated by a micropipette
(fashioned from glass capillaries with a 1 mm outer diameter that was microforged with a
digital controller (World Precision Instruments) to have a pipette diameter of 5-8 μm) using
a motor-controlled micromanipulator (Luigs and Neumann, Ratingen, Germany). All
micropipettes and glass slides were passivated in a casein solution (2.5 mg/ml casein, 20
mM Tris, 2 mM EDTA, pH 8). The tension of the aspirated vesicle was adjusted by a water
reservoir system. Membrane tension is related to the pressure difference (ΔP), which is
measured between the pipette interior and exterior and is in turn related to the pressure
difference between the vesicle interior and pipette interior (Figure 2.10a). This relationship
is defined by the following equation:
σ=

∆�

�
�
�� � �
�� ��

(2.1)

The GUV was then covered and protected by an outer capillary with an outer
diameter of 1.5 mm and then moved into the protein solution, following which the outer
capillary was removed. Time zero is considered to begin at the point at which the capillary
is removed and the GUV is exposed to the protein chamber. Time-lapse confocal imaging
(Fluoview FV 3000 confocal laser scanning microscope) was used to record protein
binding with objective 60x W 1.1 N.A. (Olympus, Center Valley, PA). The zero pressure
is carefully adjusted before each GUV transfer and checked after each experiment to ensure
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stable membrane tension. If large pressure jumps occurred (likely due to air bubbles in the
micropipette and/or micropipette holder), data were discarded. All measurements were
recorded at room temperature. Times lapse images and single xy images were analyzed
using a MATLAB code generated by Dr. Zheng Shi88 and updated by Dr. Zachary Graber
to obtain the fluorescence intensity by fitting to a Gaussian ring. The code was since
updated to calculate the projection length by either automatically or manually choosing the
end of the hemisphere of the Lp.

Figure 2.11. Schematic a single GUV transfer assay to evaluate protein dissociation.
Sequence of a GUV transfer where protein (green) is incubated with a GUV dispersion
and transferred into a vesicle reservoir (LUV dispersion with ~50-100 nm diameter):
1) a protein-coated GUV is aspirated; 2) the GUV is protected with a capillary cover;
3) transfer of the GUV; and 4) removal of protecting capillary to measure protein
dissociation.
Similarly, we can employ the GUV transfer assay to study protein dissociation45
(Figure 2.11). A chamber with a protein-bound GUV dispersion and a LUV dispersion
acting as a lipid reservoir were prepared. A protein-coated GUV was transferred into the
vesicle reservoir, and time-lapse confocal imaging was used to record protein dissociation.
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2.6

Tension-Density Protein Association
Protein was incubated with a GUV dispersion at room temperature for at least 20

minutes before transferring to a chamber between two cover slips 2 mm apart. The solution
contained a 1:1:1 mixture (300 µL total) of 0.35 M sucrose: 0.35 M glucose: 150 mM NaCl,
20 mM HEPES, 1 mM TCEP, pH 7.4 with 1-2 µL of GUVs and 2-5 µL protein. A GUV
was aspirated by a micropipette and incubated for 10-15 minutes before imaging at each
tension. The zero pressure was measured before and after each pipette-aspiration
experiment to rule out artifactual pressure drifts.
2.7

Langmuir Binding Isotherm Assay
Protein was incubated with a GUV dispersion at room temperature for at least 15-

30 minutes before transferring to a thin (< 0.2 mm) imaging chamber between two
coverslips, which were passivated with a casein solution (2.5 mg/ml casein, 20 mM Tris,
2 mM EDTA, pH 8). The protein-GUV dispersion contained a 1:1:1 mixture of 0.35 M
sucrose: 0.35 M glucose: 150 mM NaCl, 20 mM HEPES, 1 mM TCEP, pH 7.4 with 0.5-1
µL of GUVs (~25–50 μM) and 0.5-5 µL protein (~50–2000 μM). Images were recorded
with a Fluoview FV 3000 confocal laser scanning microscope. Protein density on the
membrane was plotted as a function of protein concentration and was fit with the Langmuir
binding isotherm equation89:
ρ=
2.8
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(2.2)

Transmission Electron Microscopy (TEM)
LUVs with a diameter of 400 nm were used for TEM tubulation assays. A LUV

only control and LUVs incubated with the protein of interest were applied to
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Formvar/Carbon 200 mesh, copper grids (Electron Microscopy Sciences, Hatfield, PA). A
0.1 mM LUV dispersion was directly applied to the copper grid, stained with 2% (w/v)
uranyl acetate for 2 minutes, and then rinsed with buffer three times with blotting on filter
paper each time. Proteins were incubated with a final LUV concentration of 0.1 mM for
30 minutes and applied to grids for 2 minutes. Excess protein and LUVs were removed by
gently blotting on filter paper and rinsed with buffer followed by the staining procedure
above. The copper grids were air-dried for at least 10 minutes at room temperature and
imaged with a JEM 1011 transmission electron microscope (JEOL, Tokyo Japan, Tatyana
Svitkina Lab, University of Pennsylvania, Department of Biology) with 100 kV
accelerating voltage.
2.9

Inducing membrane tension through osmotic stress
Osmotic stress (Δc = cin - cout) on LUVs or GUVs was tuned to alter membrane

tension. Under iso-osmotic buffer conditions, membrane tension is considered negligible.
Hyper- (flaccid, Δc < 0) or hypo-osmotic (tense, Δc > 0) buffer was used to dilute the
LUV/GUV dispersion. The vesicles were osmotically stressed for 30 minutes prior to the
addition of protein. Osmolality was recorded with the Advanced Micro-Osmometer Model
3300 (Advanced Instruments, Inc, Norwood, MA).

Osmotically induced membrane

tension was determined by Laplace’s equation90:
�

σ= � 𝑟∆𝑃

(2.3)

where r is the radius of the vesicle and ΔP is defined by
ΔP = (cin - cout)RT
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(2.4)

where cin is the osmolarity of the vesicle interior and cout is the vesicle exterior, R is the gas
constant, and T is the temperature in Kelvin.
2.10

Circular Dichroism (CD) Spectroscopy
H0 peptides of A1, A2, A3, and B1 were dissolved in 10 mM sodium phosphate

(monobasic) pH 7.4 at 2mg/mL and were used as is. H0 B2 was dissolved in 10 mM
sodium phosphate and sonicated for > 1 hour but was not fully soluble. H0 B2 was
microcentrifuged at 10,000 rpm for 30s, to separate dissolved and undissolved peptide.
The supernatant was carefully removed, and the concentration was determined by UV
absorbance at 280 nm. The concentration was calculated using A=εlc, with extinction
coefficient 5500 M-1cm-1, computed by ProtParam-ExPASy.
All CD measurements were taken on Jasco J-1500 Circular Dichroism
Spectrophotometer with High Precision Quartz Suprasil cuvettes (Hellma Analytics) with
a light path of 1 mm. Spectra were recorded between 180 and 260 nm, using 1 nm
increments at 8 s scan/nm, at 20°C.
Varying concentrations of TFE were titrated into each of the H0 peptides and
spectra were immediately measured. The final solution in all conditions were 50 μM H0
peptide, 10 mM sodium phosphate at pH 7.4 with the TFE concentration ranging from 0
M to 8.1 M (0 to 60% v/v TFE). All spectra were corrected with the appropriate blank.
Except where specified below for a minor subset of measurements, the
concentration of peptide remained constant at 50 µM for LUV titrations that varied the
lipid concentration up to 4 mM. In the case of H0 B2 for DOPS (25% and 100%) and the
eight-specific lipid titrations, LUVs were incrementally added to the peptide in the CD
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cuvette and gently mixed with a pipette tip at least 3 times and then measured. The volume
of LUVs added was recorded so that accurate peptide concentrations (resulting in a peptide
concentration from 50 µM to 40 µM), and peptide/lipid ratios could be calculated. All
spectra were corrected for background scattering. For peptide only measurements, a buffer
baseline spectrum was subtracted. For peptide-vesicle spectra, vesicle-only spectra were
subtracted, using the appropriate concentration of lipids. We assumed peptide / membrane
binding to have equilibrated after a short incubation time (<10 minutes), otherwise we
would not have observed isodichroic points91.
Measured values of mdeg° were converted into both values of molar ellipticity as
well as mean residue ellipticity.92, 93 Molar ellipticity (θ) can simply be converted from
millidegrees (mdeg°) by
����°

θ = ��×�×�

(2.5)

where l is the pathlength in cm and c is the molar concentration. Meanwhile mean residue
ellipticity, also denoted mean residue weight, (θMRW), can be converted by
����°

θMRW = � × (�

��� ��)

(2.6)

where Nres is the total number of residues. The fractional helicity (𝑓 H) of a peptide is
defined by
𝑓H =

����

�� ���

�.��
�
����

× 100

(2.7)

where θobs is the experimentally measured mean residue ellipticity at 222 nm, and θH
corresponds to 100% helical content (˗39,500 deg cm2/ dmol).
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2.10.1 Analysis of TFE-titration curves
The TFE-titration curves of all H0 peptides were fit with a two-state equilibrium
model, where a linear dependence of ΔG on TFE concentration was assumed94-96, defining
the equilibrium constant as:
˗RT ln KTFE = ΔGTFE = ΔG ��� – m[TFE] = m[TFE]mid – m[TFE]

(2.8)

where R is the universal gas constant, T is the temperature in Kelvin, ΔGTFE is the Gibbs
transfer free energy at a specific concentration of TFE, ΔG �� � is the Gibbs transfer free

energy in aqueous buffer, m is the measure of dependence on TFE concentration of ΔGTFE,

and [TFE]mid is the concentration of TFE at which the peptide is 50% helical. The TFEtitration curves were fit to the following equation as previously described97:
Yobs =

(�� � �� [���])�(�� � �� [���])�
�� �

�(�[���]��� ��[���]
��

�(�[���]��� ��[���]
��

(2.9)

where Yobs is the CD signal in mdeg, YD and SD are the y-intercepts and slopes,
respectively, of the pre-transition baseline (measured between 0 M and ~2 M TFE), and
YH and SH are the y-intercepts and slopes, respectively, of the post-transition baseline
(measured between ~4 M and ~8 M TFE). The four parameters (YD, SD, YH, SH) were first
determined by a linear regression analysis and then were subsequently set as fixed
parameters to simplify equation 2.9 to determine the values of m and [TFE]mid.
2.10.2 Partition Coefficient Determination
We treat the association of peptides with lipid bilayers as the partitioning between
two immiscible fluids (aqueous water/buffer and lipid bilayer phases). Here we use the
partitioning approach described by White et al.98
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𝐾� is the mole fraction partition coefficient given by equation 2.10:
𝐾� = [�]

[�]��� / ([�]�[�]��� )

����� /([�]�[�]����� )

(2.10)

[P]bil and [P]water are the bulk molar concentrations of peptide in each phase, [L] is the
molar concentration of lipid, and [W] is the molar concentration of water (55.5 M at 25°C).
We can rewrite Eq 2.10 as
[�]��� / [�]

𝐾� = [�]

(2.11)

����� /[�]

due to our experimental conditions, where [W] >> [P]water and [L] >> [P]bil. We can then
calculate the fraction of peptide (𝑓� ) partitioned in the bilayer:
�� [�]

𝑓� = [�]��

� [�]

(2.12)

We obtain a spectroscopic signal, S, from CD spectroscopy by titrating lipids, at
concentration L into a fixed peptide concentration, Ptotal:
S(L) = Ptotal �𝑓����� (𝐾, 𝐿) ∙ 𝑠����� + �1 − 𝑓����� (𝐾, 𝐿)� ∙ 𝑠���� �

(2.13)

where sbound and sfree are the CD signal (θ222) when the peptide is bound and free,
respectively. 𝐾� can be determined by the nonlinear regression equation in Eq. 2.14 by

least-squared fitting by combining Eqs. 2.12 and 2.13:
�� [�]

S(L) = Ptotal �[�]��

� [�]

∙ 𝑠����� + �1 −

�� [�]

[�]��� [�]

� ∙ 𝑠���� �

(2.14)

Here, we plot the change in CD signal (Δθ222) as a function of [L] and then use Eq 2.14 to
fit. We then have two fitting parameters 𝐾� and sbound, since Ptotal is our known input, [W]

= 55.5 M, and sfree is determine experimentally when [L] = 0.
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2.11

Dynamic Light Scattering DLS
LUVs were analyzed by dynamic light scattering (Malvern Zetasizer Nano ZS) to

confirm a monodisperse size distribution. Generally, 5 μL of a LUV dispersion was diluted
in water (final concentration between 25-50 μM). The data input for the software include
i) LUVs as the material with a refractive index of 1.5 and absorbance of 1, ii) the dispersant
as water with a refractive index of 1.33, and iii) measurement angle 173°.
2.12

Molecular Biology: Cloning Plasmid Library
A library of gene constructs was engineered for the 5 different human endophilin

isoforms.

Human endophilin A2 and B1 were custom synthesized from Biomatik

(Wilmington, DE).

Full-length human endophilin A3 double amphipathic helix

(DAH) with a C-terminal GST fusion tag plasmid was generously provided by Harvey
McMahon (MRC Laboratory of Molecular Biology, Cambridge, UK). Full-length human
endophilin B2 was generously provided by Hong-Gang Wang (Penn State University, State
College, PA). Human endophilin A1 was converted from rat endophilin A1 since there are
only 5 differences in amino acids (shown in Table 2.1). Polymerase chain reaction (PCR)
reaction mixture and cycling parameters were based on a standard PCR Protocol Phusion®
DNA Polymerase from New England Biolabs. All primers were obtained from SigmaAldrich or Invitrogen.
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Table 2.1. Five-site mutations to engineer rat to human endophilin A1
Mutation
M133I
A266P
&
G270S
A286S
Q335H

Primer
Forward: 5’GACTCTTTGGACATCGAAGTGAAGCAGAAC 3’
Reverse: 5’GTTCTGCTTCACTTCGATGTCCAAAGAGTC 3’
Forward:5’GAGCCTAGAGTTTCCCACTGGAGACAGTACGCAGC
CCAAC 3’
Reverse:5’GTTGGGCTGCGTACTGTCTCCAGTGGGAAACTCTAG
GCTC 3’
Forward: 5’GCACACCCAAACCTTCAGGTGTCCAAATG 3’
Reverse: 5’CATTTGGACACCTGAAGGTTTGGGTGTGC 3’
Forward: 5’GCTTCATGGCCACTCCGGCTTTTTCC 3’
Reverse: 5’GGAAAAAGCCGGAGTGGCCATGAAGC 3’

Ligation independent cloning (LIC) bacterial expression vector pET His6 GST
TEV (#29655) and mammalian expression vector pcDNA3 GFP (#30127) were obtained
from Addgene (Watertown, MA). Standard cloning procedures described in Gradia et al.
were employed.99 Primers for the pET His6 GST TEV LIC vector are forward tag
5’TACTTCCAATCCAATGCA...3’

and

reverse

tag

5’TTATCCACTTCCAATGTTATTA…3’. Primers for the pcDNA3 GFP vector are
forward

tag

5’TACTTCCAATCCAATGCCACC(ATG)...3’

and

reverse

tag

5’CTCCCACTACCAATGCC …3’. The ellipsis (…) in the forward and reverse primer
tags refers to our input DNA sequences. These primers tags are not shown in Tables 2.22.9 but include the input gene sequences used to amplify the insert DNA by PCR. The
amplified PCR product is analyzed on a 1% agarose gel and gel extracted (Monarch® DNA
Gel Extraction Kit). The LIC vector (3 μg) is linearized in 1x Cut Smart buffer and 60 U
SspI-HF by incubating at 37°C for 1 hour and then purified by a PCR cleanup kit
(Monarch® PCR & DNA Cleanup Kit). T4 DNA polymerase is added to the linearized
vector (with dGTP) and DNA insert (with dCTP) separately and incubated at room
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temperature for 30 minutes and then purified with a PCR cleanup kit. The vector and insert
are now primed to anneal. A vector: insert molar ratio of 1:3 and/ or 1:4 and 1:0 (vector
control) are mixed at room temperature and allowed to anneal for 30 minutes. Then 1 μL
of 25 mM EDTA pH 8 is added and incubated for an additional 15 minutes followed by
transforming the whole volume mixture in XL1-Blue competent cells.
Double H0 helix constructs were engineered from the H0 helix where the second
H0 helix was elongated from the initial H0 helix DNA sequence utilizing degeneracy in
the codons (Table 2.9). A DNA gel and a gel extraction were performed for each step.
Similarly, chimeric endophilins were engineered by sequentially elongating the H0 helix
from the BAR+Linker+SH3 (backbone).

For example, the BAR+Linker+SH3 was

generated for endophilin A1 (Table 2.5), note forward and reverse primers were also
synthesized without the LIC primer tag. Then, an overhang can be created to elongate the
gene with the H0 B1 helix (Table 2.10). Once this construct was generated, the primers in
Table 2.9 could be utilized to generate the rest of the H0 helix, creating a chimeric H0B1A1FL protein.
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Table 2.2. LIC designed primers for the full-length gene construct of the 5 isoforms of
endophilin
Endophilin
Code#
Isoform
A1-F1
A1
A1-R1
A2-F1
A2
A2-R1
A3-F1
A3
A3-R1
B1-F1
B1
B1-R1
B2-F1
B2
B2-R1

Primers
Forward: 5’ATG TCG GTG GCA GGG CTG AAG 3’
Reverse: 5’ AAT GGG GCA GAG CAA CCA 3’
Forward: 5’ ATG TCG GTG GCG GGG CTG AA 3’
Reverse: 5’ CTG CGG CAG CGG AAC CAG 3’
Forward: 5’ ATG TCG GTG GCC 3’
Reverse: 5’ CTG AGG TAA AGG CAC GAT 3’
Forward: 5’ ATG AAC ATC ATG GATT 3’
Reverse: 5’ ATT CAG CAG TTC CAG ATA 3’
Forward: 5’ ATG GAC TTC AAC ATG AAG 3’
Reverse: 5’ GCT GAG CAG TTC CAA GTA 3’

Primer are flanked by the following sequences (forward tag) 5’TACTTCCAATCCAATGCA...3’ and
(reverse tag) 5’TTATCCACTTCCAATGTTATTA…3’ when cloning into pET His6 GST TEV LIC vector.
Primer are flanked by the following sequences (forward tag) 5’TACTTCCAATCCAATGCCACC(ATG)...3’
and (reverse tag) 5’CTCCCACTACCAATGCC …3’ when cloning into the pcDNA3 GFP.

Table 2.3. LIC designed primers for engineering the H0 helix of each endophilin isoform
Endophilin
Code#
Isoform
A1
A2
A3
B1
B2

Primers

Forward: A1-F1
A1-R2 Reverse: 5’ GGC TCC TCC CAC CTT 3’
Forward: A2-F1
A2-R2 Reverse: 5’ GGC CCC ACC AAC TTT CTC 3’
Forward: A3-F1
A3-R2 Reverse: 5’ CAG CAC CAC TTA TTT TTT CAC 3’
Forward: B1-F1
B1-R2 Reverse: 5’ CTG CAC GGC CCG 3’
Forward: B2-F1
B2-R2 Reverse: 5’ CTC CGT GAA CTG CAC 3’

Primer were generated with the LIC primer tags for both vectors.
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Table 2.4. LIC designed primers for engineering the N-BAR domain of each endophilin
isoform
Endophilin
Code#
Isoform
A1
A2
A3
B1
B2

Primers

Forward: A1-F1
A1-R3 Reverse: 5’ TCTTATTCTCTCTTCCAGCCTGACAG 3’
Forward: A2-F1
A2-R3 Reverse: 5’ GCG CAT GCG ACG TTT CAG 3’
Forward: A3-F1
A3-R3 Reverse: 5’ TGA TAT TCG CAT CTG TAG CTT GC 3’
Forward: B1-F1
B1-R3 Reverse: 5’ ACT ACC CAG CTG TTT CTG C 3’
Forward: B2-F1
B2-R3 Reverse: 5’ TCT GCC CAG CTG CTT CTG C3’

Primer were generated with the LIC primer tags for both vectors.

Table 2.5. LIC designed primers for engineering BAR+Linker+SH3 domain of each
endophilin isoform
Endophilin
Code#
Primers
Isoform
A1-F2 Forward: 5’ ATT GAA GGC ACC AAG CTC GAT GAT
A1
GAC 3’
Reverse: A1-R1
A2-F2 Forward: 5’ GAA GGC ACC AAA CTG GAT GAT GAT TTT
A2
AAA G 3’
Reverse: A2-R1
A3-F2 Forward: 5’ GAA GGA ACT AAA CTA GAC GAT G 3’
A3
Reverse: A3-R1
B1-F2 Forward: 5’ GAA AAA ACC GAA CTG GAT GCC CAT CTG
B1
3’
Reverse: B1-R1
B2-F2 Forward: 5’ GAG AAA TTT GGC CAG GCT GAG AAG 3’
B2
Reverse: B2-R1

Primer were generated with the LIC primer tags for both vectors as well as without (both forward and
reverse).
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Table 2.6. LIC designed primers for engineering the N-BAR+Linker domain of each
endophilin isoform
Endophilin
Code#
Isoform
A1
A2
A3
B1
B2

Primers

Forward: A1-F1
A1-R4 Reverse: 5’ AGG CTG ATC CAT TTG GAC 3’
Forward: A2-F1
A2-R4 Reverse: 5’ CCG CCG CTG GAT CAG CCG 3’
Forward: A3-F1
A3-R4 Reverse: 5’ AGG GCT GGT CCA TGG GAA TG 3’
Forward: B1-F1
B1-R4 Reverse: 5’ ACG ACT GCC ACT GCA TTC 3’
Forward: B1-F1
B2-R4 Reverse: 5’ GCG GGT CCC ACT GGC 3’

Primer were generated with the LIC primer tags for both vectors.

Table 2.7. LIC designed primers for engineering the Linker+SH3 domain of each
endophilin isoform
Endophilin
Code#
Primers
Isoform
A1-F3 Forward: 5’ CAA GCT TCA TCT CAA CC 3’
A1
Reverse: A1-R1
A2-F3 Forward: 5’ GAA GCA AGT AGC CGC CCG AA 3’
A2
Reverse: A2-R1
A3-F3 Forward: 5’ GCT GCA TCC AGT GTC CCC AG 3’
A3
Reverse: A3-R1
B1-F3 Forward: 5’ TTT CCG AGT AAT TAT CTG AG 3’
B1
Reverse: B1-R1
B2-F3 Forward: 5’ TTT CCC GGC ACC TTC GTG GGC AC 3’
B2
Reverse: B2-R1

Primer were generated with the LIC primer tags for both vectors.
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Table 2.8. LIC designed primers for engineering the SH3 domain of each endophilin
isoform
Endophilin
Code#
Primers
Isoform
A1-F4 Forward: 5’ TGC TGC CGA GCC CTG TAT G 3’
A1
Reverse: A1-R1
A2-F4 Forward: 5’ AGC TGC AAA GCA CTG TAT G 3’
A2
Reverse: A2-R1
A3-F4 Forward: 5’ TGC TGT CGT GGT CTC TAT G 3’
A3
Reverse: A3-R1
B1-F4 Forward: 5’ AAA GCC CGC GTT CTG TAT 3’
B1
Reverse: B1-R1
B2-F4 Forward: 5’ AAA GCT CGG GTG CTC TAT 3’
B2
Reverse: B2-R1

Primer were generated with the LIC primer tags for both vectors.
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Table 2.9. LIC designed primers for the double-H0 helix of each endophilin isoform by
multi-step elongation
Endophilin
Code#
Forward Primers
Isoform
A1-F5 Step 1: 5’ GTT AGC GAA AAA GTA GGT GGT GCA ATG
TCG GTG GCA GGG 3’
A1-F6 Step 2: 5’ CAA TTT CAT AAG GCA ACC CAA AAG GTT
A1
AGC GAA AAA GTA GG 3’
A1-F7 Step 3: 5’ ATG AGT GTA GCC GGA TTG AAA AAA CAA
TTT CAT AAG GCA ACC 3’
A1-F8 Step 4: 5’ ATG AGT GTA GCC GGA TTG 3’
A2-F5 Step 1: 5’ GTT TCA GAA AAG GTA GGA GGA GCA ATG
TCG GTG GCG GGG 3’
A2-F6 Step 2: 5’ CAA TTT TAT AAA GCC TCG CAA TTA GTT
A2
TCA GAA AAG G 3’
A2-F7 Step 3: 5’ ATG AGT GTA GCC GGA TTG AAA AAA CAA
TTT TAT AAA GCC TCG C 3’
Step 4: A1-F8
A3-F5 Step 1: 5’ TTC TCA GAG AAG ATC TCA GGA GCA ATG
TCG GTG GCC G 3’
A3-F6 Step 2: 5’ CAA TTT CAT AAG GCA TCA CAA TTG TTC
A3
TCA GAG AAG ATC 3’
A3-F7 Step 3: 5’ ATG AGT GTC GCA GGA TTG AAA AAA CAA
TTT CAT AAG GC 3’
A3-F8 Step 4: 5’ ATG AGT GTC GCA GG 3’
B1-F5 Step 1: 5’ TTC ACT GAG GAG AAG TTA GGA CAA
GCT ATG AAC ATC ATG GAT TTC 3’
B1-F6 Step 2: 5’ ACG TTC TTA TCA AGA GCA GTA CAA TTC
ACT GAG GAG AAG TTA 3’
B1-F7 Step 3: 5’ AAA AAG TTA GCA GCC GAC GCG GGA
B1
ACG TTC TTA TCA AGA GCA 3’
B1-F8 Step 4: 5’ ATG AAT ATT ATG GAC TTT AAT GTG AAA
AAG TTA GCA GCC GAC 3’
B1-F9 Step 5: 5’ TACTTCCAATCCAATGCCACC ATG AAT
ATT ATG GAC TTT 3’
B2-F5 Step 1: 5’ ACA AGG GCA GTC CAA TTT ACA GAA ATG
GAC TTC AAC A 3’
B2-F6 Step 2: 5’ GCT AGT GAC GCT GGG ATA TTT TTT ACA
B2
AGG GCA GTC 3’
B2-F7 Step 3: 5’ ATG GAT TTT AAT ATG AAA AAA CTC GCT
AGT GAC GCT GGG 3’
B2-F8 Step 4: 5’ ATG GAT TTT AAT ATG 3’

Only the italicized forward primers have the LIC tags. Reverse primers used are described in Table 2.2 (#
A1-R1, A2-R2, A3-R3, B1-R1, and B2-R2).
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Table 2.10. Engineering Chimeric Endophilins by multi-step elongation PCR
Endophilin
H0
Forward Primers
backbone*
A2 5’ GTT TCA GAA AAG GTA GGA GGA GCA ATT GAA GGC
ACC AAG CTC 3’
A3 5’ TTC TCA GAG AAG ATC TCA GGA GCA ATT GAA GGC
ACC AAG CTC 3’
A1
B1 5’TTC ACT GAG GAG AAG TTA GGA CAA GCT ATT GAA
GGC ACC AAG CTC 3’
B2 5’CAA TTT ACA GAA GAA AAG TTC GGA CAA GCA ATT
GAA GGC ACC AAG CTC 3’
A1 5’ GTT AGC GAA AAA GTA GGT GGT GCA GAA GGG ACC
AAA CTG GAT 3’
A3 5’ TTC TCA GAG AAG ATC TCA GGA GCA GAA GGG ACC
AAA CTG GAT 3’
A2
B1 5’ TTC ACT GAG GAG AAG TTA GGA CAA GCT GAA GGC
ACC AAA CTG GAT 3’
B2 5’ CAA TTT ACA GAA GAA AAG TTC GGA CAA GCA GAA
GGc ACC AAA CTG GAT 3’
A1 5’ GTT AGC GAA AAA GTA GGT GGT GCA GAA GGA ACT
AAA CTA G 3’
A2 5’ GTT TCA GAA AAG GTA GGA GGA GCA GAA GGA ACT
AAA CTA G 3’
A3
B1 5’ TTC ACT GAG GAG AAG TTA GGA CAA GCT GAA GGA
ACT AAA CTA G 3’
B2 5’CAA TTT ACA GAA GAA AAG TTC GGA CAA GCA GAA
GGA ACT AAA CTA G 3’
A1 5’ GTT AGC GAA AAA GTA GGT GGT GCA GAA AAT CTG
CTG AGT AAA 3’
A2 5’ GTT TCA GAA AAG GTA GGA GGA GCA GAA AAT CTG
CTG AGT AAA 3’
B1
A3 5’ TTC TCA GAG AAG ATC TCA GGA GCA GAA AAT CTG
CTG AGT AAA 3’
B2 5’ CAA TTT ACA GAA GAA AAG TTC GGA CAA GCA GAA
AAT CTG CTG AGT AAA 3’
A1 5’ GTT AGC GAA AAA GTA GGT GGT GCA GAG AAG ACT
GAG CTT GAT GCC 3’
A2 5’ GTT TCA GAA AAG GTA GGA GGA GCA GAG AAG ACT
GAG CTT GAT GCC 3’
B2
A3 5’ TTC TCA GAG AAG ATC TCA GGA GCA GAG AAG ACT
GAG CTT GAT GCC 3’
B1 5’ CAA TTT ACA GAA GAA AAG TTC GGA CAA GCA GAG
AAA TTT GGC CAG GCT GAG AAG3’

*Backbone denotes the BAR+Linker+SH3 domain. Reverse primers used are described in Table 2.2 (# A1R1, A2-R2, A3-R3, B1-R1, and B2-R2).
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2.13

Mammalian Cell Culture
HeLa cells were obtained from ATCC®. HeLa cells were cultured in Dulbecco's

Modified Eagle Medium (DMEM high glucose 4.5 g/l, Life Technologies) containing 10%
fetal bovine serum (FBS) (Invitrogen) and 1% penicillin/ streptomycin (0.1 mg/ml)
(Mediatech). Cells were cultured in MatTek glass bottom poly-D-lysine coated culture
dishes (Ashland, MA), and cells were transfected once they reached ~90% confluency.
Specified endophilin gene (pcDNA GFP) constructs (0.5-1 μg plasmid) were transfected
with Lipofectamine 3000 reagent (Life Technologies, Invitrogen) and incubated at 37°C,
5% CO2 for ~8-10 hours, and then the culture was exchanged with fresh DMEM. Live
cells were imaged after 24 hours. After the cells were imaged live, cells were transfixed
with 4% paraformaldehyde (Affymetrix). Cells were permeabilized with 3% (w/v)
BSA/0.1% (v/v) TritonX-100 for 15 minutes. Cell were washed three times with phosphate
buffer saline (PBS) (without Ca2+, Mg2+, or phenol red, GE Healthcare Life Science). AntiEEA1-Alexa Fluor® 647 conjugate (early endosome marker, Abcam) and MitoTrackerTM
Red (Invitrogen) were diluted to a working concentration (3 μL/mL for Anti-EEA1 and 0.5
μL/mL for MitoTrackerTM Red) in blocking buffer (3% (w/v) BSA) and then added to the
fixed cells for an overnight (~10-12 hours) incubation. The fixed cells were washed in
PBS three times and imaged; fixed cells were stored for up to 1 week at 4°C.
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Chapter 3: α-Synuclein–Membrane Interactions
3.1

α-Synuclein structure and pathology
α-Synuclein is a relatively small (~14 kilodaltons), intrinsically disordered protein

in solution that forms an extended helix upon membrane binding.100, 101 This protein has
been discovered to aggregate into amyloid fibrils under certain conditions in vitro and in
human patients, which ultimately leads to distinct synucleinopathies.102,

103

The

accumulation of fibrillized α-synuclein, found in Lewy bodies, is a pathogenic hallmark of
neurodegenerative diseases such as Parkinson’s disease, Lewy body dementia, and
multiple system atrophy.104 Numerous cell localization105-108, knockout109-111, and
overexpression112-120 studies indicate that this protein may function in synaptic vesicle
trafficking and recycling, neuronal plasticity, as well as other cellular trafficking processes,
such as endo- and exocytosis. However, the primary function, or possible multiple cellular
functions, of α-synuclein and its mechanism of action remain unclear to date. Therefore,
insights into the biophysical characterization and function of monomeric α-synuclein can
ultimately aid in understanding what role it plays in the cell. Additionally, we seek to
discover key insights into how α-synuclein’s dynamic ensemble of interconverting
conformations interacts with membranes and in turn regulates cell functions.
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Figure 3.1. Domain structure of α-synuclein.
a) The schematic diagram of the domain structure of α-synuclein shows three
distinctive regions.

R1-7 indicate the seven imperfect, lysine-rich, repeats of

xKTK(E/Q)GVxxx within the N-terminal membrane-binding domain. Denoted with a
black arrow are single point mutations found in familial Parkinson’s disease, which
accounts for roughly 2% of cases. The NAC, or non-amyloid-beta component, is a
highly hydrophobic region also found within the membrane binding domain. The Cterminal tail remains disordered due to its high negative charge. b) A schematic
depiction of a membrane-bound extended helix and a broken helix when bound to
micelles, highlighting the different conformations of α-synuclein in a hydrophobic
environment. c) Micelle bound α-synuclein (in green) from PDB: 1XQ8. Residues
Serine-9 (in blue) and Glutamine-130 (in red) are highlighted. Serine-9, when bound
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to micelles, does not interact with the underlying surface, thereby making it a prime
residue for mutagenesis and dye labeling while minimizing interference from labeling
and membrane interactions. Glutamine-130 is found in the disordered C-terminal
region of α-synuclein even when bound to micelles, which also makes this a good
candidate for labeling. This figure was adapted from Shvadchak et al.121
The primary structure of α-synuclein has three distinctive regions, including an Nterminal membrane binding domain (residues 1-93), a hydrophobic NAC (non-amyloid-β
component) region (residues 61-95), and a highly acidic C-terminal region (residues 96140)51, depicted in Figure 3.1a. The first 89 residues consist of seven imperfect 11-aminoacid repeats, which contain both charged and non-polar amino acids.51 The hydrophobic
NAC region is implicated in protein fibrillization, since when it is engineered out of the
protein, α-synuclein no longer aggregates into fibrils.51, 100 The C-terminal acidic tail has a
disordered random coil structure due to its low hydrophobicity and high negative charge
with 10 glutamate and 5 aspartate residues.122 This C-terminal domain is hypothesized to
have a key role in protein-protein interactions and can undergo phosphorylation at Ser129.122 Phosphorylated Ser-129 is hypothesized to be linked to synucleinopathies since
90% of α-synuclein deposits in Lewy bodies have this post-translational modification,
whereas less than 4% of α-synuclein is phosphorylated in healthy brain tissue.123-126
3.2

α-Synuclein interactions with membranes as a long amphipathic helix
As previously mentioned, the amphipathic helix (AH) motif is common among

membrane proteins, and it often plays a critical role in membrane curvature sensing,
membrane-remodeling, and membrane destabilization.34 It is suggested that α-synuclein is
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adsorbed on the membrane surface through electrostatic interactions between the
negatively charged lipids and several positive lysine residues within the membrane binding
domain.34, 54 The protein then undergoes a disordered to ordered helical transition, where
the hydrophobic face is buried within the lipids’ hydrocarbon chains and the lysine residues
interact with the lipids’ polar head group. α-Synuclein forms a uniquely long AH upon
binding to negatively charged lipid membranes, containing residues 1-93 that has one of
two conformations: a single elongated α11/3 helix if bound to large or giant unilamellar
vesicles (LUV, GUVs) (> 100 nm diameter) or a helix broken into two shorter fragments
when bound to small unilamellar vesicles (SUVs) (< 50 nm diameter), while the C-terminal
domain (residues 100-140) remains highly unstructured (Figure 3.1b).100, 127-129
The exact structure of physiologically relevant α-synuclein is still debated. Both
membrane composition, size, and lipid-to-protein ratios can influence how α-synuclein
interacts with the membrane.129 In fact, previously determined in our lab, α-synuclein
induces a substantial membrane area expansion by the binding of monomers to
membranes.85 This area expansion results from both membrane thinning and membrane
remodeling that is dependent upon lipid composition.85 One possible mechanism for this
area expansion is ‘wedging’ into the membrane, through insertion of lysine residues, which
may implicate α-synuclein in cellular processes such as endo- and exocytosis by making
the membrane more susceptible to three-dimensional remodeling.130
3.3

Membrane tension influences peripheral protein binding
Cells must sense, incorporate, and respond to mechanical stimuli, both externally

and internally, in order to function properly, and AHs may play a critical role in this process
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by altering their activity in response to mechanical forces. Membrane tension has long
been implicated in the regulation of cellular function, but the underlying mechanisms are
still largely unknown.131 Tension plays a mechanical role by regulating the amount of force
necessary to deform the membrane during trafficking phenomena.65, 131 AH insertion is
just one of four major mechanisms that have been assumed to aid in membrane curvature
sensing and generating by these proteins, while the other mechanisms include scaffolding,
oligomerization, and the crowding effect.5
In this chapter, we investigate a potential physiological function of α-synuclein,
which is implicated in numerous cellular trafficking events and can lead to the pathogenesis
of many synucleinopathies. We characterize the binding behavior of α-synuclein and probe
its function as a tension sensing protein by using a model membrane system and
micropipette aspiration to accurately control in-plane lateral membrane tension. We
employ the use of two different α-synuclein mutants in our studies, S9C and E130C shown
in Figure 3.1c, to enable fluorescence detection by labeling with Alexa Fluor® 488 C5
maleimide. These two mutations were chosen to avoid potential inhibiting fluorophoremembrane interactions. The S9C position is found within the membrane binding domain.
However, it is found on the polar face of the helix, and hence, the side chain is pointing
away from the membrane. Meanwhile, the E130C mutant is labeled at a position in the
flexible C-terminal domain that is known to not interact with the membrane. Therefore,
the fluorescence observed in binding experiments is not an artifact contributed from
fluorophore-membrane interactions.
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3.4

Association and dissociation of α-synuclein on DOPS vesicles
First, to study α-synuclein-membrane association using confocal microscopy,

individual giant unilamellar vesicles (GUVs) were transferred from a GUV dispersion into
a protein solution to determine the protein’s membrane binding equilibrium (Figure 3.2a).
In this experiment, the individual GUV is protected by an outer capillary. Once the GUV
is transferred into the protein solution, the capillary is carefully removed, releasing the
GUV and its surrounding buffer layer. This buffer layer slows down protein association
and equilibration, and α-synuclein-membrane equilibration occurred within 10 minutes for
pure DOPS GUVs (Figure 3.2). The kinetics measured are apparent values for this system
since minute changes in the set-up can influence how quickly the protein can bind. For
example, the varying amounts of surrounding buffer layer will slow down protein
association and equilibrium differently. Interestingly, the association rate is not influenced
by membrane tension. Transfer experiments were performed with a tension range of 0.05
– 0.25 mN/m, which have an apparent association rate and standard error of the mean
(SEM) are 0.035 ± 0.0066 s-1 (Figure 3.2a). In comparison to stopped-flow binding

kinetics121, α-synuclein’s rate of binding is > 10,000-fold greater for highly anionic charge
vesicles measured in our GUV transfer assay.

The significantly different kon(app)

measurements are influenced by experimental set-up, including size of vesicles, lipid-toprotein ratios, buffer conditions/salt content, and unstirred buffer layers.
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Figure 3.2. Apparent binding kinetics using a GUV transfer assay of α-synuclein on
highly negatively charged membranes.
Acetylated α-synuclein S9C labeled with Alexa Fluor® 488 was used in these
experiments. a) A schematic diagram showing the vesicle transfer assay for protein
association, red = GUV dispersion; green = protein solution: 1) GUV aspiration; 2)
GUV protection with capillary cover; 3) transfer of GUV from GUV dispersion into
protein solution; 4) removal of protecting capillary to initiate protein binding.
Representative graphs of association of α-synuclein at different protein concentrations
measured on 99.7 mol% DOPS and 0.3% Texas RedTM-DHPE and fit with a one phase
association (black line), where kon(app) = 0.035 ± 0.0066 s-1 (SEM = 22). b) A

schematic diagram showing the vesicle transfer assay for protein dissociation into a
SUV reservoir. Dissociation of α-synuclein on 99.7 mol% DOPS and 0.3% Texas
RedTM-DHPE, where koff(app) is determined by a single exponential fit (black line) and
is dependent upon the amount of free membrane lipid available. The dissociation time
increases with decreasing concentrations of SUVs, composition 100 mol% DOPS,
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present. For 0 µg/mL SUVs, koff(app) is 0.0094 s-1 (1 trial), 20 µg/mL SUVs, koff(app) is
0.0018 s-1 (1 trial), 50 µg/mL koff(app) is 0.0005 ± 0.0002 s-1 (SEM = 2).
The apparent dissociation rate of α-synuclein was also determined in a similar GUV
transfer assay. Here, we initially pre-equilibrated α-synuclein and pure DOPS GUVs in a
microcentrifuge tube for at least 10 minutes before transferring to our confocal microscopy
chamber set-up (Figure 3.2b). We then transferred an α-synuclein-coated GUV into a SUV
(100% DOPS) reservoir ranging from 0 – 50 µg/mL lipid. The apparent dissociation rate
of α-synuclein increased 5-fold in the presence of 20 µg/mL SUVs and 18-fold in the
presence of 50 µg/mL SUVs when compared to transferring into buffer only. Therefore,
the dissociation of α-synuclein from membranes is likely to be highly dependent upon an
increase of specific binding partners.
3.5

Osmotically inducing tension leads to an increase of maximal α-synuclein

density on DOPS vesicles
The membrane is considered under negligible membrane tension when the
osmolarities of the vesicle interior and exterior are equal. Under hyper-osmotic conditions,
the vesicle exterior has a greater concentration of solutes than the vesicle interior.132 The
GUV will deform and become non-spherical under these conditions.132 Meanwhile, a GUV
will become tense under hypo-osmotic conditions, where the solute concentration is greater
in the vesicle interior than the exterior.132 Binding of α-synuclein to 100 mol% DOPS
membranes under negligible and osmotically induced tensions was observed to follow the
Langmuir adsorption isotherm (Figure 3.3a and parameters in Table 3.1). α-Synuclein
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favors negatively charged lipids with smaller head groups and poly-unsaturated tails, which
allows for AH insertion into the membrane.51, 54 The values obtained in this experiment
are comparable to literature affinity values of α-synuclein to model membranes (Table 3.2),
and they are in close agreement to a similar GUV binding assay by Stockl et al133. αSynuclein’s membrane binding affinity is greatest for small unilamellar vesicles (SUVs),
which have large packing defects allowing for deeper membrane insertion, and SUVs are
similar in size to synaptic vesicles.80

Figure 3.3. Binding of α-synuclein measured from Langmuir binding isotherm assays
with osmotically induced membrane tensions and individual GUV transfer assays.
a) Langmuir binding isotherm of α-synuclein on pure DOPS (99.7/0.3=DOPS/ Texas
RedTM-DHPE) GUVs under different osmotically induced membrane tensions with
buffer conditions: 50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP, pH 7.4, 117 mM
sucrose, and the glucose concentration was adjusted to tune osmotic stress. Three
individual trials were performed for each osmotic condition, error bars are SEM. b)
Individual GUV transfer assay (99.7/0.3=DOPS/ Texas RedTM-DHPE) performed
under different protein concentrations and varied membrane tension. Buffer conditions:
117 mM sucrose, 117 mM glucose, 50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP pH
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7.4. Dotted and dashed lines indicate trend: more α-synuclein binds as tension is
increased. Overall density is not influenced by bulk protein concentration. Acetylated
α-synuclein S9C labeled with Alexa Fluor® 488 was used in these experiments.

Table 3.1. Langmuir fit parameters from Figure 3.3.

-2

ρmax (µm )
KD (nM)

Iso-osmotic

Hypo-osmotic

Hyper-osmotic

18,700 ± 1,100

22,300 ± 830

20,200 ± 1,400

610 ± 80

650 ± 40

710 ± 100

Three independent Langmuir binding isotherms were measured for each condition. All errors (±) are the
standard error determined by fitting in GraphPad Prism software.

Table 3.2. Literature survey of α-synuclein-membrane binding affinities determined
from different biophysical methods and model membrane systems
Membrane
Size

93 nm

46 nm
77 nm
116 nm
162 nm
> 1 mm
100 nm

Membrane
Composition
POPA/POPC (1:1)
POPS/POPC (1:1)
POPG/POPC (1:1)
POPC
DPPG/DPPC (1:1)
DPPC

KD (µM)

Biophysical
Method

1.60 ± 0.49
100 ± 5
128 ± 11
1,690 ± 210 Fluorescence
48 ± 12
correlation
spectroscopy
241 ± 137
(FCS)
5.7 ± 1.3
75 ± 14
POPS/POPC (1:1)
169 ± 6
136 ± 39
DOPS/DOPC (7:3)
~0.5
GUV binding
DOPS/DOPC (1:1)
~0.625
assay
DOPS/DOPC (3:7)
~0.77
POPS
1.556 ± 0.32
Fluorimetry
POPC
1.645 ± 0.50

Reference

80

133
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Here, we find α-synuclein binding affinity is independent of membrane tension on
highly negatively charged DOPS vesicles (Figure 3.3a, Table 3.1). The dissociation
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constants for all three tensions are within statistical error based on the fitting to a standard
Langmuir binding model (Table 3.1). However, the values for maximal protein density
changes with osmotically induced tension. When we compare ρmax for negligibly tense
membranes (iso-osmotic) with relaxed (hyper-osmotic) membranes, the maximal density
is within the statistical error. Therefore, the maximal binding of α-synuclein is similar for
membranes at negligible tension or at ˗0.25 mN/m. However, there is an observed increase
in ρmax density for hypo-osmotic membranes when compared with hyper- and iso-osmotic
conditions. Specifically, there is a 10% and 20% increase in ρmax density for α-synuclein
on tense (hypo-osmotic) membranes when compared to hyper- and iso-osmotic
membranes, respectively.
Similarly, to study the effect of membrane tension on protein equilibrium density,
individual GUVs held under varied membrane tensions controlled by pipette aspiration
were transferred into chambers with different concentrations of α-synuclein (Figure 3.3b).
Here, we find that there is an overall increasing trend of greater α-synuclein binding with
increased membrane tensions. Therefore, we hypothesize that α-synuclein is a membrane
tension sensing protein. α-Synuclein monomers favor tenser membranes and hence will
dissociate when tension is lowered in a reversible process.
3.6

α-Synuclein can respond to large tension jumps
To study α-synuclein interactions with membranes under varied lateral tension, we

used individual pipette-aspirated GUVs that were previously incubated for at least 15
minutes with the monomeric protein labeled with Alexa Fluor® 488 so that the protein
reached a density equilibrium. A single GUV was aspirated, and the suction pressure was
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applied to alternate between high and low membrane tension (Figure 3.4a). For vesicles
containing 100 mol% DOPS, α-synuclein does not reversibly bind and unbind to vesicles
when membrane tension is altered (Figure 3.4a).

Figure 3.4. α-Synuclein responds to tension changes on membranes with 45 mol% DOPS
but not 100 mol% DOPS.
Fluorescence intensity data were fit with a Gaussian ring at the equatorial plane in xyplane images over the time course of the experiment. Acetylated α-synuclein S9C is
labeled with Alexa Fluor® 488. Buffer conditions: 117 mM sucrose, 117 mM glucose,
50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4. a) Large tension jumps were
applied to a vesicle with α-synuclein pre-equilibrated on GUVs with 99.7 mol% DOPS
and 0.3% Texas RedTM-DHPE. α-Synuclein protein density remains largely unchanged
when tension jumps were applied.

b) Tension-dependent binding pattern of α-

synuclein to a GUV with composition 45 mol% DOPS, 30 mol% DOPE, 24.7 mol%
DOPC, and 0.3% Texas RedTM-DHPE.
Next, we altered the lipid composition by reducing the total amount of negative
charge, thereby making it more biologically relevant to the inner leaflet of the plasma
membrane.75 We incubated α-synuclein with 45 mol% DOPS, 30 mol% DOPE, and 25
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mol% DOPC and applied large tension jumps, and we find that α-synuclein density
responds to the applied tension changes (Figure 3.4b). Binding of α-synuclein to 45 mol%
DOPS membranes under negligible tensions was also observed to follow the Langmuir
adsorption isotherm (Figure 3.5). α-Synuclein binding affinity is two-fold less for 45%
DOPS GUVs than 100% DOPS vesicles under negligible tension. Hence, α-synuclein’s
binding affinity is controlled by the total amount of negative charge, which allows αsynuclein binding to be susceptible to tension changes on the membrane (Figure 3.4b).
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Figure 3.5. Langmuir binding isotherm of α-synuclein.
Protein

density

measured

on

GUVs

with

composition

45/30/24.7/0.3

=

DOPS/DOPE/DOPC/Texas RedTM-DHPE under varied protein concentrations. Buffer
conditions: 117 mM sucrose, 117 mM glucose, 50 mM NaCl, 7 mM HEPES, 0.3 mM
TCEP pH 7.4. Acetylated α-synuclein E130C is labeled with Alexa Fluor® 488. The
data was fitted with the Langmuir binding isotherm equation: ρ0= ρmax/ (1 + KD/
-2

[αSyn]), where ρmax = 7710 ± 300 µm and KD = 1.1 ± 0.09 µM. In this experiment,
vesicles were freely floating (i.e. not pipette-aspirated) and assumed to be under
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negligible lateral tension. Error bars represent SEM from 4 independent Langmuir
binding experiments.
3.7

Evaluation of potential experimental artifacts
Reversible tension-dependent membrane binding shown in Figure 3.4b was not

consistently observed. Therefore, we sought to optimize our experimental set-up to
minimize potential artifacts that would impact our measurements of α-synuclein density on
the membrane. We evaluated potential z-drifts and photobleaching from our confocal setup. Additionally, we evaluated the binding behavior of labeled α-synuclein.
3.7.1

Tension-related protein density changes are not caused by artifactual z-drifts
In our confocal microscopy experimental set-up, we aspirate a single GUV in which

a suction pressure is applied through changes in a water-reservoir system.

The

micropipette is held with a motorized micropipette system that allows movement in x-, y-,
and z-directions. The plane in which we image GUVs can change over time due to
artifactual z-drifts or from mechanical movements in the set-up, such as
increasing/decreasing tension through the water reservoir system can lead to defocusing of
the GUV. As the imaging plane moves away from the equatorial plane, there is a decrease
in fluorescence intensity and radius of the GUV (Figure 3.6). The fluorescence distribution
of the XZ scans were obtained from the amplitudes of Gaussian ring fits to xy scans in
different z-planes. Since we observed the tension-related apparent density changes with
imaging conditions that were not influenced by GUV defocusing or drifting, we can be
confident that density changes are dependent upon α-synuclein acting upon the underlying
membrane and are not due to slight GUV focal plane fluctuations. We therefore concluded
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that the changes in protein density are due to α-synuclein sensing membrane tension. To
eliminate concerns from focal drifts in future experiments, images will be taken by XZ
confocal scans rather than XY scans.

Figure 3.6. Tension-related protein density changes are not caused by artifactual z-drifts.
The data shown in these images were all obtained from fluorescence images of Alexa
Fluor® 488 labeled acetylated α-synuclein E130C. a) Representative relationship
between the radius of a GUV and the protein density from a single XZ scan. The further
away from the equatorial plane, the smaller the apparent radius of the GUV. The circled
data point represents the equatorial radius. b) Summary of the relationship between the
equatorial radii with protein density for 15 GUVs. Data shown in a) represents one
data point in b). Error bars are SEM. The graph shows a stronger dependence for GUVs
with smaller radii. c) Representative relationship between membrane tension and
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equatorial radius from a single GUV at different membrane tensions. The linear fit is
represented by the dashed grey line; the slope is zero within statistical error. d)
Summary of the relationship between membrane tension and the equatorial radius for
15 GUVs. Each color represents a single GUV at the corresponding membrane tension.
Error bars are SEM. The linear fit is represented by the dashed gray line; the slope is
zero within statistical error. We conclude that there is no dependence on membrane
tension due to changes in the equatorial radii.
3.7.2

Photobleaching does not influence results from tension-dependent protein

density changes on membranes
Photobleaching of fluorescent dyes is a common phenomenon in fluorescence
microscopy. α-Synuclein is labeled with a highly photostable dye, Alexa Fluor® 488, but
photobleaching can still occur depending on the laser power intensity and exposure time.
We carefully excluded the possibility of photobleaching over the time course of these
experiments (Figure 3.7). α-Synuclein was incubated with a GUV dispersion, aspirated,
and imaged under the same conditions as the tension-changing measurements, and
therefore, the measured protein density values are not obscured by photobleaching.

Figure 3.7. Photobleaching does not influence tension-related density changes.
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a) Apparent protein density of acetylated α-synuclein E130C-Alexa Fluor® 488 remains
constant on 45/30/24.7/0.3 = DOPS/DOPE/DOPC/TR-DHPE GUVs over the same 488
nm laser exposure power and time as when tension is changed. Data points plotted are
the amplitude of a fitted Gaussian curve from an xz scan. b) Fluorescence intensity
used for tension-change experiments is within the linear regime (0 – 1% power of 488
nm laser).
3.7.3

α-Synuclein overshoot versus self-quenching
A potentially interesting phenomenon is observed during α-synuclein binding with

our aspirated GUV transfer experiments, shown in Figure 3.8 and experimental set-up
shown in Figure 3.2a. α-Synuclein fluorescence intensity changes, during GUV aspiration
experiments measuring protein-membrane binding, are not always observed to follow a
time dependence that can be described by a single exponential function. In some cases, we
observed α-synuclein binding to reach a maximal density which is then followed by a
decrease in intensity, described here as an overshoot density. This phenomenon has been
observed for all protein concentrations and applied membrane tensions for both tested lipid
compositions (100% DOPS and 45/30/25=DOPS/DOPE/DOPC), but not in 100% of GUV
transfer assays, which will be discussed later in this section. In Figure 3.8b, the 488 nm
laser was periodically turned off to determine if the decrease in intensity was a
photobleaching effect. The intensities measured after the laser is turned off do not recover
and instead continue to decay in the grey data points (Figure 3.8b). Therefore, this
observed overshoot is not due to photobleaching.
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Figure 3.8. Representative time traces of α-synuclein GUV transfer association assays.
a) α-Synuclein binding to GUVs can results in two different binding phenomena,
which is observed for both 100% DOPS and 45/30/25=DOPS/DOPE/DOPC GUV
compositions. In the first (black circles), α-synuclein binds to the GUV and then
reaches a plateau, which can be fit with a single exponential (black line). In the second
case (grey squares), described as an overshoot, α-synuclein binds to the GUV, reaches
a maximal protein density and then is followed by a decrease in fluorescence intensity.
This overshoot phenomenon is observed both in a wide range of protein densities (0.1
– 1 µM) and membrane tensions (0.05 – 0.50 mN/m). In this graph, association
measurements were taken at 100 nM α-synuclein. b) Representative time traces of the
overshoot density, or the decrease in fluorescence intensity over time. The red arrow
represents the time the laser was turned off from the experiment. The protein density
is expected to recover, i.e. an increase in fluorescence intensity, if photobleaching of
the fluorophore occurred. A significant decay in fluorescence intensity is observed for
the gray data points and a slight decrease in fluorescence intensity in the black data
points; therefore, the overshoot is not due to photobleaching.

The decrease in

fluorescence observed occurs at different times points (< 3 minutes to 25 minutes). The
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black circles represent an experiment performed at 0.38 mN/m and the grey squares is
0.06 mN/m. Acetylated α-synuclein S9C is labeled with Alexa Fluor® 488.
This overshoot binding curve may be an interesting result of a process of membrane
catalyzed monomer to oligomeric α-synuclein conformational change, with the following
kinetic scheme: αSynmonomer + Lipid ↔ αSynLipid ↔ αSynoligomer. Alternatively, we

considered if this overshoot phenomenon of α-synuclein binding behavior is a fluorescence

self-quenching artifact (Figure 3.9). Fluorescence self-quenching is a phenomenon where
the fluorophore and quencher are the same molecule type, in this case Alexa Fluor® 488
labeled α-synuclein. Self-quenching is particularly evident at high concentrations of
fluorophores.134 Furthermore, self-quenching over time is a known phenomenon of
monomeric and fibrillized α-synuclein labeled with fluorescein (an Alexa Fluor® 488
structurally related dye).135 In our GUV transfer association experiments, α-synuclein
monomers bind to the membrane, which leads to an increase in protein density and
proximity between monomers. The α-synuclein monomers may be in an optimal position
for self-quenching on the membrane at high protein densities. Figure 3.10 supports this
hypothesis of α-synuclein fluorescence self-quenching. As we decrease the amount of
fluorophore in the sample, we no longer see the overshoot phenomena, and therefore the
overshoot density is likely due to fluorophore self-quenching.
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Figure 3.9. Association of α-synuclein while varying the amount of labeled protein using
a GUV transfer assay to access the overshoot phenomenon.
A single GUV is transferred into a solution containing a) 60%; b) 12%; and c) 6%
labeled α-synuclein. As the amount of labeled α-synuclein decreases, this decrease in
fluorescence over time (overshoot phenomenon) is not observed, evidence of selfquenching. α-Synuclein E130C is labeled with Alexa Fluor® 488.
Since α-synuclein is an intrinsically disordered protein, minuscule differences in
how the protein is purified and prepared for experiments, including the age of the protein
once thawed, may lead to differences in the microstates of the protein and ultimately lead
to the overshoot effect in Figure 3.8. Furthermore, the degree of α-synuclein binding is
dependent upon lipid charge. GUV heterogeneity can result from inhomogeneous lipid
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mixing136 or electrofusion of vesicles to form GUVs with unknown lipid compositions137.
Therefore, the nominal DOPS composition may vary from the actual amount. If there is a
higher percent of DOPS compared to the nominal percent, this can lead to an increase in
labeled protein bound to the membrane and hence, more self-quenching. Moreover, since
increasing membrane tension may lead to more α-synuclein binding resulting in a higher
α-synuclein density on the membrane, this could lead to self-quenching and an artificially
lower measured protein density at high tensions. Therefore, if self-quenching occurs
during the tension jump experiments, we may not observe any protein density related
changes, resulting in a false negative experiment.
3.8

Evaluation of a biophysical function of α-synuclein as a membrane tension

sensing protein
Membrane tension of each aspirated GUV was varied over a period of time (< 2
hours), and α-synuclein number density was recorded on the membrane at each membrane
tension. We included a 10-minute incubation time at each tension step before imaging,
which ensured equilibration (Figure 3.10). We used a lipid mixture containing DOPS,
DOPE, and DOPC to approximate the inner leaflet head group composition of a cellular
plasma membrane. Membrane tension was accurately adjusted via the pressure difference
between the inside and outside of the GUV, as well as the radius of the pipette and the
GUV with a total tension range of 0.067 – 0.78 mN/m. Tensions above 0.80 mN/m
frequently resulted in ruptured vesicles during the comparatively long time course of our
experiments and where therefore avoided.
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Figure 3.10. α-Synuclein protein density equilibrates on the membrane in < 2 minutes
after a tension increase or decrease.
Data represents tension-dependent binding of α-synuclein to a representative GUV with
composition 45/30/24.7/0.3 = DOPS/DOPE/DOPC/TexasRedTM-DHPE and allows for
measurement of the protein membrane association equilibration time.
We then imaged, through xyz (3-D) scans obtained with a confocal microscope, αsynuclein on GUV membranes held at variable tensions (Figure 3.11). We used xyz scans
to determine protein densities in order to avoid any mechanical drifts contributing to errors
in fluorescence intensity measurements from xy (2-D) scans. Figure 3.11a demonstrates an
increase in protein fluorescence when tension is increased. The fluorescence images of the
xyz scans were quantified using scripts written in MATLAB fitting the GUV with a
Gaussian ring. The amplitude of the Gaussian ring was then plotted as a function of zposition and fit with a Gaussian function, where the protein density at the equator was
determined by the amplitude of the Gaussian (Figure 3.11b.) An increase in membrane
tension leads to an increase in α-synuclein number density on the membrane, and
subsequently a decrease in membrane tension leads to less α-synuclein bound to the
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membrane (Figure 3.11c). Tension-related protein density changes from xy (data not
shown) and xyz scans both gave statistically significant differences (p < 0.01) in the protein
channel, but not in the lipid channel (Figure 3.11c-d), as expected. Therefore, in this case,
α-synuclein senses membrane tension changes.

Figure 3.11. α-Synuclein density on the membrane can respond to tension changes.
a) Xy slices from xyz confocal scans show an increase in protein fluorescence intensity
comparing low and high membrane tensions. α-Synuclein is labeled with Alexa Fluor®
488, while the GUVs are labeled with Texas RedTM-DHPE. Scale bars are 5 µm. b)
Representative xyz scan measurement of apparent protein density at different z-planes
fitted with a Gaussian function. c) Tension-dependent binding of α-synuclein to a
representative GUV with composition 45/30/24.7/0.3 = DOPS/DOPE/DOPC/TRTM76

DHPE, where fluorescence intensity data are the amplitudes of Gaussian distribution
functions fitted to the amplitudes of Gaussian ring fits to xy images at different z planes.
The density values at each tension are different with statistical significance (p < 0.05)
using an unpaired Student’s t-test. d) Lipid fluorescence is also shown where values
are not statistically significantly different (p > 0.05) using an unpaired Student’s t-test.
As previously mentioned, binding of α-synuclein to membranes under negligible
tension was observed to follow the Langmuir adsorption isotherm (Figure 3.5). We
determined the area expansion constant through the linear function defined in Eq 3.6, where
ρ is protein density and ρmax its maximum, ∆𝑎 is the area expansion constant, and KD is the

dissociation equilibrium constant (derivation of area expansion equation from Dr. Zheng
Shi and Dr. Tobias Baumgart):
Pipette-aspirated GUVs are held under a suction pressure ΔP that can be related to

the lateral tension  of the membrane with the help of measured pipette radius Rp and the
vesicle radius Rv:
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σ = ∆𝑃 �(���
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(3.1)

Under the conditions of our experiment, the vesicle volume is constant. Therefore,
the binding to the GUV membrane of a protein that increases membrane area per molecule
by an amount a , results in a mechanical work per molecule of a that decreases the
free energy of the GUV. Accordingly, the chemical potential of such a membrane-bound
protein can be expressed as

m m0  kT ln
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1

 a

(3.2)

In this expression, m0 is a reference potential, and the middle term is an entropic
contribution assuming saturable binding in the absence of interactions among binding sites
(i.e. Langmuir-type binding, k is Boltzmann constant, T is temperature, and  is fractional
coverage.
The chemical potential of proteins in solution is expressed as:


s0  kT ln c
s

(3.3)

Here, s0 is a standard chemical potential and c is the bulk solution concentration
(relative to the reference concentration) of the protein. At binding equilibrium one finds:

  0  m0  a  1    c
exp   s

kT




(3.4)

where the left-hand side can be interpreted as an effective equilibrium constant for
dissociation of the protein from the membrane affected by membrane tension. Defining a
dissociation constant in the absence of lateral tension as
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results in

Here, the fractional coverage has been expressed as     max , where the
maximal membrane binding density (proteins per membrane area)  max is assumed to not
be membrane tension dependent.
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We note that this model assumes tension to affect the thermodynamic binding
constant KD, but to not affect the maximal binding density. Although this remains a model
assumption yet to be verified, we believe that this assumption is reasonable given the small
area expansion of the bilayer upon application of tension. Given a typical area expansion
modulus of on the order of 200 mN/m, a tension of 0.2 mN/m is expected to lead to an area
expansion on the order of 0.1%. This implies that the membrane packing defect density,
which is commonly assumed to affect peripheral protein binding138, can be regarded as
remaining essentially constant.

Figure 3.12. Overview of α-synuclein protein density response to changes in membrane
tension of 12 individual GUV experiments.
A re-scaled relationship between α-synuclein density and membrane tension of pipetteaspirated GUVs indicates that α-synuclein expands membrane area from ~2-20 nm2.
The grey dashed line represents a linear fit based on equation 3.6 using a ρmax value of
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7710 µm-2 (from Figure 3.5), with a slope = 4.6 ± 0.3 nm2, y-intercept = 0.85 ± 0.022,
and R2 = 0.99.

We can directly fit this linear function between ln �
-2

����
�

− 1� and membrane

tension, using a ρmax value of 7710 µm determined from the binding data shown in Figure
3.5, with the slope directly related to the area expansion constant (Figure 3.12). On average,
for 12 GUVs with a nominal composition of 45/30/24.7/0.3 = DOPS/DOPE/DOPC/Texas
RedTM-DHPE, the membrane area expansion constant was determined to be 7.7 ± 1.9 nm2
(average ± SEM) with a standard deviation of 6.7 nm2, and a range of 1.9 ± 0.35 to 19.1 ±
2 (uncertainties here are standard errors of the linear fit). Therefore, while this range is
large, values were always found to be positive with statistical significance.
Possible reasons for the large range include variations in the lipid composition of
individual vesicles. We have not found systematic effects based on bulk protein
concentration or vesicle radius. Furthermore, an accurate protein density is critical to
determine the area expansion constant, and correct intensity measurements and
conversions are influenced by a variety of factors. If fluorescence self-quenching does
occur while measuring α-synuclein membrane binding, this would arbitrarily lower the
measured protein density when we increase membrane tension and the resulting area
change. Additionally, there have been two different methods for calibrating the 488 nm
laser (mentioned in more detail in Chapter 2.4), using GUVs and supported lipid bilayers
(SLB) on silica microspheres. In the latter method, the fluorescence intensity could be a
measurement of a single SLB or many, thereby artificially leading to an inaccurate
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calibration factor. Moreover, the greater the distance of the pipette from the objective lens
will also lead to an artificial decrease in fluorescence intensity, and therefore inaccurate
protein density calculations if not correctly adjusted.
3.9

Tension sensitivity is not a biophysical parameter of all peripheral membrane

proteins
Next, we asked the question if tension sensitivity is coupled with membrane
insertion of the peripheral membrane protein.

The cholera toxin subunit B (CT-B)

pentamer is known to bind to the surface of membranes through specific interactions with
the saccharide moiety on the GM1 ganglioside but is known not to insert into the
membrane.139 We carried out aspirated GUV experiments in the presence of cholera toxin
subunit B, and we did not observe tension sensitivity of CT-B upon binding to GM1-rich
membranes under varied membrane tensions (Figure 3.13). This observation is consistent
with the notion that tension sensitivity is absent for a protein that does not show membrane
wedging.

Figure 3.13. Cholera toxin B does not respond to tension changes on membranes.
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A representative graph of CT-B protein density on GUVs with composition 94.7/5/0.3
= DOPC/GM1/Texas RedTM-DHPE. The density values at each tension are not
statistically significance (p > 0.05) using an unpaired Student’s t-test.
3.10

Implications of α-synuclein’s tension responsiveness
α-Synuclein membrane interactions are believed to be critical for both its

physiological and pathological role in the central nervous system. Its aggregation into
Lewy bodies is related to Parkinson’s disease, a neurodegenerative movement disorder
characterized by the loss of dopaminergic neurons.140 Numerous studies suggest that αsynuclein plays a role in neurotransmission and may play a critical role in synaptic vesicle
trafficking since it is localized in the cytosol at presynaptic terminals and found at
micromolar concentrations in neurons (~40 µM).57
Membrane tension is linked to the membrane dynamics of cellular trafficking.
Lateral in-plane tension has previously been measured for cells of different types, ranging
from 0.003 mN/m for neuronal growth cones to over 0.08 mN/m in a confluent monolayer
of MDCK (kidney) cells to 0.5 mN/m for adherent motile cells.67, 141, 142 In-plane tension
is modulated through various stresses, and local changes in membrane tension are used to
control flux of membrane area changes through endo- and exocytosis. Previously
examining in-plane lateral tension of cells through tether-pulling experiments, authors
modulated cellular tension of rat basophilic leukemia cells (RBL) through osmotic swelling
and shrinkage.62 The authors quantified the changes in membrane tension corresponding
to secretion and endocytosis to be 0.008 mN/m to > 0.5 mN/m while the resting in-plane
tension was determined to be 0.025 mN/m.62 The tension values used to evaluate α82

synuclein’s response to changes in lateral tension in this contribution therefore are
biologically relevant. Thus, if α-synuclein functions as a membrane tension sensing
protein, local changes in membrane tension can influence α-synuclein affinity to the
membrane and its potential remodeling ability.
In summary, we found that α-synuclein may function as a membrane-tension
dependent peripheral membrane binding protein through osmotically changed membrane
tensions. In GUV aspiration experiments, the tension responsiveness of membrane binding
is not fully clear. Further experiments are necessary to evaluate whether the tensionresponse is thermodynamically consistent with our earlier characterization of α-synuclein’s
membrane area expansion during protein association85 by determining the extent selfquenching influences α-synuclein’s membrane density. Future experiments will use preequilibrated α-synuclein GUVs, with fluorescently labeled and dark protein.

The

combined use of dark and labeled protein will lower the probability of self-quenching, thus
the measured density will be more accurate.
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Chapter 4: Evaluating the influence of membrane tension on FBP17 membrane
curvature sensing and generation
The formin-binding protein 17 (FBP17) is a homodimeric F-BAR protein that
regulates cell membrane shape by inducing positive curvature, or bending of the membrane
away from the sides of the protein, upon the association with negatively charged
phospholipids.50 The domain structure of FBP17 is depicted in Figure 4.1a. FBP17 is a
member of the highly homologous Toca subset of F-BAR proteins, which includes Toca1 and CIP4 (Toca-3).143 The N-terminal region of the Toca family consists of the extended
Fes/CIP4 (FC) domain (EFC), including a coiled-coil region and a Cdc15 homology
domain.143 This EFC domain weakly resembles the canonical BAR domain structure.144
The elongated homodimeric BAR domain crystal structure of FBP17 is shown in Figure
4.1b. After the EFC domain, there is a linker region containing a poly-basic stretch of
amino acids and a proline-rich region followed by an HR1 (a GTPase) binding region and
the protein interactive Src Homology 3 (SH3) domain.143 There are multiple splice variants
of FBP17 with differing lengths of the intrinsically disordered linker region (IDR).145
In the in vitro studies described in the following sections, we use the FBP17 gene
construct termed FBP17s, or FBP17 short. This alternative splice variant is missing the
proline rich IDR (~90 residues). The poly-PXXP region in the longer splice isoform has
recently been linked to regulating subcellular localization.145 However, the EFC domain is
sufficient for both in vitro and ex vivo membrane curvature sensing and generation.144
Additionally, both splicing isoforms with and without the poly-PXXP region can tubulate
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membranes.144 Therefore, the shorter splice variant (FBP17s) is not expected to
substantially influence FBP17 membrane curvature generation in vitro.

Figure 4.1. Domain and crystal structures of FBP17.
a) The BAR domain of FBP17 comprises the first ~300 amino acids, which include the
Fes/CIP4 (FCH) homology domain, the coiled-coil (CC) region, and the Cdc15
homology domain. This region is also termed as the extended FC or EFC domain of
FBP17. Directly following the EFC domain, there is a poly-basic region and an
intrinsically disordered proline-rich sequence. FBP17 also contains an HR1 domain,
or protein kinase C-related kinase homology region (a GTPase), which can bind to
Cdc42, and an SH3 domain known to interact with actin-associated protein, N-WASP.
b) The crystal structure of the BAR domain of FBP17 (PDB: 2EFL) shows an elongated
curved scaffold domain.
Cellular trafficking is associated with the formation of transient membrane
deformations and highly curved structures.146 FBP17 is known to couple membrane
curvature generation with cytoskeletal function, which is also a critical modulator of
membrane remodeling.147 FBP17 membrane recruitment and subsequent actin
polymerization is depicted in Figure 4.2. FBP17 is recruited to the membrane by signaling
lipid, PIP2, and other anionic lipids.148

FBP17 accomplishes membrane-cytoskeletal
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coupling through its C-terminal SH3 domain.148 This SH3 domain recruits, binds, and
activates Wiskott-Aldrich syndrome protein/ Neural Wiskott-Aldrich syndrome protein
(WASP/N-WASP) proteins, which are crucial factors in actin nucleation and Arp2/3
dependent branched actin polymerization.50

Figure 4.2. FBP17 provides a critical link between the plasma membrane and the
cytoskeleton.
FBP17 activates actin polymerization through association with N-WASP, thereby
unlocking the inactive Wasp interacting protein (WIP): N-WASP complex. WIP is now
free to initiate (non-branched) actin polymerization. Meanwhile, Arp2/3 dependent
branched actin polymerization is activated through the concerted action among FBP17,
GTPase Cdc42, PIP2, and N-WASP. This figure was adapted from Aspenstrom.149
The molecular mechanism of membrane shape deformation and regulation has not
yet been fully elucidated for F-BAR proteins. FBP17 has been shown to play a key role in
coupling membrane tension with leading edge formation during cell migration through
localization at the membrane as well as coupling actin nucleation and assembly.49 As
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previously mentioned in Chapter 3, the underlying mechanism of membrane tension in the
regulation of cellular function is still unknown.131 Tension plays a mechanical role by
regulating the amount of force necessary to deform the membrane throughout the whole
cell.65, 131 Furthermore, membrane tension is likely involved in maintaining membrane
area homeostasis, through the balancing of endo- and exocytosis.59 Higher membrane
tension leads to an increase in exocytosis and subsequently acts to decrease membrane
tension, while endocytosis is initiated by lower membrane tension and acts to increase
tension.59
As stated previously in Chapter 1, BAR proteins are intricately involved in clathrinmediated endocytosis150 and understanding BAR protein membrane curvature sensing and
generation in respect to membrane tension may help in understanding BAR protein
recruitment and involvement in this process. FBP17 is an important regulator of cell
membrane shape coupled with cytoskeletal function.41 Therefore, an understanding of the
mechanism of shape transitions induced by BAR proteins and its modulation through actin
polymerization will contribute significantly to the broader field of membrane biophysics
and biochemistry.
In the research thrust described in this chapter, we aimed to develop a model for
the molecular basis of the function of F-BAR protein FBP17 as a plasma membrane tension
sensor. Possible mechanisms of FBP17 function (depicted in Figure 4.3) include i) that
FBP17 binding affinity decreases with increasing membrane tension (Figure 4.3a), and
therefore decreasing tension will increase FBP17 concentration on the membrane and
recruit N-WASP for actin polymerization; and alternatively ii) that local increases in
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membrane charge can induce FBP17 to locally aggregate (through lateral diffusion) on the
membrane and this increase in protein density can generate a membrane shape transition
(Figure 4.3b).

Figure 4.3. Mechanistic depiction of curvature sensing and generation by FBP17 as a
tension sensing protein.
a) FBP17 (purple) membrane density is greater under low membrane tension (σ).
FBP17 will generate curvature, as seen by the invaginated pit from the plasma
membrane (PM – dark grey) and will recruit N-WASP (red oval) to the membrane
(left). N-WASP recruitment ultimately leads to branched actin filament (small dark
blue circles) formation by Arp2/3 (light grey). Under increased membrane tension
(right), FBP17 weakly binds to the membrane, which prevents actin polymerization.
This figure was adapted from Tsujita et al.49 b) FBP17 favorably binds to anionic
lipids, such as PIP2 (yellow) and phosphatidylserine (PS – red), and zwitterionic
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phosphatidylcholine (PC) is shown in blue. When FBP17 membrane density is
sufficiently high, usually associated with a highly negative membrane charge and low
membrane tension, FBP17 can generate membrane curvature (left). High protein
density can lead to an immobile FBP17 coat due to strong protein-protein association
and can either stabilize tubule formation or prevent tubule formation.

FBP17

membrane density is low with lower amounts of negatively charge lipids available, and
therefore FBP17 can laterally diffuse across the membrane, which is indicated by the
double arrow (right).
The molecular protein density on membranes is intricately connected to membrane
tension and cooperation between these two phenomena can initiate membrane
remodeling.87 Therefore, we must assess FBP17’s ability to sense and generate curvature
under negligible membrane tensions. We generate Langmuir binding isotherms of FBP17
on membranes with and without PIP2 and subsequently determine the effect of N-WASP
on FBP17 membrane binding. Furthermore, we assess FBP17’s tension sensing ability
through inducing tension through osmotically shocking GUVs and subsequently
quantifying FBP17 protein density on the membrane. We then evaluate the curvature
generation capacity of FBP17 by employing techniques such as confocal microscopy,
micropipette manipulation, and transmission electron microscopy and show that membrane
tension inhibits tubule formation (i.e. curvature generation). Additionally, we demonstrate
that curvature generation can be facilitated by the presence of cholesterol.
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4.1

Characterization of membrane curvature sensing of FBP17 through confocal

microscopy
4.1.1

Membrane binding ability of FBP17 in the presence of PIP2
The EFC domain of FBP17 has been previously identified as a novel

phosphoinositide binding module.144 FBP17 was determined to preferentially bind to
PI(4,5)P2 lipids, herein denoted as PIP2, as well as phosphatidylserine (PS).144 We sought
to address FBP17’s binding affinity to membranes with and without PIP2 (Figure 4.4a).
FBP17 was added at varying concentrations in the presence of GUVs, where the negative
charge of the membranes remained constant at ˗45 per 100 lipids. The two membrane
compositions used were: i) 45% DOPS/ 30% DOPE/ 25% DOPC; and ii) 30% DOPS/ 30%
DOPE/ 35% DOPC/ 5% brain PIP2. Here, we assume PIP2 having a net charge of ˗3 even
though the charge of the lipid can become < ˗3 based on its environment.151-154 The data
was then fit with the Langmuir binding isotherm and parameters are shown in Table 4.1.
In agreement with literature values144, FBP17 has a strong binding affinity (< 100 nM) for
membranes with and without PIP2 and a high negative charge content. However, the
maximum binding density of FBP17 is 16% less for PIP2 containing membranes than
without PIP2. There are two possible reasons for the discrepancy in binding to membranes
that have the same nominal charge. Firstly, the area of the PIP2 head group is larger than
PS, and the elongated dimeric membrane binding interface of FBP17 is limited in its ability
to bind multiple large PIP2 head groups than the smaller PS head group. Secondly, the
total negative charge content is not equivalent despite the same nominal charge for each
membrane composition. The effective incorporation of PIP2155 and asymmetric desorption
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of PIP2156 can result in a lower percent of PIP2 in the membrane, thereby lowering the
amount of negative charge and decreasing the maximal density of FBP17 membrane
association. In experiments with PIP2 membranes, brain PIP2 was used, which has
previously been shown to leach from the membrane and generate internal tubules.156
Generation of spontaneous curvature from our GUVs can lead to misinterpretation when
studying curvature generating proteins, such as FBP17, on those membranes.

The

spontaneous curvature of FBP17 on membranes that are asymmetric and spontaneously
generate curvature has not been previously characterized, and we must consider the
spontaneous curvature of brain PIP2-containing membranes in our analysis.

Figure 4.4. Langmuir binding isotherms of F-BAR protein FBP17 with membranes
containing the same nominal charge but different lipids compositions.
a) Protein density measured on GUVs with composition 45/30/24.7/0.3 =
DOPS/DOPE/DOPC/TRTM-DHPE and 30/30/34.7/5/0.3 = DOPS/DOPE/DOPC/brain
PI(4,5)P2/TRTM-DHPE under varied FBP17 concentrations. Buffer conditions were
iso-osmotic with the GUV interior: 1:1:1 = 133 mM sucrose: 133 mM glucose: 50 mM
NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4. The data was fitted with the Langmuir
binding isotherm equation:  = max/ (1 + KD/ [P]), with fitting results summarized in
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Table 4.1. Error bars are SEM, n = 15. FBP17 binds with high nanomolar affinity to
both membrane compositions. b) Langmuir binding isotherm of FBP17 in the presence
of PIP2 containing membranes and a constant N-WASP concentration (250 µM), with
fitting parameters shown in Table 4.1.

Table 4.1. FBP17: Langmuir Binding Isotherm fit parameters from Figure 4.4.
Lipid Composition

KD (nM)

ρmax (µm-2)

- PIP2

50 ± 7

8,700 ± 280

+ PIP2

80 ± 10

7,300 ± 310

+ PIP2 / + N-WASP

100 ± 15

8,500 ± 310

All errors (±) are standard errors determined by fitting a single Langmuir binding isotherm in GraphPad
Prism software.

4.1.2

Membrane binding ability of FBP17 in the presence of actin nucleator N-

WASP
N-WASP is a key regulator of Arp2/3 dependent branched actin polymerization.157
N-WASP contains an N-terminal autoinhibition domain that regulates its function.158 This
autoinhibitory domain consists of a short basic region (B motif) and a GTPase binding
domain (GBD) that binds PIP2 and Cdc42, respectively.157

PIP2 and Cdc42 work

synergistically to activate N-WASP by disrupting the autoinhibitory interactions, thereby
allowing the C-terminal region of N-WASP (VCA domain) to carry out its core activity of
stimulating actin nucleation.157 The SH3 domains of F-BAR proteins (Toca-1 and FBP17)
bind to a proline rich region, located immediately before the VCA domain, and activates
the WIP: N-WASP complex cooperatively with PIP2 and Cdc42 (Figure 4.2).159
Understanding the binding ability of FBP17 on membranes and in the presence of actin
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nucleators will ultimately aid in understanding the molecular mechanisms for the key roles
they play in endocytosis and other cellular processes.
Due to the cooperative interactions between FBP17 and N-WASP during actin
polymerization in cells, we sought to understand the molecular mechanisms of FBP17 and
N-WASP membrane interactions. Previously, we have shown FBP17 binding behavior
decreases in the presence of PIP2 containing membranes. Next, we evaluated FBP17
binding in the presence of both PIP2 and N-WASP (Figure 4.4b). The addition of N-WASP
does not significantly change FBP17’s binding affinity for PIP2 membranes (Table 4.1).
However, the ρmax density of FBP17 on PIP2 membranes increases in the presence of NWASP. This increase in maximal protein density is likely due to N-WASP-mediated PIP2
interactions157, where FBP17 can bind to N-WASP through its SH3 domain148 in addition
to its BAR domain (with shallow curvature) binding to the bulky inositol group.
4.1.3

Membrane binding ability of N-WASP
One possible mechanism of curvature-dependent actin polymerization is the

recruitment of SH3 binding partners/actin nucleators through local increases of BAR
proteins at the membrane surface.148 Since N-WASP is known to bind to the membrane159,
N-WASP membrane recruitment should also be examined.
We used our GUV transfer assay and Langmuir binding isotherm assay to measure
the protein association of N-WASP to PIP2 containing membranes (Figure 4.5 a-b). NWASP weakly bound to PIP2 containing membranes in comparison with FBP17 binding
density (Figure 4.4a). The nanomolar affinity of N-WASP to PIP2 membranes is in
agreement with previously reported literature values.157 The protein density of N-WASP
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minimally changed (~200 µm-2) over a range of protein concentrations (100–1000 nM)
(Figure 4.5b). One explanation for this minimal membrane association may be due to the
ultrasensitive binding behavior of N-WASP to PIP2, where N-WASP responds in a switchlike manner to increases in PIP2 density.157 This switch-like activation of N-WASP in vitro
has previously been shown to occur at a PIP2 density above 12 mol%.157

Figure 4.5. N-WASP interactions with PIP2 containing membranes.
a) A representative GUV transfer assay in which a single GUV, with membrane
composition 30/30/34.7/5/0.3 = DOPS/DOPE/DOPC/brain PI(4,5)P2/BODIPYTMDHPE, was transferred into a chamber containing 250 nM N-WASP labeled with Alexa
Fluor® 594 (n= 3). b) Langmuir binding isotherm of N-WASP on 30/30/34.7/5/0.3 =
DOPS/DOPE/DOPC/brain PI(4,5)P2/BODIPYTM-DHPE from two independent
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experiments (n = 15 at each N-WASP concentration). The dissociation constant, KD is
determined to be 27 ± 6 nM while maximal protein density of N-WASP is 208 ± 11
µm-2. c) GUV transfer assay time traces of three individual GUV transfers, where a
single GUV, with membrane composition 30/30/35/5/0.3 = DOPS/DOPE/DOPC/brain
PI(4,5)P2/BODIPYTM-DHPE, was transferred into a chamber containing 250 nM
FBP17-Alexa Fluor® 488 and 250 nM – 1 µM N-WASP-Alexa Fluor® 594 (n=5). The
blue data points represent FBP17 protein density and the red data points are N-WASP
density. Data with the same shape ( , , ) refer to the same GUV transfer experiment.
In all transfer experiments, N-WASP protein density either increases 2-7-fold or
remains constant on membranes when FBP17 is present when compared with its
maximal protein density on 5 mol% PIP2 containing membranes. Buffer conditions
were: 1:1:1 = 133 mM sucrose: 133 mM glucose: 150 mM NaCl, 7 mM HEPES, 0.3
mM TCEP pH 7.4 for all experiments.
We then measured binding of both N-WASP and FBP17 on PIP2 containing
membranes using our GUV transfer assay (Figure 4.5c). The presence of FBP17 on
membranes influences N-WASP protein density to remain either constant or increases 27-fold when compared to the N-WASP maximal binding density at 5 mol% PIP2.
Therefore, the favorable recruitment of N-WASP through FBP17 may induce curvaturedependent actin polymerization.
4.1.4

Osmotically induced membrane tension influences FBP17 membrane affinity
It has been demonstrated that FBP17 responds to osmotically induced membrane

tension changes in cells.49 In response to an increase in plasma membrane tension, FBP17
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localizes to the leading edge of migrating cells.49 Our aim was to reconstitute this tension
sensitivity phenomenon in vitro to understand the molecular mechanism behind this
functionality. When the GUV interior and exterior experience differences in solute
concentrations, the GUV volume is adjusted so that it swells in hypo-osmotic buffer
(increase in tension) and deforms in hyper-osmotic buffer (decrease in tension).160
Individual Langmuir binding isotherm assays were measured with osmotically increased
membrane tension (Figure 4.6 a-e). The osmolality of the GUV interior was measured,
and the outer solution was adjusted to create a hypo-osmotic environment. We observe an
increase in the dissociation constant for FBP17 association with PIP2 containing
membranes as membrane tension is increased (Figure 4.6f). FBP17 binding affinity
decreases as membrane tension increases, in support of our hypothesis that high membrane
tension decreases curvature generation because less protein density is on the membrane.

Figure 4.6. Langmuir binding isotherms of FBP17 under osmotically increased
membrane tension.
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The Langmuir binding isotherm of FBP17 under increased membrane tension on GUVs
with composition 30/30/34.7/5/0.3 = DOPS/DOPE/DOPC/brain PI(4,5)P2/TRTMDHPE: a) 0.13 mN/m; b) 0.32 mN/m; c) 0.44 mN/m; d) 0.49 mN/m; e) 0.52 mN/m.
The final salt concentration was 50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4,
133 mM sucrose, and the glucose content varied to adjust tension osmotically. Error
bars are SEM, n = 15. f) Graph summarizing the relationship between the dissociation
constant, KD, and osmotically increased membrane tension of FBP17. There is a slight
increasing trend (red dashed line) that indicates as membrane tension increases
osmotically, membrane binding affinity decreases. Error bars are standard errors
calculated when fitted to the Langmuir binding isotherm equation using GraphPad
Prism.
Furthermore, we evaluated FBP17 curvature generation under osmotically induced
membrane tension through a TEM tubulation assay (Figure 4.7). FBP17 can generate
membrane curvature under iso-, hypo-, and hyper-osmotic conditions (Figure 4.7), as
indicated by tubule formation generated from LUVs and in agreement with previous
studies49, 161. The average tubule diameter of FBP17-generated tubules in iso- and hypoosmotic buffer conditions is not significantly different, indicating that the increase in
membrane tension is not sufficient to prohibit protein interactions.30 Meanwhile there is a
significant decrease in tubule diameter when comparing hyper-osmotic conditions with
both iso- and hypo-osmotic conditions. Hyper-osmotic stress can lead to bud nucleation
on membranes without protein present.162 Therefore, the tubules that we are observing
under hyper-osmotic conditions may be initiated by stress162, which FBP17 can bind to the
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nucleated bud and further elongate into membrane tubules. This difference in curvature
generation mechanisms may explain the significant differences in average tubule diameter
under different osmotic conditions.

Figure 4.7. TEM tubulation assay of FBP17 under osmotically induced membrane
tensions.
a) A representative image from TEM tubulation assay showing a membrane tubule
(indicated by red arrow) generated by FBP17. LUVs (extruded with a 400 nm pore
size filter) with composition 30/30/35/5 = DOPS/DOPE/DOPC/brain PI(4,5)P2 were
incubated with 5 µM FBP17, and membrane tension was osmotically varied. The blue
arrow indicates an intact vesicle. b) Quantification of the average tubule diameter for
isosmotic (0 nM/m), hypo-osmotic (0.06 mN/m), and hyper-osmotic (-0.06 mN/m)
buffer conditions. Error bars are SEM, n = 20. P values were calculated using an
unpaired, two-tailed Student’s t-test, where P ≤ 0.05 is indicated by *, P ≤ 0.005 is ***,
and when P ≥ 0.05, data are considered not significant (n.s.).
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4.2

Characterizing membrane curvature generation capacity of FBP17 through

confocal microscopy with micropipette manipulation and transmission electron
microscopy
The formation of transient membrane deformations and highly curved structures
occurs through various cellular processes.146 Membrane tension has been thought to be an
important regulator in cellular trafficking.68 Previous studies in our lab indicate membrane
tension reduction initiates tubulation by N-BAR endophilin.87 Therefore, we aim to
determine if F-BAR FBP17 follows the same model as endophilin to understand the role
of membrane tension involved in F-BAR protein membrane recruitment.
A shape stability diagram correlates membrane tension and protein density with
membrane shape deformations, or a shape instability.87 Shi and Baumgart have previously
shown that endophilin N-BAR generates membrane curvature after reaching a certain
threshold molecular density (transition density), which is associated with a visible and
measurable membrane area decrease.87 This transition density is defined as the protein
density necessary to initiate a shape deformation under different membrane tensions.87 An
increase in protein density leads to a dramatic change in membrane shape.87 Additionally,
as tension increases, flattening the membrane, a higher protein density will be necessary to
induce a shape transition.87 Such shape stability diagrams provide a framework to relate
membrane tension and protein density at a membrane shape transition that can easily be
interpreted.87 The shape stability diagram allows determination of C0, the spontaneous
curvature generated, ρ0, the protein density required to initiate a shape instability at zero
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membrane tension, and ρmax, the maximal membrane tension necessary to induce a shape
transition.87

Figure 4.8. Representative time-lapse images of confocal transfer experiment with
density and area traces.
a) In the time-lapse confocal images, we can see an increase in FBP17 protein density,
i.e. fluorescence intensity, where the GUV composition used was 30/30/34.7/5/0.3 =
DOPS/DOPE/DOPC/brain PI(4,5)P2/TRTM-DHPE. Vesicle membrane area (apparent)
can be used as a gauge to evaluate GUV geometry changes and is calculated from the
spherical vesicle and the aspirated projection length: Areaapp (t) = 4πRv (t) + 2πRpLp
�

(t). Membrane volume was also calculated as: Volume (t) = �π R�� (t) + πR�� (t) Lp.
FBP17 membrane binding results in a decrease in the aspirated projection length

leading to a decrease in apparent membrane area. GUV membrane volume remained
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constant overtime, which indicates that i) protein binding does not induce pore
formation; and ii) the GUV interior and exterior were osmotically balanced. We
attribute curvature generation as the cause for the observed area decrease in a) and
indicated by the arrow in b). The corresponding density is considered the transition
density, or the density in which a shape instability occurs. However, membrane tubules
are not visible. Scale bars are 5 μm.
In order to generate a membrane shape stability diagram for FBP17, we employed
our single GUV transfer assay (Figure 4.8).87 Membrane tubules were never visible during
the GUV transfer assay for membranes containing +/˗ PIP2 dissimilar to previous
endophilin assays87. Since tubules are not visible and we observe a gradual area decrease,
we cannot detect an accurate transition density. Therefore, we cannot complete an accurate
stability diagram for FBP17 since membrane tubules are not visible.
There are many potential reasons why tubules are not observed even though there
is a membrane area decrease (Figure 4.8b). The following reasons will be discussed and
evaluated in more detail in the following sections. i) Tubules and small vesicles may be
produced and shed from the GUV that are below the detection limit of the confocal
microscope. ii) The tubules emanating from GUVs are dynamic, and it is possible that we
cannot image at a speed and magnification to observe this phenomenon. iii) Further, the
protein may not be fully active and may not generate membrane tubules. iv) Low salt
conditions and v) high membrane tension may inhibit tubule formation. vi) Additionally,
the intrinsic behavior of the protein may prevent curvature generation.
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4.2.1

TEM tubulation assay to assess protein activity/ tubulation ability
A TEM tubulation assay was employed to determine that FBP17 deforms the

membrane at the membrane compositions (+/˗ PIP2) used in the GUV transfer assays
(Figure 4.8). The GUV transfer assay shown in Figure 4.8a confirms that FBP17 can sense
membrane curvature since FBP17 binding to the GUV is observed. Protein coupling with
membrane curvature, including both sensing and generating membrane curvature, is
confirmed for both low and high salt conditions and +/˗ PIP2 membranes (Figure 4.9). The
red arrows indicate membrane tubules that FBP17 deformed from intact LUVs (shown by
the blue arrow). Since FBP17 activity was confirmed through our TEM tubulation assay,
it remained elusive as to why membrane tubules are not visible in our GUV stability assay
under our membrane and buffer conditions. Therefore, we further evaluated the effect of
our buffer conditions used in our GUV transfer experiments.

Figure 4.9. Representative TEM images of FBP17 curvature generation in both low and
high ionic strength buffer conditions and in the presence and absence of PIP2.
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LUVs (extruded with 400 nm pore size filter) with composition (˗PIP2 membranes)
45/30/25 = DOPS/DOPE/DOPC or (+PIP2 membranes) 30/30/35/5 = DOPS/DOPE/
DOPC/brain PI(4,5)P2 were incubated with 5 µM FBP17 under low salt (50 mM NaCl,
7 mM HEPES, 0.3 mM TCEP pH 7.4) and high salt (150 mM NaCl, 7 mM HEPES,
0.3 mM TCEP pH 7.4). Membrane tubules are indicated by the red arrows, and the blue
arrows indicate intact vesicles. FBP17 can sense and generate curvature under both
low and high salt conditions in the presence and absence of PIP2. Scale bars are 500
nm.
4.2.2

Low salt concentration inhibits tubule formation
GUVs were incubated with FBP17 in low and high salt concentrations in order to

evaluate FBP17’s curvature generation ability under negligible membrane tension. We
aimed to examine the buffer conditions from our GUV transfer assay to determine if the
low salt conditions have a detrimental effect on the protein’s curvature generation ability.
Previous TEM assays indicate that FBP17 can generate curvature in the presence of low
and high salt (Figure 4.9). Here we employ two different techniques to generate GUVs: i)
electroformation for low salt conditions; and ii) PVA-assisted hydration for high salt
conditions. Generally, we hydrate vesicles electroformed on indium tin oxide (ITO) glass
slides with a sucrose solution since GUV formation in a saline solution with charged lipids
is challenging.163 Electroformed GUVs were rehydrated in sucrose, and experimental low
salt buffer imaging conditions consisted of 50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP,
pH 7.4 in addition to sucrose and glucose. In order to generate vesicles with a
physiologically relevant salt condition164, 165, we used gel-assisted GUV formation in a high
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salt and sucrose solution (137 mM NaCl, 7 mM HEPES, 0.3 mM TCEP, 133 mM sucrose
pH 7.4) in the GUV interior (where the exterior buffer/imaging conditions consist of the
NaCl solution, sucrose, and glucose) that enables GUV formation under high salt.77

Figure 4.10. Low salt inhibits the total number of tubules and tubule length.
a) FBP17 curvature generation was quantified under low and high salt. GUVs, with
composition 45/30/25= DOPS/DOPE/DOPC (formed by electroformation for low salt
and PVA-assisted for high salt), were incubated with 75–250 nM FBP17 under low salt
(50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4) (n= 86 GUVs) and high salt (137
mM NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4) (n= 98 GUVs). Buffer conditions
were: 1:1:1 = 133 mM sucrose: 133 mM glucose: 50/137 mM NaCl, 7 mM HEPES,
0.3 mM TCEP pH 7.4. b) Membrane tubule length was quantified. Generally, low
salt produced shorter tubules than high salt buffer conditions. FBP17 can sense and
generate curvature under both low and high salt conditions, but curvature generation is
suppressed under low salt.
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In the GUV incubation experiment, FBP17 is incubated with GUVs for 20-30
minutes, and then the protein coated GUV dispersion is transferred to an imaging chamber,
which consisted of two glass slides sandwiched by a thin layer of grease. The protein is
incubated with the GUVs to ensure that binding equilibrium has been reached; which was
determined from our previous GUV transfer assay. GUVs were imaged under both low
and high salt conditions, and the curvature generation capacity of FBP17 was quantified
and shown in Figure 4.10. In the low salt buffer conditions, most of the vesicles displayed
very few tubules (< 4) that were generally short (< 3.5 μm) in nature (Figure 4.10). In
comparison, high salt buffer conditions generally resulted in numerous (> 5) and long (>
3.5 μm) tubule formation. Therefore, low salt inhibits both numerous and long tubule
formation for the 45/30/25=DOPS/DOPE/DOPC membrane composition under negligible
membrane tension.
The previous TEM tubulation assay shown in Figure 4.9 suggests that FBP17 can
readily generate membrane curvature under both low and high salt buffer conditions
contrary to our GUV incubation assay where a few tubules per GUV are typically observed.
The differences in experimental observations may be caused by: i) FBP17’s preferential
binding to higher curvature membranes (LUVs > GUVs)166; ii) curvature is generated in
the form of small vesicles (for both GUV and/or LUV membrane system(s)) but the size is
below the detection limit; iii) tubules are dynamic and fall off the GUV before we can
image; and iv) tubulation may occur at another point on the membrane and are not captured
on our imaging (xy) plane.
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Since few (and short) tubules are observed under negligible membrane tension
under our buffer conditions (Figure 4.10), we would expect to see a similar observation in
our GUV aspiration assay or even fewer tubules since the membrane would be held under
tension, which is in agreement with our observations (Figure 4.8). Further studies,
discussed later in the chapter, will aim to elucidate the precise role of membrane tension in
the GUV transfer assay.
4.2.3

Immobile coat formation of FBP17 by local aggregation on the membrane
We assessed FBP17 behavior on membranes with relatively high negative charge

(45/30/25=DOPS/DOPE/DOPC). We explored the mobility of FBP17 on membranes by
using fluorescence recovery after photobleaching (FRAP) and evaluated the mobile
fraction of the photobleached area. FRAP is a microscopy-based method that allows us to
select a region of interest (ROI) on the GUV and apply a high-intensity laser source to
bleach the ROI.167 If the protein is mobile, the bleached molecules in the ROI will
exchange with the labeled protein diffusing from the surrounding regions on the GUV,
thereby observing an increase in intensity in the ROI.167
Figure 4.11a shows experimental images of two FRAP scenarios, one in which the
protein fraction is immobile (i.e. no recovery) and one that is mobile (i.e. recovery). The
bleached and immobile ROI is shown in the white box, while the recovered, mobile protein
is depicted in the red box (Figure 4.9a). We can quantify the mobile fraction (Fm) within
the ROI given by equation: Fm = IE – I0/ INB – I0, where IE is the end frame of the ROI, I0 is
the initial intensity of the ROI, and INB is the intensity of the non-bleached area outside the
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ROI.168 Here, we consider the protein is mobile when the mobile fraction is ≥ 45% and the
protein is immobile at ≤ 20%.

Figure 4.11. Immobile coat formation of FBP17 occurs by local aggregation on the
membrane under negligible membrane tension.
a) Representative images of GUVs from FRAP experiments. FBP17 does not recovery
on a GUV after photobleaching a small area (top) (GUV1 – Fm = 4.8%), and (bottom)
a GUV with FBP17 recovery after photobleaching (GUV2 – Fm = 67.8%). Recovery
fraction (Fm) was calculated using IE – I0/ INB – I0. An image is taken immediately
before photobleaching. The white box indicates the photobleached area on the GUV.
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The post-photobleaching image is taken either ~1-5 minutes after photobleaching for
‘recovery’ samples and ~15-30 minutes for ‘no recovery’ samples. The red box
indicates the membrane segment where recovery of fluorescence is observed, i.e.
FBP17 can diffuse on the membrane and is mobile. Scale bars are 10 μm. FRAP
experiments examining FBP17 recovery on GUVs with composition 45/30/24.7/0.3 =
DOPS/DOPE/DOPC/TRTM-DHPE under b) low salt (50 mM NaCl, 7 mM HEPES, 0.3
mM TCEP pH 7.4), n = 75 and c) high salt (137 mM NaCl, 7 mM HEPES, 0.3 mM
TCEP pH 7.4) conditions, n = 20. The recovery and no recovery GUV samples for low
salt conditions were determined to be significantly different using an unpaired, twotailed Student’s t-test where P < 0.001. Buffer conditions were: 1:1:1 = 133 mM
sucrose: 133 mM glucose: 50/137 mM NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4.
Recovery is defined when the mobile fraction is ≥ 45% and no recovery is defined at ≤
20%. At a high threshold protein density, FBP17 becomes immobile.
Our FRAP experiments under low salt conditions (Figure 4.11b) indicate that
FBP17 becomes immobile at high threshold protein densities (~7000 μm-2). The difference
in equilibrated protein densities of FBP17 coated GUVs for recovered and immobile
protein is determined to be significantly different, using an unpaired, two-tailed Student’s
t-test, where P < 0.001. The recovered and immobile GUVs under high salt conditions
were not found to be significantly different (Figure 4.11c). A smaller number of samples
were taken at high salt conditions than at low salt, and it is possible a greater number of
experiments may result in a significant difference in the measured protein densities.
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Alternatively, high salt may inhibit strong protein binding to the membrane, and hence
FBP17 remains mobile.

Figure 4.12. Immobile coat formation of FBP17 also occurs at high membrane tension.
a) A representative FRAP experiment of an aspirated GUV indicates that FBP17 can
form an immobile coat under applied membrane tension ranging from 0.05 – 0.40
mN/m (n = 3). A representative GUV transfer assay time trace, where a single GUV,
with membrane composition 45/30/24.7/0.3 = DOPS/DOPE/DOPC/TRTM-DHPE, was
transferred into a chamber containing 250 nM FBP17-Alexa Fluor® 488 (n=5). After
protein reached equilibrium (after ~20-25 minutes, shown by the black circles), a small
area on the GUV was photobleached (indicated by the white box). The protein density
on the membrane decreased and never recovered, shown in grey circles. The laser was
turned off to prevent further photobleaching, and the protein still does not recover,
indicating that FBP17 formed an immobile coat. b) A representative FRAP experiment
for aspirated and non-aspirated GUVs where the entire GUV is bleached and does not
recover. Buffer conditions were: 1:1:1 = 133 mM sucrose: 133 mM glucose: 50 mM
NaCl, 7 mM HEPES, 0.3 mM TCEP pH 7.4 for all experiments.
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Additionally, we examined if FBP17 protein density reaches the threshold
immobile density with aspirated GUVs (Figure 4.12a). A GUV was transferred into a
FBP17 containing solution and then allowed to reach binding equilibrium. An area on the
membrane was selected for photobleaching, upon which protein recovery was not detected.
Therefore, FBP17 can become immobilized on membranes with both negligible membrane
tension and with applied membrane tension. A control experiment was performed where
the entire vesicle was photobleached to measure recovery for both aspirated and nonaspirated GUVs (Figure 4.12b). Protein recovery was not detected, and therefore protein
recovery observed in our recovered samples was due to protein diffusion on the membrane
and not from the bulk protein environment.
Discovering FBP17’s propensity to form an immobile protein coat at high
molecular densities on membranes suggests that FBP17 has a strong aggregation tendency.
In agreement with literature, FBP17 has previously been found to polymerize in solution
into fibril-like structures in the absence of membranes.27 FBP17’s immobility may prevent
curvature generation at low salt concentrations under the GUV aspiration experiments.
Therefore, we next aimed to evaluate the influence of membrane tension and immobile
coat formation during the GUV transfer assay to give insights into FBP17’s curvature
generation capacity under low salt conditions.
4.2.4

Membrane tension inhibits FBP17 curvature generation
To give insights into the influence of membrane tension and immobile coat

formation during our GUV transfer experiments, we designed two different GUV transfer
assays to address both phenomena. In the first experiment (Figure 4.13a), we explored the
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effect of GUV aspiration and membrane tension. During this transfer assay, a GUV is
selected from a GUV dispersion, held under tension (0.1-0.2 mN/m), and transferred into
the FBP17 containing chamber. Once the protecting capillary is removed and the GUV is
immersed in the protein chamber, the suction pressure was rapidly (< 5s) decreased to ~0
mN/m but so that the vesicle was still attached to the micropipette. In this experiment, we
aimed to assess whether the protein can generate membrane curvature using our GUV
transfer assay and previous buffer conditions (low salt) while reducing membrane tension.
In 60% of transfer experiments (n = 10), curvature generation from FBP17 was visible,
suggesting that membrane tension can inhibit FBP17-induced tubule formation.
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Figure 4.13. Membrane tension inhibits FBP17 tubule formation
Images of the protein (488 nm) and lipid (561 nm) channel from a GUV transfer assay,
using membrane composition 45/30/24.7/0.3 = DOPS/DOPE/DOPC/TRTM-DHPE. a)
A single GUV was transferred into a chamber containing 100 nM FBP17-Alexa Fluor®
488 (n=10, individual GUV transfers). After the capillary was removed, the tension
was rapidly (< 5s) reduced to zero in order to observe membrane curvature generation
before an immobile protein coat could form. Tubules were observed in 60% of
experiments. b) A single GUV was transferred into a chamber containing 100 nM
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FBP17-Alexa Fluor® 488 (n=13, individual GUV transfers) so that a protein coat could
form (~10-20 minutes). Suction pressure was then decreased to negligible tension to
observe tubule formation, which occurred in only 23% of experiments (3/13). Tubules
from the 3 experiments in which tubules were observed are shown. Tubules are
emanating from the junction of the pipette and GUV. Red arrows indicate tubule
formation. Buffer conditions were: 1:1:1 = 133 mM sucrose: 133 mM glucose: 50 mM
NaCl, 7 mM HEPES, 0.3 mM TCEP, pH 7.4 for all experiments. Scale bars are 5 μm.
In the second experiment type (Figure 4.13b), a single GUV was transferred into a
FBP17 solution similar to the transfer assay in Figure 4.8a. In this case, FBP17 equilibrated
on the GUV and a protein coat was formed after 10-20 minutes. After FBP17 coated the
membrane, membrane tension was then released to determine if FBP17 could generate
membrane tubules after the immobile coat was formed. In only a small fraction of transfer
assays (23%, 3 out of 13 GUVs), membrane tubules were observed. These two types of
transfer assays suggest that membrane curvature generation is suppressed when suction
pressure (i.e. high membrane tension) is applied. Additionally, the immobile coat FBP17
forms when protein density is sufficiently high inhibits curvature generation under low salt
conditions. Therefore, our goal was to determine how to alter membrane composition so
that protein density would not reach the high threshold density inducing an immobile
protein coat, but so that the protein would still bind and generate membrane curvature,
which is discussed in the next section.

113

4.3

Cholesterol facilities FBP17 membrane curvature generation
In order to prevent immobile coat formation, the overall negative charge was

lowered to reduce FBP17 binding to the membrane. When membrane charge was lowered
to 25% (Figure 4.14), protein density remained in the low regime and FBP17 generated
short membrane tubules (Figure 4.14b). Lowering the overall charge aided FBP17 in
generating membrane curvature, but tubules were not consistently observed during transfer
experiments at that membrane composition. Therefore, we sought to introduce cholesterol
into our membrane composition since it was previously determined to facilitate FBP17induced membrane tubulation.49

Figure 4.14. Reducing negative charge allows FBP17 to associate with GUVs and
initiate membrane curvature by preventing immobile coat formation due to lower protein
density on the membrane.
a) A single GUV was transferred into a chamber containing 35 nM FBP17-Alexa
Fluor® 488, with membrane composition 25/30/44.7/0.3 = DOPS/DOPE/DOPC/TRTMDHPE, and protein association was measured over time.

At this bulk protein

concentration, the FBP17 density remained low and the protein did not become
immobile, as assessed by FRAP. b) Images of the GUV transfer experiment show
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membrane tubules emanating from the GUV, indicated by the red arrow. Buffer
conditions were: 1:1:1 = 133 mM sucrose: 133 mM glucose: 50 mM NaCl, 7 mM
HEPES, 0.3 mM TCEP pH 7.4. Scale bars are 5 μm.
Replacing DOPE with cholesterol in our GUVs greatly enhanced FBP17’s ability
to generate membrane curvature (Figure 4.15). Under our GUV incubation assay where
GUVs are under negligible membrane tension, GUVs display an increase in the number of
membrane tubules as FBP17 concentration is increased, where tubule length appears to
increase with increasing FBP17 concentration (Figure 4.15). Since cholesterol enhances
FBP17-induced tubule formation under negligible membrane tension, we sought to
determine how membrane tension would influence FBP17’s curvature generation with
cholesterol-containing membranes.

Figure 4.15. FBP17-induced curvature generation is enhanced by cholesterol.
Various concentrations of FBP17 were incubated with 25/30/44.7/0.3 =
DOPS/cholesterol/DOPC/TRTM-DHPE GUVs and subsequently imaged after protein
equilibration (~20 minutes). Z-projections from xy confocal scans at different z
positions are shown in the above images. Cholesterol enhances global curvature
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generation. As FBP17 concentration is increased, membrane tubules increase in both
number and length. Scale bars are 5 μm.
We applied our GUV transfer assay with cholesterol-containing membranes over a
range of membrane tensions (0.07 – 0.70 mN/m). Under low membrane tension conditions
(< 0.10 mN/m), smaller tubules emanating from nucleation sites all over the vesicle are
observed (Figure 4.16a). As membrane tension increases, there are fewer and smaller
tubules around the vesicles, indicating that increased membrane tension prevents FBP17induced global tubule formation. Meanwhile, under high membrane tension (> 0.25
mN/m), we observe longer tubules emanating from a single area on the GUV. High
membrane tension prevents FBP17 from generating tubules initiated at multiple areas on
the membrane and instead concentrates at a single point, which is then elongated. Finally,
tubule formation is inhibited at very high membrane tensions. Our results are in agreement
with a previous literature assessment of membrane tension and curvature generating
proteins.30 Figure 4.16b is a schematic representation of our observations of FBP17’s
interaction with cholesterol and membrane tension.

FBP17 can nucleate membrane

tubulation at negligible and low membrane tensions, but curvature generation is inhibited
at high membrane tensions.
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Figure 4.16. Cholesterol facilitates FBP17-induced membrane curvature generation.
a) A single GUV was transferred into a chamber containing 100 nM FBP17-Alexa
Fluor® 488 (n=16, individual GUV transfers), with membrane composition
25/30/44.9/0.1 = DOPS/cholesterol/DOPC/TRTM-DHPE, under varied membrane
tensions. Under low membrane tensions (< 0.10 mN/m), the vesicle is populated with
many tubules all over the vesicle. As membrane tension increases, the tubules tend to
be less populated and shorter in length. Under high membrane tensions (> 0.25 mN/m),
tubules emanate from a single area on the GUV, and these tubules are typically
117

elongated by FBP17, until membrane tension reaches the point at which no tubules are
observed. Scale bars are 5 μm. b) Schematic representation of FBP17’s membrane
curvature generation with cholesterol containing membranes and membrane tension.
Under low membrane tension, many short tubules populate the vesicles, and this
population density of tubules decreases as membrane tension is increased. At high
membrane tension, long tubules are observed originating from a single starting area on
the GUV. High membrane tension ultimately inhibits FBP17 curvature generation.
We hypothesized the molecular mechanisms of FBP17 function (depicted in Figure
4.3). Our data show evidence that the two proposed mechanisms likely contribute to
FBP17-induced curvature generation. FBP17 aggregates on the membrane under local
increases of anionic lipids. At high threshold protein densities, FBP17 forms an immobile
protein coat (Figure 4.11), which occurs when the membrane has a high negative charge.
This threshold protein density may prevent curvature generation. The second proposed
mechanism is that membrane tension inhibits curvature generation, which is evaluated in
Figure 4.13b and 4.16. Membrane curvature generation capacity is heavily influenced by
membrane composition (Figures 4.8, 4.14, & 4.15). The presence of cholesterol increases
FBP17’s curvature generation capacity (Figure 4.15 & 4.16).

FBP17 can initiate

membrane curvature globally under both negligible and low membrane tension, while high
membrane tension inhibits curvature generation.
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Chapter 5: Comparison of the molecular mechanisms of curvature sensing of NBAR proteins to evaluate functional redundancy
5.1

Overview of N-BAR function
The involvement, and possible redundant role, of N-BAR proteins during clathrin-

mediated endocytosis (CME) remains an area of great interest. Endophilin, amphiphysin,
and sorting nexin 9 (SNX9) are three such BAR proteins that share significant structural
features (Figure 5.1). According to the crystal structures of endophilin, amphiphysin, and
SNX9 (Figure 5.1a), these N-BARs share similar intrinsic curvature in their dimeric BAR
scaffold. These three proteins are heavily recruited to the plasma membrane during CME
and are hypothesized to be involved in generating and stabilizing the membrane neck
during CME.12, 169 Each of these three proteins contains a Src Homology 3 (SH3) domain
(Figure 5.1), that is involved in the recruitment of downstream CME components such as
dynamin and synaptojanin, which are involved in GTPase hydrolyzed vesicle scission and
vesicle uncoating, respectively.12 Differential recruitment dynamics of these BAR proteins
in CME were previously elucidated.170,

171

These differences in plasma membrane

recruitment may correlate to functional differences and additional post-scission
downstream effects. Moreover, several cellular events involving the plasma membrane
have been identified that appear to rely primarily on only one BAR domain protein.17, 172,
173

Hence, characterizing the similarities and differences of these N-BARs will ultimately

aid in understanding the key roles these proteins play in endocytosis and other cellular
processes.
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Figure 5.1. Crystal and domain structures of three N-BAR proteins.
a) The dimeric crystal structures of N-BAR domain proteins endophilin (PDB: 2C08),
amphiphysin (PDB: 4ATM), and sorting nexin 9 (SNX9) (PDB: 2RAI) show similar
degrees of curvature. The homodimer for endophilin and amphiphysin was generated
using PDBePISA. The distance from tip-to-tip for endophilin is 12.8 Å, amphiphysin
is 15.0 Å, and SNX9 is 13.7 Å. b) The domain structures of endophilin,
amphiphysin, and sorting nexin 9 are diverse, where the blue is the BAR domain,
grey indicates linker/ low complexity regions, purple is the Phox-homology (PX)lipid binding domain, and red is the Src Homology 3 (SH3) domain.
5.2

Highlighting the functional and subcellular localization differences among

three N-BAR proteins: endophilin, amphiphysin, and SNX9
5.2.1

Endophilin
Endophilin has been identified as a critical mediator in both clathrin-dependent174

and independent17 pathways. Endophilin was discovered as the main membrane
remodeling protein in fast endophilin-mediated endocytosis (FEME).17,

18

Unlike

amphiphysin and SNX9, endophilin has two amphipathic helices: i) its N-terminal H0
helix; and ii) its insert helix (H1I) located at the center of its dimeric BAR scaffold.20 The
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precise role of the amphipathic helices of endophilin remains of high interest, and they are
implicated in regulating protein function.175 Chapter 6 will give a more detailed account
of the N-terminal H0 helix of endophilin. Endophilin is concentrated at pre-synaptic
terminals.176 Additionally, endophilin is abundantly found in the cytosol in both diffuse
and punctate patterns177 and localizes to synaptic vesicles upon synaptic stimulation176.
Recent evidence indicates that endophilin plays a role in exocytosis by coordinating
neurosecretory vesicle membrane fusion.178
5.2.2

Amphiphysin
Amphiphysin has one N-terminal amphipathic helix in addition to a large

intrinsically disordered linker region of ~400 amino acids, which has been shown to
amplify its membrane curvature sensing.179

Similar to endophilin, the subcellular

localization of amphiphysin has been found to be mainly cytosolic where a small fraction
is associated with synaptic vesicles.173, 180 Amphiphysin is critical in CME, where the SH3
domain recruits dynamin 1 through interactions with the proline-rich motif.173,

181

Additionally, amphiphysin involvement in the regulation of synaptic vesicle recycling has
been suggested through its interactions with cain and calcineurin,182 but amphiphysin is not
critical for synaptic vesicle exocytosis.183
5.2.3

Sorting Nexin 9 (SNX9)
Sorting nexin 9 is a multifunctional protein that is classified as both a protein and

lipid-binding scaffold.172 An overview of SNX9 binding partners and its involvement in
various cellular pathways were reviewed in Bendris and Schmid.172 SNX9 has a Phoxhomology (PX) domain (Figure 5.1b), which is known as a promiscuous PIP binding
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domain.171, 184 SNX9 is recruited to clathrin-coated pits through its interaction with PIP
lipids after endophilin, amphiphysin, and dynamin membrane association.185 SNX9 has
been

found

to

colocalize

with

clathrin

at

the

plasma

membrane186,

glycosylphosphatidylinositol-anchored proteins187, lamellipodia187, and dorsal rings187.
SNX9’s subcellular localization patterns reflect its role in both clathrin-dependent and
independent pathways. Recruitment of SNX9 during late CME is spatiotemporally
controlled by the timed formation of PI(3,4)P2.171 Additionally, SNX9 is involved in
endocytosis-independent events. SNX9 is required for the progression of mitosis and the
completion of cytokinesis.188 SNX9 also localizes at the Golgi apparatus186, where it may
function in the transport of both a disintegrin and metalloprotease domain precursor189 and
GM130190 from the Golgi to invadopodia, resulting in tumorigenesis191. SNX9’s diverse
subcellular localization highlights its multifaceted scaffold and its involvement in various
cellular processes.
Endophilin, amphiphysin, and SNX9 share similarities in overall structure and
involvement in clathrin-mediated endocytosis. These N-BAR proteins are involved in
numerous cellular trafficking processes, and dysfunction and overexpression of these
proteins lead to various cancers.191-193 Therefore, elucidating the molecular mechanisms
of membrane curvature sensing, and ultimately membrane curvature generation, will aid in
understanding their corresponding roles in the cell. In this chapter, we demonstrate that
the membrane binding ability of endophilin N-BAR is highly dependent on its N-terminal
amphipathic helix, as previously mentioned.25 Additionally, we compare the curvature
sensing ability of endophilin N-BAR, full-length amphiphysin, and full-length SNX9.
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Here, we note the use of the N-BAR domain of endophilin rather than the full-length
protein. Full-length and N-BAR endophilin were reported to have a qualitatively similar
curvature generation capacity, with the full-length protein having a slight tendency for
higher transition densities.87 Additionally, cryo-EM studies revealed a similar lattice
formation on membrane tubules for both endophilin N-BAR and the full-length protein.26
However, endophilin has been suggested to undergo an autoinhibition mechanism in the
full-length protein, and the use of endophilin N-BAR prevents this potential
autoinhibition.19
5.3

Membrane binding ability of endophilin N-BAR
As previously mentioned, endophilin has two helices (H0 and H1I) that insert into

the bilayer when associated with anionic membranes.44 It has been proposed that
endophilin forms highly structured and stable oligomeric lattices on membrane tubules
through contributions from the H0 helix facilitating inter-dimer interactions.26, 48 In order
to study the influence of the H0 helix on endophilin’s membrane curvature sensing ability,
mutants of the endophilin A1 N-BAR (ENB) (residues 1-247) were made that altered the
H0 helix (residues 1-24). Residue F10 was chosen for mutations to either tryptophan or
alanine. Since phenylalanine is a hydrophobic residue, it is hypothesized to wedge into the
membrane. If we substitute the phenylalanine with a bulkier residue such as tryptophan,
the H0 helix would more strongly associate with the membrane due to deeper wedging into
the membrane. Conversely, if we exchange the phenylalanine for a small hydrophobic
residue such as alanine, we would expect weaker membrane binding. Additionally,
sequential H0 helix deletion mutants (Δ 1-6, Δ 1-10, Δ 1-14, Δ 1-18, Δ 1-24) were made to
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determine if, and to what extent, the H0 helix contributes to endophilin’s molecular
curvature sensing capacity.
Protein densities were measured for each of the ENB mutants under various protein
concentrations

on

GUVs

with

membrane

composition

45/30/24.7/0.3=

DOPS/DOPE/DOPC/TRTM-DHPE, and then were fitted with the Langmuir binding
equation, shown in Figure 5.2. As hypothesized, the exchange resulting in a bulkier amino
acid (F10W) leads to deeper membrane insertion and a decrease in the dissociation constant
(i.e. stronger membrane association) (Table 5.1). The dissociation constant for ENB F10W
indicates a 20% increase in binding affinity than wild-type (WT) endophilin.

In the

absence of any bulky amino acid at position 10 (F10A), there is ~8-fold decrease in
membrane binding affinity. Taken together, the F10 residue is critical for ENB membrane
binding.
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Figure 5.2. Langmuir binding isotherm of endophilin N-BAR wild-type and mutants.
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density
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with
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DOPS/DOPE/DOPC/TRTM-DHPE under varied protein concentrations.

=
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conditions were 133 mM sucrose, 133 mM glucose, 50 mM NaCl, 7 mM HEPES, 0.3
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mM TCEP, pH 7.4. It is important to note that the data were taken within two days and
that the same GUV batch was used for each experiment. Lipid oxidation usually occurs
in aged vesicles, which can drastically change the properties of the membrane194 and
thus effect protein binding. The data was fitted with the Langmuir binding isotherm
equation: ρ= ρmax/ (1 + KD/ [P]), with fitting results summarized in Table 5.1. Error
bars are SEM, n = 20 for WT and n = 10 for ENB mutants.

Table 5.1. Langmuir binding isotherm fitting results from Figure 5.2
Endophilin N-BAR

KD (nM)

ρmax (μm-2)

WT

710 ± 120

31,000 ± 3,000

F10W

590 ± 120

37,100 ± 4,000

F10A

4,700 ± 3300

47,700 ± 29,400

All errors (±) are standard errors determined by fitting a single Langmuir binding isotherm in GraphPad
Prism software.

Membrane binding for the H0 truncation mutants of ENB was also determined
(Figure 5.2, Table 5.1). Deletion mutants, Δ 1-6 and Δ 1-10, weakly bound to the
membrane, and therefore, a KD and ρmax could not be accurately calculated. Furthermore,
protein density could not be ascertained for Δ 1-14, Δ 1-18, and Δ 1-24 mutants due to
significantly weaker binding under various protein concentrations, which resulted in a high
background fluorescence intensity. Perturbation of the H0 helix through any of the deletion
mutants resulted in nearly immeasurable fluorescence intensity, which indicates the
importance of the amphipathic H0 helix for curvature sensing. Interestingly, Chen et al.
showed that the transition density, or density on the membrane that signifies a shape
transition from planar to tubular, is not significantly different between ENB WT, F10W,
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F10A, Δ 1-6, and Δ 1-10.25 This indicates that while the H0 helix is necessary for
membrane association, it does not contribute to endophilin’s membrane curvature
generation capacity.
5.4

Comparison of membrane binding ability of endophilin, amphiphysin, and

SNX9
Biophysical characterization of the membrane association of BAR domain proteins
will lead to insights into the molecular mechanisms of the protein’s cellular function. It
must be first understood how much of the protein binds to a specific membrane
composition since membrane protein density is intricately linked to the protein’s curvature
sensing and generation capacity.87, 179
GUVs were incubated with N-BAR proteins under the same buffer conditions and
protein concentrations. It should be emphasized that these measurements were taken under
low salt conditions (50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP, pH 7.4). As mentioned
in Chapter 4, GUVs with anionic lipids can be readily prepared (with high yields) by
electroformation with sucrose on the vesicle interior and low salt buffer on the exterior.163
Ultimately, further evaluation of the N-BAR domain containing proteins will be extended
to their curvature generation capacity with our GUV transfer assays in low salt conditions,
as previously assessed by Dr. Zhiming Chen195 and Dr. Zheng Shi88. GUVs prepared in
physiologically relevant buffer conditions generally result in adhesion to the micropipette
interior walls (even with casein passivation). Data from such vesicles, even in low salt
conditions, are discarded because this stickiness results in an inaccurate measurement of
the observed membrane area and thus the transition density. Improved passivation methods
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are needed to prevent membranes (and proteins) from adhering to the glass capillary, and
PEG-silane passivation is one such promising method.196
The membrane binding ability of the N-BAR proteins were measured under a
saturating protein concentration (1 μM) in order to compare the maximal protein density
of these N-BAR proteins on membranes with and without PIP2 (Figure 5.3). All three NBAR proteins have been shown to favorably interact with PI(4,5)P2 lipids.171,

173, 197

Therefore, we are highly interested in comparing the curvature sensing capacity with and
without PIP2 present in the membrane. Here, the maximal protein density is directly
evaluated and compared from protein-GUV incubation experiments. Later in this section,
the fitted ρmax, or the maximal protein density, in addition to dissociation constants
determined from a Langmuir binding isotherm will be compared among the three proteins.

Figure 5.3. Comparison of the maximal protein density of N-BAR proteins on
membrane compositions containing +/˗ PIP2.
Membrane binding ability decreases from endophilin to amphiphysin to SNX9 on
membrane composition without PIP2 (45 DOPS/ 30 DOPE/ 24.7 DOPC/ 0.3 TRTM127

DHPE) and with PIP2 (30 DOPS/ 30 DOPE/ 34.7 DOPC/ 5 brain PI(4,5)P2/ 0.3 TRTMDHPE) incubated with 1 μM of protein. Error bars are SEM, n =13 without PIP2 and n
= 43 with PIP2. P values were calculated using an unpaired, two-tailed Student’s t-test,
where P ≤ 0.01 is indicated by **, P ≤ 0.005 is ***, and when P ≥ 0.05, data are
considered not significant (n.s.).
The membrane binding ability increases from SNX9 to amphiphysin to endophilin
for membranes with and without PIP2, shown in Figure 5.3. There is a statistically
significant difference (using an unpaired Student’s t-test) between the binding ability of
amphiphysin and SNX9 on membranes with and without PIP2, but no significant difference
for endophilin on either membrane composition. Moreover, there is significantly more
binding of endophilin to membranes with and without PIP2 than amphiphysin and SNX9,
which may be due to the N-BAR domain rather than the full-length protein. Therefore, to
compare the curvature sensing abilities of these three proteins and to determine whether
their membrane recruitment is spatiotemporally controlled by the presence of specific
lipids, we utilized a wider range of protein concentrations to measure protein density on
membranes +/˗ PIP2.
The strength of the membrane binding behavior of BAR proteins is critically
dependent on the molecular density on the membrane. Curvature sensing is loosely linked
to a low protein coverage regime.179, 198 Meanwhile, at higher surface densities, BAR
proteins have a tendency to oligomerize on the membrane.28, 45 Additionally, membrane
protein density influences the curvature generation capacity of BAR proteins.84, 87
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In order to explore the binding strengths of N-BAR proteins, Langmuir binding
isotherms were obtained for the N-BAR proteins on GUVs with and without PIP2 under
various protein concentrations, which are shown in Figure 5.4 with fitting parameters
summarized in Table 5.2. To summarize our findings, ENB has a 2-fold stronger binding
affinity than SNX9 on membranes without PIP2. SNX9 has a 3-fold stronger binding
affinity to membranes containing PIP2 than without the phosphoinositide while the
dissociation constant of amphiphysin remains constant in either case. Amphiphysin
exhibits significantly stronger association (low nM binding) to the membrane with and
without PIP2 present than either ENB or SNX9. For ˗PIP2 membranes, amphiphysin has a
30- and 60-fold increase in binding affinity to ENB and SNX9, respectively. Meanwhile,
in the presence of PIP2, amphiphysin exhibits a ~16-fold increase in binding strength when
compared to SNX9. This striking difference in membrane affinity for amphiphysin may
be attributed from contributions from its BAR domain scaffold, its N-terminal amphipathic
helix membrane, and its intrinsically disordered region inducing local membrane
crowding.84, 179

Figure 5.4. Langmuir binding isotherm of N-BAR domain containing proteins in the
presence and absence of PI(4,5)P2.
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a) Protein density measured on GUVs with composition 45 DOPS/ 30 DOPE/ 24.7
DOPC/ 0.3 TRTM-DHPE under varied protein concentrations. b) Protein density
measured on GUVs with composition 30 DOPS/ 30 DOPE/ 34.7 DOPC/ 5 brain
PI(4,5)P2/ 0.3 TRTM-DHPE under varied protein concentrations.

Buffer conditions

were 133 mM sucrose, 133 mM glucose, 50 mM NaCl, 7 mM HEPES, 0.3 mM TCEP,
pH 7.4. The data was taken within two days and the same GUV batch was used for
each experiment. The data was fit with the Langmuir binding isotherm equation: ρ=
ρmax/ (1 + KD/ [P]), with fitting results summarized in Table 5.2. Error bars are SEM, n
= 20.
Table 5.2. Langmuir binding isotherm of N-BAR proteins on membranes with and
without PIP2 fitting results from Figure 5.4.
˗PIP2

+PIP2

N-BAR

KD (nM)

ρmax (μm-2)

KD (nM)

ρmax (μm-2)

ENB

710 ± 120

31,000 ± 3,000

n.d.

n.d.

Amphiphysin

22 ± 3

1,800 ± 24

28 ± 5

1,800 ± 40

SNX9

1,300 ± 260

6,100 ± 790

460 ± 120

3,900 ± 450

All errors (±) are standard errors determined by fitting a single Langmuir binding isotherm in GraphPad
Prism software.
n.d. = not determined

The N-BAR proteins also have significantly different ρmax densities with an overall
trend of highest maximal protein density: ENB > SNX9 > amphiphysin. SNX9 displays a
1.5-fold increase in maximal protein density on ˗PIP2 in comparison to +PIP2 membranes
but has 3.5-fold weaker membrane binding for ˗PIP2. SNX9 has the lowest amount of
curvature of its BAR scaffold, and similar to FBP17 mentioned in Chapter 4, it likely
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accommodates PS rather than the bulky inositol group under its BAR scaffold. Its greater
binding preference for +PIP2-containing membranes is due to its PX-phosphoinositide
binding domain. Meanwhile, the ρmax and KD remained constant under +/˗PIP2 membranes
for amphiphysin.
The measured protein densities differ from Figure 5.3 because these are the fitted
maximal proteins determined from the Langmuir binding isotherm where we assume the
energy of adsorption is equal for all sites.89

In comparison, Figure 5.3 shows the

experimentally measured protein densities at high bulk protein concentrations, which
follows a similar trend of maximal protein association: ENB > amphiphysin ~ SNX9. The
differences in maximal protein densities from both experiments (Figures 5.3 and 5.4) is
likely due to using different GUV batches, highlighting the importance of using the same
GUV batch to eliminate variations in membrane compositions and membrane properties.
Here, an additional variable needs to be considered with the use of brain PIP2, as mentioned
in Chapter 4, which has been recently discovered to leach from the membrane.156
The N-BARs evaluated in this chapter have different biophysical properties,
specifically, maximal protein density and binding affinity. We found that maximal protein
density followed a trend of ENB > SNX9 ≥ amphiphysin while binding affinity followed
amphiphysin > ENB > SNX9. High densities of endophilin and amphiphysin can prevent
proper dynamin assembly, thereby inhibiting dynamin-mediated membrane scission185, 199
while SNX9 regulates dynamin by stimulating its GTPase activity.186 It is likely that
endophilin, amphiphysin, and SNX9 have a synergistic role in CME that finely tunes
dynamin assembly and ultimately membrane scission.
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Chapter 6: Membrane partitioning and lipid selectivity of the N-terminal
amphipathic H0 helix of endophilin isoforms
The amphipathic helix (AH) motif is a common domain in numerous proteins and
peptides. The AH is defined by having two opposing faces, a polar and nonpolar side.
Through long-range electrostatic interactions, an unfolded AH will accumulate at the
surface of anionic membranes and begin to bind.35 In this process mainly driven by the
hydrophobic effect, the AH is transferred to the membrane by insertion of hydrophobic
residues between lipid acyl chains and water releasement.35 Then the AH partitions into
the membrane and undergoes a conformational change with α-helical secondary structure;
the disordered amphipathic peptide folds into an α-helix to optimize molecular interactions
with the membrane-water interface.35 This process is also known as partitioning-folding
coupling, where the overall free energy of the membrane / peptide system is significantly
lower in the case of the α-helical AH than for the disordered AH.36
Many cellular processes are initiated through reversible protein association at the
membranous organelle surface. AHs possess unique physicochemical values, such as
hydrophobicity, net charge, and hydrophobic moment (which is a measure of
amphiphilicity).34 These unique parameters determine specific membrane interactions.
Membranous organelles have different lipid compositions and, as a consequence, vary in
their preferences for specific membrane binding partners.200

Bigay and Antonny have

previously described two main categories that govern AH association with membranous
organelles: i) electrostatics via an increase in negatively charged lipid head groups, and ii)
lipid packing defects via an increase in the ratio of unsaturated and saturated acyl chains
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and the ratio of small and large polar head groups.73 For example, binding partners of the
early secretory pathway, which include the endoplasmic reticulum (ER) and cis Golgi
apparatus (GA), appear to be guided by lipid packing defects more so than electrostatic
interactions.73 Conversely, association with the late secretory pathway, including late
endosomes (LE) and the plasma membrane (PM), seem to be primarily guided by
electrostatics.73 Recent advances in lipidomics suggest that the inner leaflet of the PM
contains a higher amount of unsaturated lipids than has been previously characterized
(leading to an increase in packing defects, albeit to a lesser extent than ER and GA
membranes201).75
A unique subfamily within the BAR domain superfamily is the N-terminal
amphipathic helix-BAR, or N-BAR, protein family. Endophilin is a widely studied NBAR domain containing protein that induces positive membrane curvature, or bending of
the membrane away from the sides of the protein, and is recruited in clathrin-mediated
endocytosis and other membrane trafficking processes.44-46 There are two subfamilies of
endophilins: the extensively studied A subfamily, which was first identified in 1997202, and
the lesser studied B subfamily discovered in the early 2000s203. Through the use of
crystallography in addition to sequence alignment and secondary structure tools, the A and
B endophilins share a similar overall structure that includes a conserved BAR domain
dimeric scaffold, H0 and H1I amphipathic (AH) helices, a variable loop region, and a Cterminal Src Homology 3 (SH3) domain.175 The A subfamily (A1, A2, A3) are known to
associate with the plasma membrane.

The endophilin As are involved in clathrin-

dependent pathways where they aid in stabilizing the neck of a budding vesicle and may
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assist dynamin, a large GTPase, in vesicle scission events.12,

170

Additionally, this

subfamily constitutes key players in different clathrin-independent pathways, such as fast
endophilin-mediated endocytosis (FEME)17, 175 and a newly discovered endocytic pathway
involving A3 and transmembrane protein CD166.204 The B subfamily (B1, B2) localizes
to mitochondria, the endoplasmic reticulum (ER), and the Golgi apparatus.175, 205-207 This
subfamily has been implicated in the regulation of endocytic membrane dynamics and in
the maintenance of mitochondrial morphology.
The role of the H0 helix has been indirectly studied through different modifications
of the full-length protein, including various deletion mutants20, 25, H0 addition mutations to
form a double AH208, and single site mutations25, 207. Previously, our lab has shown through
systematic deletion of H0 residues that the H0 helix for endophilin A1 is necessary for the
promotion of binding to the membrane but not for the generation of membrane curvature.25
Comparatively few studies have focused on H0 helix binding interactions (in the absence
of the rest of the BAR domain protein). In this study, we evaluate the different H0 helix
isoforms of endophilin through circular dichroism (CD) spectroscopy and determine
differences in membrane selectivity and binding energetics of H0-membrane partitioning.
We have determined the free energy disordered-to-helix transition using 2,2,2trifluorethanol (TFE)-titrations curves. The TFE-titration curves are consistent with a twostate equilibrium model for all H0 peptides. Our results indicate that TFE promotes α-helix
formation from helices found to be instable in aqueous buffer. Furthermore, secondary
structure prediction tools suggest that the two endophilin subfamilies have distinctive
hydrophobicities while maintaining similar hydrophobic moments.
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Overall, we

determined that the membrane binding behavior of the H0 helices of endophilin follows a
two-state model of binding to anionic membranes. The secondary structure was monitored
by CD in the presence of varying membrane compositions. Through these lipid titrations,
we observed that the two endophilin subfamilies have distinctive degrees of membrane
partitioning into organelle-mimicking membranes and their corresponding lipid
components. Contributions for the preferential membrane binding of the H0 helices was
heavily influenced by electrostatic interactions and the varying amounts of aromatic
residues within the AH (i.e. hydrophobicity of the H0 helix). Therefore, we hypothesize
that the H0 helix of endophilins functions as an organelle localization motif.
6.1

H0 helix design
The H0 helix peptides chosen for this study are based on the full N-terminal H0

helix sequence (Table 6.1) rather than the predicted helical segment of the five endophilin
isoforms. The H0 helix is conserved within each endophilin subfamily. This AH forms a
helical structure upon the addition of membranes containing negatively charged lipids. The
predicted helical portion175 of the H0 helix is also shown in Table 6.1. Some studies
suggest that the physicochemical parameters of only the helical portion should be evaluated
due to potential fraying of end residues not participating in membrane binding.209 We
emphasize here that we study the full length of the H0 helix instead of just the predicted
helical portion in order to understand the characteristics of the peptide in its native,
physiologically relevant form.
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Table 6.1. Amino Acid Sequences for the H0 Helices of the 5 Endophilin Isoforms
a

H0 helix
A1
A2
A3
B1
B2

Sequence
MSVAGLKKQWHKATQKVSEKVGGA
MSVAGLKKQWYKASQLVSEKVGGA
MSVAGLKKQWHKASQLFSEKISGA
MNIMDFNVKKLAADAGTWLSRAVQFTEEKLGQA
MDFNMKKLASDAGIWFTRAVQFTEEKFGQA

Predicted helical structure using JPred210 Secondary Structure Prediction is underlined
a
N-termini is unmodified, and C-termini is amidated. The bolded W residue indicates the F  W mutation
employed in this study.

Figure 6.1. Helical wheel projection and predicted structure of each endophilin H0 helix
assuming an α-helical conformation.
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a) Helical wheel projections for each endophilin H0 helix computed by NetWheels211
using an α-helix conformation. The downward arrow indicates the hydrophobic face.
Surface plots depicting the b) polar face and c) non-polar face of the amphipathic H0
helices. Aromatic amino acids are in magenta, Asp and Glu in red, Lys and Arg in
blue, and Gly in brown. All other hydrophobic residues are depicted in black and polar
amino acids are in grey. Surface plots were produced in PyMOL after the helix was
generated using the 3D-Hydrophobic Moment (3D-HM) vector calculator.212
Table 6.2. Physicochemical Parameters of the H0 Helices of Endophilin
H0 helix
Net
peptide Charge
A1
4.25
A2
3
A3
3.25
B1
0
B2
0

a

H��
6.81
4.14
3.79
7.14
5.34

b

ΔG��(�)
˗8.66
˗9.03
˗9.38
˗0.91
˗2.11

c

H��

4.06
7.27
7.56
11.22
10.47

d

μH��
5.91
4.93
6.74
5.54
5.57

e

μH��
8.71
7.08
8.47
8.88
7.20

Physicochemical parameters have been determined for the F  W mutants used in this study
a
Hydrophobicity, H, (kcal/mol) calculated using the Wimley-White (WW) scale213 (the whole-residue free
energy of transfer from water to POPC bilayer) using the APD3 peptide calculator214
b
ΔGWW(e) is the transfer free energy (kcal/mol) calculated using the MPEx tool215, with the Wimley-White
(WW) interfacial (IF) scale213 at 50% helicity and ˗100 mV.
c
Hydrophobicity computed from HeliQuest (HQ) server 216 using the Fauchere and Pliska217 hydrophobicity
scale
d
Hydrophobic moment, µH, calculated using the WW–IF scale213 and the MPEx tool215
e
Hydrophobic moment computed from HeliQuest (HQ) server 216 using Eisenberg218 method

Within the subfamilies of endophilin, each H0 helix has distinctive
physicochemical properties, including net charge, hydrophobicity, and hydrophobic
moment as shown in Table 6.2. The H0 A helices have a net positive charge and a narrow
hydrophobic face (Figure 6.1). Meanwhile the B subfamily has a neutral net charge with
its wider hydrophobic face populated by a greater number of bulky hydrophobic residues
(Figure 6.1). The hydrophobicity and hydrophobic moment values for the whole peptide
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were calculated using several in silico tools. The hydrophobicity scale was conceived in
1962 by Tanford and Lovrien.219 Many hydrophobicity scales have since been
experimentally determined to calculate and evaluate the physicochemical properties of
peptides for both structural prediction and the detection of membrane association.220
Twenty years later, Eisenberg et al. introduced the concept of the hydrophobic moment to
categorize the amphiphilic nature of helices218, 221 A large predicted hydrophobic moment
value suggests a greater likelihood for the AH to fold perpendicularly to its axis.222
The HeliQuest server216 by Gautier et al. is a commonly used peptide analyzer tool
that employs the Eisenberg method218 to calculate hydrophobic moment and uses the
Fauchere and Pliska217 1983 hydrophobicity scale. The Membrane Protein Explorer
(MPEx) tool215 (Stephen White Laboratory, University of California, Irvine) and the APD3
calculator and predictor214 utilizes the Wimley-White (WW) whole-residue interfacial (IF)
hydrophobicity scale213. The Fauchere and Pliska 1983 hydrophobicity scale is
experimentally

determined

from

the

partitioning

of

N-acetyl-amino-acids

in

octanol/water.217 Meanwhile, the WW whole-residue IF hydrophobicity scale (1996) is
derived from the transfer free energy of the partitioning of pentapeptides into POPC
LUVs.213 The physicochemical parameters obtained from both methods and
hydrophobicity scales are reported in Table 6.2 for all H0 peptides in order to compare the
scales’ accuracy with experimentally obtained results from TFE and lipid titrations. On
average, the hydrophobicity values from both scales (H�� and H�� ) are predicted to be

lower for the H0 A subfamily, while the hydrophobic moment (μH�� and μH�� )

calculated from each scale does not show a discernable division between the endophilin
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H0 subfamilies. The MPEx Totalizer tool allows the user to account for electrostatic
interactions as well as peptide helicity.215 Therefore, the ΔG��(�) value is an in silico

prediction of the hydrophobicity of the H0 peptides in the presence of an anionic membrane
with 50% (the average helicity in the presence of 100% DOPS membranes) peptide
helicity. The ΔG��(�) values predict a favorable binding interaction for all H0 peptides
when electrostatic interactions are considered.

6.2

Determination of helical propensities for the H0 peptides using 2,2,2-

trifluoroethanol
2,2,2-trifluoroethanol (TFE) is a widely used co-solvent to induce and stabilize αhelix conformation in peptides.94, 223 In order to determine the helical propensities for the
H0 peptides, we titrated with TFE. The disordered-to-helix transitions were monitored by
CD spectroscopy.94, 96, 223 A dominant helical structure can be assigned to macromolecules
if spectra include characteristic minima of similar intensities at 208 nm and 222 nm and a
positive ellipticity at shorter wavelengths (~192 nm) where the ellipticity changes signs at
~200 nm.224 All three characteristic phenomena of an α-helical CD spectrum are observed
for all H0 peptides (shown in Figure 6.2) occurring after the TFE-titration transition point.
The TFE-titration curves of all five H0 helix peptides are sigmoidal, each with a single
transition point (Figure 6.3), consistent with a two-state folding process.225 This two-state
folding is also supported by the presence of a single isodichroic point at 203 nm observed
in the CD spectra (Figure 6.2) for all TFE concentrations.225, 226
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Figure 6.2. TFE-titration curves of H0 helix peptides monitored by CD spectroscopy
indicate a two-state binding equilibrium with an isodichroic point at 203 nm.
CD spectra of the H0 peptides (50 μM) were measured at 20°C for varying TFE
concentrations, ranging from 0 M to ~8 M TFE, with a final buffer concentration of 10
mM sodium phosphate pH 7.4.

Figure 6.3. TFE-titration curves of H0 helix peptides monitored by CD spectroscopy are
consistent with a two-state equilibrium model.
CD spectra of the H0 peptides (50 μM) were measured at 20°C for various TFE
concentrations, ranging from 0 M to ~8 M TFE, with a final buffer condition of 10 mM
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sodium phosphate pH 7.4 (shown in Figure 6.2). The observed CD signal (in mdeg°)
at 222 nm was plotted as a function of TFE concentration for a) H0 A peptides and b)
H0 B peptides.

The sigmoidal TFE-titration curve was fitted with a two-state

equilibrium model (equation 2.9 – red line) to determine the transition point, or
[TFE]mid, m, the TFE dependence, and ΔG �� � (fitting parameters are reported in Table
6.3).

The TFE-titration data fit well to a two-state equilibrium model94-97, where m (a
measure of the dependence of ΔG��� on TFE concentration), [TFE]mid (the concentration

of TFE at which the peptide is 50% helical), and ΔG �� � (the transition free energy in

aqueous buffer) were extracted (shown in Table 6. 3). The [TFE]mid for all H0 peptides
were within ± 0.4 M (ranging from 17.3-20.1% v/v) (Table 6.3). The positive ΔG ��� for

all H0 peptides is consistent with unfavorable α-helix formation in aqueous buffer as

evidenced by the low helical content in water (𝑓H in H2O – Table 6.3). The lack of helical
structure in aqueous buffer is supported by the CD spectra (Figure 6.2) showing a random
conformation with a minimum intensity at ~200 nm224 and by the helical content analyzer
for peptides AGADIR227-231 webtool (𝑓H predicted – Table 6.3).
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Table 6.3. Thermodynamic parameters for the α-helix transition for the H0 helices
H0
helix
A1
A2
A3
B1
B2

a

a

b

[TFE]mid
(M)

m
(kcal/mol/M)

ΔG �� �
(kcal/mol)

2.58 ± 0.03
2.73 ± 0.05
2.69 ± 0.05
2.64 ± 0.04
2.35 ± 0.10

2.60 ± 0.30
1.92 ± 0.30
2.55 ± 0.50
1.13 ± 0.10
2.55 ± 1.30

6.71
5.24
6.83
2.99
5.99

c

𝑓H
predicted
(%)
0.45
0.64
0.44
1.64
0.82

f
e
[θ]222:
𝑓H
𝑓H
(H2O) (TFE) [θ]208 nm
(TFE)
(%)
(%)
3.4
63.8
0.82
6.7
71.7
0.83
3.6
51.7
0.87
10.2
80.9
0.88
0.83
32.4
0.87
d

All errors (±) are the standard errors determined by fitting a single titration curve in the GraphPad Prism
software.
a
[TFE]mid and m were determined from fitting the data in Figure 6.3 with the two-state equilibrium
equation shown in equation 2.9.
b
ΔG ��� is the change in free energy in aqueous buffer calculated from parameters, [TFE] mid and m, obtained
from Figure 6.3, using ΔG ��� = 𝑚[TFE]mid.
c
Fractional helicity (𝑓 H) predicted with AGADIR227-231, using parameters 293 K, 0.01 ionic strength at pH
7.4.
d
Fractional helicity (𝑓 H) in aqueous buffer (0% TFE) calculated using equation 2.7.
e
Fractional helicity (𝑓 H) at high TFE concentrations (~8 M, ~60% v/v TFE) calculated using equation 2.7.
f
The ratio of [θ]222: [θ]208 nm at 50% TFE.

The addition of TFE stabilized the α-helical structure for all H0 peptides as
demonstrated by the increase in fractional helicity at high (> 7 M) TFE concentrations (𝑓 H
in TFE – Table 6.3). The peptides of the H0 A subfamily exhibit similar stabilities in TFEinduced helices, while the peptides of the B subfamily display a substantial difference in
helical stability. TFE is known to destabilize hydrophobic regions in proteins and
peptides.232 The ~50% helical difference between B1 and B2 is likely due to the presence
of a greater number of aromatic residues in B2 since aromatic residues are known to disrupt
helix formation.233
Furthermore, the [θ]222nm:[θ]208nm ratio can be used as a gauge of helix stability;
however, the meaning of these ratios are not as well-understood for peptides as opposed to
proteins.224, 234 A [θ]222nm:[θ]208nm ratio ≥ 1 is generally an accepted feature of an α-helix
stabilized in a coiled-coil conformation.234, 235 The [θ]222nm:[θ]208nm ratio increases as the
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TFE concentration increases for all peptides, further supporting the stabilizing effect of
TFE on the secondary structure of the H0 peptides. At high TFE concentrations (~8 M),
the ratio reaches a maximum at 0.85 ± 0.03 for all peptides, indicative of non-interacting
helices in solution.235
6.3

Influence of two-component negatively charged vesicles on H0 Helix binding
Model membrane systems, such as lipid vesicles, are widely used as a biomimetic

model to study membrane processes, including molecular recognition and membrane
trafficking.236 The secondary structures of the H0 helices of endophilin were investigated
by CD spectroscopy and compared in solution and in the presence of large unilamellar
vesicles. CD spectra obtained in solution revealed a disordered structure (Figure 6.4a) for
all H0 helix peptides, in agreement with earlier observations.20, 47 In accordance with these
data, a predicted helicity of less than ~2% for the H0 helices in solution was determined
by AGADIR227-231 (Table 6.3). In the presence of anionic membranes, all H0 peptides
undergo a conformational change to an α-helical structure. The three characteristics of an
α-helical CD spectrum are observed in Figure 6.4b with 100 mol% DOPS vesicles for each
H0 peptide. Furthermore, decomposition of the CD spectra with BeStSel237, 238, revealed
~55% α-helical structure for each H0 helix with the exception of B2, which is 36%, in the
presence of 1 mM DOPS (Table 6.4). These results complement the calculated fractional
helicity at high TFE concentrations (Table 6.3), signifying that anionic membranes
stabilize the H0 peptide secondary structure similarly to the addition of known helix
stabilizer TFE.
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Figure 6.4. The secondary structure of the H0 helices were evaluated in the presence of
membranes.
CD spectra of the H0 helices of endophilin in a) buffer only (10 mM sodium phosphate
pH 7.4) and b) 100% DOPS LUVs. a) The H0 helices are disordered in solution,
indicated by the single minimum at ~200 nm. b) In the presence of negatively charge
lipids (100% DOPS), the H0 helices undergo a conformational change to α-helical,
which is indicated by two minima at 208 nm and 222 nm and a maximum intensity at
~192 nm. LUVs were extruded with a 50 nm pore size. 1 mM lipids were mixed with
50 µM H0 peptides to maintain a peptide-to-lipid ratio of 1:20.
Next, we systematically increased the complexity of our model system by
extending our evaluation of H0 peptide interactions with lipid bilayers to a two-component
lipid bilayer system. Mixed LUVs composed of zwitterionic DOPC and anionic DOPS
lipids were used, and structural changes in the H0 peptide were monitored with CD
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spectroscopy. Figure 6.5 shows representative CD spectra of lipid titrations into H0
peptides in the presence of 0%, 25%, and 100% DOPS lipids (the remaining H0 peptide
data is shown in Figure 6.6). In the presence of 100% DOPC lipids (i.e. 0% DOPS), the
H0 helix spectra are indicative of being disordered/random coil as indicated by a single
minimum at ~200 nm239 even at a high (1 mM DOPC) lipid concentration (Figures 6.5a &
6.6 (top panel)). Since these data are similar to spectra of the H0 peptide in solution and
literature47, we can conclude that the H0 helix remains in solution and does not bind to
zwitterionic lipids. In agreement with the full length protein240, 241, the H0 helices bind
only when anionic lipids are introduced (Figures 6.5b-c & 6.6 (middle and bottom panels)),
as indicated by the three characteristic α˗helical features in the CD spectra. Comparing the
calculated fractional helicities (𝑓H) (shown in Table 6.4) of 25 mol% and 100 mol% DOPS,
the helicity of all H0 peptides increases by roughly two-fold when exposed to membranes
with greater negative charge.
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Figure 6.5. The helicity of the H0 helix peptides increases as the molar percentage of
anionic lipids increase.
Representative CD spectra of the H0 helix peptides in the presence of two different
percentages of negatively charged lipids. Titrations of 50 µM H0 B1 in the presence of
a) 0% DOPS (100% DOPC); b) 25% DOPS/ 75% DOPC; and c) 100% DOPS vesicles.
The secondary structure of the H0 helix undergoes a conformational change from
disordered to helical only in the presence of anionic lipids. An isodichroic point is
observed in both anionic lipid conditions and is indicative of a two-state equilibrium
system: random coil and α-helical. Lipid concentrations: 0 μM (blue), 50 μM (red), 175
μM (green), 250 μM (purple), 500 μM (orange), 1000 μM (black), 2000 μM (brown).
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Figure 6.6. The helicity of all remaining H0 helix peptides (A1, A2, A3, B2) increases as
the molar percentage of anionic lipids increase.
CD spectra of H0 a) A1, b) A2, c) A3, and d) B2 peptides in the presence LUVs with
varying amounts of anionic lipids. Titrations of 50 µM H0 peptides in the presence of
100% DOPC (top panel), 25% DOPS/ 75% DOPC (middle panel), and 100% DOPS
(bottom panel) vesicles. The secondary structure of the H0 helices undergoes a
conformational change from disordered to helical only in the presence of anionic lipids.
An isodichroic point is observed in both anionic lipid conditions and is indicative of a
two-state system: random coil and α-helical. Lipid concentrations: 0 μM (blue), 50 μM
(red), 100 μM (green), 175 μM (purple), 250 μM (orange), 500 μM (black), 750 μM
(magenta), 1000 μM (brown), 2000 μM (dark green).
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Table 6.4. Experimentally determined Gibbs Free Energy of Binding (ΔG), Fractional
Helicity (𝑓H), and [θ]222nm: [θ]208nm ratio of H0 Helices of Endophilin Bound to Different
Molar Percentages of Anionic Lipids
H0 peptide
A1
aΔG (kcal/mol)
˗7.2
b𝒇 (%)
61
H
cBeStSel (%)
54
d[θ]
222nm:[θ]208 nm 0.78

100% DOPS
A2
A3
B1
˗7.4 ˗7.5 ˗7.9
53
53
51
55
57
50
0.76 0.86 0.99

B2
˗6.6
29
36
1.02

A1
˗6.5
23
26
0.61

25% DOPS
A2
A3
B1
˗6.4 ˗6.3 ˗6.9
23
27
34
28
57
35
0.64 0.75 0.89

ΔG was calculated from fitting parameter Kp (Figure 6.7) using ΔG = ˗RTlnKp
𝑓H is calculated from θ222nm (at 1 mM lipid, 1:20 peptide: lipid ratio) as θobs
c
Percent of α-helical character determined from BeStSel237, 238 decomposition tool at 1 mM lipid
d
[θ]222nm: [θ]208nm is determined from 1 mM lipid (1:20 peptide: lipid ratio)
a

B2
˗6.8
19
12.4
0.81

b

Increased helicity is indicative of increased membrane binding and helix
stability.242 The degree of partitioning into the membrane can be determined from the
anionic lipid titrations of H0 peptides (shown in Figure 6.7a-e) by plotting the molar
ellipticity as a function of lipid concentration by using equation 2.14. The partition
coefficient (Kp) of all H0 peptides (shown in Figure 6.7f) increases from 25 mol% to 100
mol% DOPS lipids, with the exception of H0 B2 where binding remains constant within
statistical error. Similarly, the [θ]222nm: [θ]208nm ratio increases for all H0 peptides as the
mol% of DOPS increases for all lipid concentrations (1 mM lipid concentration shown in
Table 6.4). At high lipid (> 0.175 mM for B1 and 1 mM for B2) concentrations for vesicles
of 100 mol% DOPS, the [θ]222nm:[θ]208nm ratio for the B subfamily is ≥ 1, indicating a more
stable helix235 compared to the A subfamily (Table 6.4). In summary, the increase in molar
percentage of anionic lipids results in both greater helical stability and membrane
partitioning, indicating that H0-membrane binding is fundamentally controlled by
electrostatic interactions in a two-component lipid environment.
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Figure 6.7. Partitioning of H0 helices into membranes is modulated by anionic lipids.
The molar ellipticity at 222 nm from titrations of anionic lipids (shown in Figures 6.5
& 6.6 – 25% and 100% DOPS vesicles) with H0 a) A1, b) A2, c) A3, d) B1, and e) B2
were plotted as a function of lipid concentration. f) The partition coefficient (Kp) was
determined (equation 2.14) and shown for all H0 helices. Partitioning into 100% DOPS
vesicles is a favorable interaction for all H0 peptides, while the B subfamily displays
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stronger binding to 25% DOPS vesicles than the A subfamily. Error bars are standard
errors determined by fitting titration data in the GraphPad Prism software.
6.4

H0 Helix-membrane partitioning amongst complex organelle-membrane

mimics leads to a similar overall trend in binding, with variations among the two
subfamilies
Membrane shape and lipid composition are key parameters that regulate the
partitioning of proteins and/or peptides into the phospholipid bilayer.243 This partitioning
is finely tuned due to the heterogenous distribution among membrane-bound organelles of
> 1,000 different lipid species in all eukaryotic cells.72 Membrane-bound organelles have
diverse shapes and functions throughout the cell, and their individual function is supported
by their unique phospholipid and sterol distribution. In contrast to the plasma membrane
(PM), the endoplasmic reticulum (ER) and the Golgi apparatus (GA) are richer in
monounsaturated lipids and hence the membrane is loosely packed due to a higher number
of

packing

defects.243

Late

endosomes

(LE)

are

enriched

in

bis(monoacylglycerol)phosphate, or BMP, which is not found elsewhere in the cell.244 The
outer mitochondrial matrix (OMM) of mammalian cells is highly enriched in PI lipids as
well as cardiolipin.245 Meanwhile, the plasma membrane is loosely defined as having a
high negative charge with important signaling lipids (~1%), a high cholesterol content, and
low packing defects.72
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Table 6.5. Organelle-Mimicking Membrane Compositions
Organelle

Lipid Composition

Outer Mitochondrial
Matrix (OMM)246, 247
Inner Leaflet of
Plasma Membrane
(PM)75, 248
Endoplasmic
Reticulum (ER)249, 250
Late Endosome
(LE)72, 251
Golgi Apparatus
(GA)72

47% PC, 22% PE, 20% PI, 3% PA, 2% PS, 6%
CL
23% PC, 22% PE, 27% PS, 2% PI, 2% PA, 24%
Chol
47% PC, 20% PE, 10% PI, 8% PS, 3% PA, 10%
Chol, 1% CL, 1% DG
47% PC, 20% PE, 2% PI, 1% PS, 18% BMP,
12% SM
52% PC, 20% PE, 10% PI, 3% PS, 15% SM

Negative
Charge/100
lipids
˗37
˗31
˗23
˗15
˗13

BMP = Bis(Monoacylglycero)Phosphate; CL = Cardiolipin; Chol = Cholesterol; DG = Diacylglycerol; PA
= Phosphatidic acid; PC = Phosphatidylcholine; PE = Phosphatidylethanolamine; PI = Phosphatidylinositol;
PS = Phosphatidylserine; SM = Sphingomyelin

The H0 helix is critical for endophilin curvature sensing.25 We hypothesize that,
similar to proposed functions of the ALPS motif73, 252, the H0 peptides selectively bind to
different organelles resulting in sorting of the full-length protein in cells. In the previous
section, we have shown that the degree of H0-membrane binding as a function of anionic
lipid concentration generally increases for all H0 peptides. In this section, we evaluate
membrane partitioning and helicity of organelle-like membrane mimics through CD
spectroscopy (compositions shown in Table 6.5). Hence, in this study we determined
whether the H0 helices prefer, i.e. having a greater membrane partition coefficient,
membranes composed of complex lipid mixtures of one or multiple membrane-bound
organelles. The addition of saturated acyl chains, found in ER243, GA243, and PM
membranes75, can affect membrane fluidity, and ultimately, can lead to membrane phase
separation. Therefore, we note that only dioleoyl (DO)-chained lipids are used in this study
to limit the complexity of the membrane composition and lateral lipid raft/domain
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formation for interpretable results across all membrane-bound organelles probed.
Additionally, peptide-peptide interactions are considered negligible253, since the peptide
concentration is small relative to the lipid concentration.
To assess whether the endophilin H0 peptides bound to organelle-mimicking
membranes and to what extent, titrations of the five different organelle-membrane mimics
and each H0 peptide were performed and the changes in CD signal were monitored
(Figures 6.8-6.12). An isodichroic point at ~203 nm is present in all H0 peptide-titration
measurements, which indicates a two-state population: a disordered and an α-helical
state.226 Binding isotherms of each H0 helix and the corresponding organelle-mimic
compositions (shown in Figure 6.13a-e) were determined by evaluating the molar
ellipticity at 222 nm as a function of lipid concentration and subsequently fit with a twostate model225, 226 to determine fit parameter Kp (shown in Figure 6.13f). Each endophilin
subfamily shows distinctive membrane binding differences. Upon closer inspection of
Figure 6.13f, we note interesting anomalies in the magnitude of partition coefficients
among each of the H0 peptides, which can provide key insights into H0 subfamily
selectivity for membranes.
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Figure 6.8. Titrations of organelle-mimicking membrane vesicles into the H0 A1 peptide
measured by CD to evaluate H0 specificity.
Organelle-mimicking vesicles were titrated into a constant peptide concentration of 50
μM for the H0 A1 helix: a) OMM, b) PM, c) ER, d) LE, and e) GA, and the exact lipid
compositions are described in Table 6.5. A single isodichroic point is observed at ~203
nm for each lipid composition, indicating a random coil state and an α-helical state.

Figure 6.9. Titrations of organelle-mimicking membrane vesicles into the H0 A2 peptide
measured by CD to evaluate H0 specificity.
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Organelle-mimicking vesicles were titrated into a constant peptide concentration of 50
μM for the H0 A2 helix: a) OMM, b) PM, c) ER, d) LE, and e) GA, and the exact lipid
compositions are described in Table 6.5. A single isodichroic point is observed at ~203
nm for each lipid composition, indicating a random coil state and an α-helical state.

Figure 6.10. Titrations of organelle-mimicking membrane vesicles into the H0 A3
peptide measured by CD to evaluate H0 specificity.
Organelle-mimicking vesicles were titrated into a constant peptide concentration of 50
μM for the H0 A3 helix: a) OMM, b) PM, c) ER, d) LE, e) GA, and the exact lipid
compositions are described in Table 6.5. A single isodichroic point is observed at ~203
nm for each lipid composition, indicating a random coil state and an α-helical state.
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Figure 6.11. Titrations of organelle-mimicking membrane vesicles into the H0 B1
peptide measured by CD to evaluate H0 specificity.
Organelle-mimicking vesicles were titrated into a constant peptide concentration of 50
μM for the H0 B1 helix: a) OMM, b) PM, c) ER, d) LE, e) GA, and the exact lipid
compositions are described in Table 6.5. A single isodichroic point is observed at ~203
nm for each lipid composition, indicating a random coil state and an α-helical state.

Figure 6.12. Titrations of organelle-mimicking membrane vesicles into the H0 B2
peptide measured by CD to evaluate H0 specificity.
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Organelle-mimicking vesicles were titrated into a constant peptide concentration of 50
μM for the H0 B2 helix: a) OMM, b) PM, c) ER, d) LE, e) GA, and the exact lipid
compositions are described in Table 6.5. A single isodichroic point is observed at ~203
nm for each lipid composition, indicating a random coil state and an α-helical state.

Figure 6.13. Membrane partitioning of the H0 helices of endophilin into organellemimicking lipid compositions differ between subfamilies.
The molar ellipticity at 222 nm from lipid titrations into a) A1, b) A2, c) A3, d) B1,
and e) B2 was plotted as a function of lipid concentration for all organelle-mimics,
where OMM is blue, PM is red, ER is green, LE is purple, and GA is orange. CD
spectra from the corresponding lipid titrations are shown in Figures 6.8-6.12. f) The
experimentally determined partition coefficients for all H0 helices and organellemembrane mimic compositions were extracted by fitting the data shown in a-e with
equation 2.14. The B subfamily displays stronger partitioning into the membrane than
the A subfamily. The H0 A1 and H0 B2 peptides have the weakest membrane
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partitioning within their respective subfamilies. Error bars are standard errors
determined by fitting data in GraphPad Prism software.
In agreement with computed ΔGWW(e) values (Table 6.2), the H0 A subfamily
displays a similar favorable transfer free energy for organelle-mimicking membranes.
Among the A subfamily, each H0 A peptide surprisingly displays a unique trend in
selectivity to the organelle-mimicking vesicles (Figure 6.13f). The H0 A1 peptide binding
is roughly linked to total anionic charge (OMM > PM ~ LE > ER ~ GA), indicating a heavy
contribution from electrostatic interactions with its high net charge (+4.25). The H0 A1
peptide displays an overall weaker partitioning into all organelle-mimicking membranes
among the A subfamily. This weaker partitioning of A1 may be a result from differences
in its hydrophobic face and lower hydrophobicity (Table 6.2). The A2 and A3 peptides
have an additional aromatic residue that can participate in cation-π interactions with
choline head groups.254 In keeping with this conclusion, the fractional helicity (Table 6.6)
and the [θ]222nm:[θ]208nm ratio (Table 6.7) at high organelle (mimic) membrane
concentrations (2 mM) reveal overall lower helicity and ratio values, supporting A1’s lower
binding and stability than its A subfamily counterparts.
Table 6.6. Experimentally Determined Fractional Helicity (𝑓H) of the H0 Helices of
Endophilin in the Presence of Organelle-Mimicking Membranes
OMM
PM
ER
LE
GA

A1
48.4
46.9
38.4
24.7
17.9

A2
54.0
51.1
45.2
29.9
22.6

A3
64.1
62.8
54.8
37.4
26.6

B1
59.7
53.5
46.7
34.6
29.0

B2
50.9
51.3
44.8
28.7
21.6

𝑓H is calculated from θ222nm (at 2 mM lipid, 1:40 peptide: lipid ratio) as θobs from Figures 6.8-6.12
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Table 6.7. [θ]222nm: [θ]208nm ratio of the H0 Helices of Endophilin in the Presence of
Organelle-Mimicking Membranes
OMM
PM
ER
LE
GA

A1
0.82
0.81
0.82
0.68
0.55

A2
0.79
0.83
0.73
0.66
0.54

A3
0.87
0.94
0.88
0.81
0.72

B1
0.98
0.99
0.92
0.83
0.73

B2
1.06
1.12
1.12
1.16
0.82

[θ]222nm: [θ]208 nm is determined from 2 mM lipid (1:40 peptide: lipid ratio) from Figures 6.8-6.12

The B subfamily displays a similar trend in selectivity to the organelle-mimicking
vesicles (OMM > GA> LE > PM > ER) (Figure 6.13f), and this membrane partitioning is
likely based on contributions from both electrostatics and hydrophobicity. The more
hydrophobic B subfamily generally demonstrates stronger membrane partitioning than the
A subfamily, with the neutral H0 B1 peptide having the most favorable membrane binding
energetics. The ΔGWW(e) values (Table 6.2), evaluating the electrostatic contributions of
H0 B peptide-membrane interactions, are considered favorable transfer free energies.
However, the experimental transfer free energies (Table 6.8) determined for organellemimicking membranes are ˗5 to ˗7 more favorable than the predicted values, indicating
that hydrophobicity plays a significant role in H0 B peptide-membrane interactions. The
discrepancy between the predicted and experimental values is likely due to the initial input
of the WW-IF scale that was experimentally determined from zwitterionic membranes.
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Table 6.8. Experimentally Determined ΔG of the H0 Helices of Endophilin in the
Presence of Organelle-Mimicking Membranes
OMM
PM
ER
LE
GA

A1
˗6.00
˗5.74
˗5.53
˗5.69
˗5.55

A2
˗6.14
˗6.00
˗5.76
˗5.88
˗6.22

A3
˗6.11
˗5.72
˗5.54
˗5.93
˗5.75

B1
˗6.76
˗6.21
˗6.16
˗6.43
˗6.59

B2
˗6.31
˗5.59
˗5.37
˗6.25
˗6.27

ΔG was calculated from fitting parameter Kp (Figure 6.13) using ΔG = ˗RTlnKp

Overall, the higher calculated fractional helicity (Table 6.6) supports the stronger
partitioning of the H0 B peptides. In addition, the [θ]222nm:[θ]208nm ratios (Table 6.7) are
greater for the H0 B peptides, where some ratios are ≥ 1, revealing that an increase in bulky,
hydrophobic residues is critical for increased helical stability and can induce selfassociation.235 Although the H0 B2 peptide has a larger number of bulky aromatic residues
than B1, we do not, however, observe significant preferential membrane binding that is
expected from an increase in cation-π interactions with zwitterionic headgroups. Upon
membrane binding, the wider hydrophobic domain (subtended angle by the hydrophobic
side chains)34 of the B2 peptide may prevent some phospholipid-aromatic residue
interactions, thereby resulting in the observable weaker membrane partitioning. It is likely
that the amino acid sequence resulting in greater segregation of hydrophobic residues of
the H0 B1 nonpolar face as well as its narrower hydrophobic domain allows for an overall
more favorable transfer free energy and deeper membrane insertion than B2.255
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6.5

Specified-lipid components of the organelle-mimics in a tertiary mixture lead

to distinct preferences between the A and B subfamilies of endophilin
To characterize further the H0 peptide interactions with organelle-mimicking
membranes, we investigated the individual organelle-specific lipids to determine distinct
lipid preferences among the H0 peptides. In order to determine the contribution from the
lipid of interest, a baseline composition of 25 mol% DOPS and 75 mol% DOPC was used.
This membrane composition is the transition point at which helical structure is detected for
all H0 peptides at a high lipid-to-peptide ratio (Figure 6.14). If a higher percentage of
negatively charged lipids were used, interpretation of membrane binding energetics would
be dominated by electrostatic interactions, as previously shown in Figures 6.4, 6.5, & 6.6.

Figure 6.14. Titrations of varying amounts of negatively charged lipids into the H0
peptides.
Titrations of varying amounts of anionic lipids into peptides: a) H0 A1, b) H0 A2, c)
H0 A3, d) H0 B1, and e) H0 B2. The conformation of the H0 peptides remains
unstructured at low negative charge vesicles (0-10%). At higher mol% of negative
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charge beginning at 25% DOPS (orange line), each H0 peptide undergoes a
conformational change to α-helical secondary structure indicated by two peaks at 208
nm and 222nm and a positive ellipticity at < 200 nm. A single isodichroic point is
observed at ~203 nm for each lipid composition, indicating a random coil state and an
α-helical state.
Generally, the lipid compositions consisted of DOPC:DOPS:X = (75˗X):25:X,
where X is the specified lipid of interest (compositions shown in Table 6.9). In the case of
diacylglycerol (DG) (5%), the contribution to the membrane composition was lowered
significantly below 37.5%, since unsaturated DG has previously been found to induce the
formation of non-bilayer lipid phases above 25 mol%.256 The structure, geometry, and net
charge of each of the lipids of interest are reported in Table 6.10. Evaluation of lipid
geometry and charge on H0 peptide-membrane interactions will provide further insights
on the propensity of specific H0 peptide-organelle (mimic) membrane interactions. Eight
lipids of interest were titrated into each H0 peptide and spectra were monitored by CD
spectroscopy (Figures 6.15-6.19). Similar to TFE and organelle-mimic titrations, each H0
peptide-lipid titration reveals an isodichroic point at ~203 nm, indicating a two-state
equilibrium between unfolded and helical conformations. The binding isotherms for each
lipid of interest with the H0 peptides are shown in Figure 6.20a-e. The binding behavior
of the H0 peptides follow a similar trend as the binding results for the organelle-mimic
lipid titrations, where the H0 peptides of A1 and B2 reveal weaker partition coefficients
than their respective subfamily counterparts (Figure 6.20f). Both membrane charge and
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hydrophobicity are critical influences on the membrane selectivity of the H0 helix of
endophilin.
Table 6.9. Specific-Lipid Membrane Compositions
Lipid of Interest
Phosphatidylinositol (PI)
Cardiolipin (CL)
Bis(monoacylglycerol)phosphate (BMP)
Phosphatidic acid (PA)
Sphingomyelin (SM)
DOPE
Cholesterol (Chol)
Diacylglycerol (DG)

Lipid Composition
37.5% PI, 37.5% DOPC, 25% DOPS
37.5% CL, 37.5% DOPC, 25% DOPS

Net Charge/
100 lipids
˗62.5
˗100

37.5% BMP, 37.5% DOPC, 25% DOPS

˗62.5

37.5% PA, 37.5% DOPC, 25% DOPS
37.5% SM, 37.5% DOPC, 25% DOPS
37.5% DOPE, 37.5% DOPC, 25% DOPS
37.5% Chol, 37.5% DOPC, 25% DOPS
5% PA, 70% DOPC, 25% DOPS

˗62.5
˗25
˗25
˗25
˗25
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Table 6.10. Lipid Structure, Shape, and Net charge
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Figure 6.15. Titrations of specific organelle lipids into the H0 A1 peptide measured by
CD to evaluate lipid specificity.
Different compositions of the following specific lipids studied in organelle-membrane
mimics were evaluated: a) phosphatidylinositol (PI), b) cardiolipin (CL), c)
bis(monoacylglycerol)phosphate (BMP), d) phosphatidic acid (PA), e) sphingomyelin
(SM), f) DOPE, g) cholesterol (chol), and h) diacylglycerol (DG), and the exact lipid
compositions are described in Table 6.9. At 0 µM (in blue) lipid concentration, H0 A1
is an unstructured random coil as depicted by the single minimum at ~200 nm. As lipid
concentration increases, the H0 A1 peptide undergoes a conformational change to an
α-helical structure indicated by two minima at 208 and 222 nm and a positive ellipticity
at < 200 nm. A single isodichroic point is observed at ~203 nm for each lipid
composition, indicating a random coil state and an α-helical state.
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Figure 6.16. Titrations of specific organelle lipids into the H0 A2 peptide measured by
CD to evaluate lipid specificity.
Different compositions of the following specific lipids studied in organelle-membrane
mimics were evaluated: a) phosphatidylinositol (PI), b) cardiolipin (CL), c)
bis(monoacylglycerol)phosphate (BMP), d) phosphatidic acid (PA), e) sphingomyelin
(SM), f) DOPE, g) cholesterol (chol), and h) diacylglycerol (DG), and the exact lipid
compositions are described in Table 6.9. At 0 µM (in blue) lipid concentration, H0 A2
is disordered as depicted by the single minimum at ~200 nm. As lipid concentration
increases, the H0 A2 peptide undergoes a conformational change to an α-helical
structure indicated by two minima at 208 and 222 nm and a positive ellipticity at < 200
nm. A single isodichroic point is observed at ~203 nm for each lipid composition,
indicating a random coil state and an α-helical state.
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Figure 6.17. Titrations of specific organelle lipids into the H0 A3 peptide measured by
CD to evaluate lipid specificity.
Different compositions of the following specific lipids studied in organelle-membrane
mimics were evaluated: a) phosphatidylinositol (PI), b) cardiolipin (CL), c)
bis(monoacylglycerol)phosphate (BMP), d) phosphatidic acid (PA), e) sphingomyelin
(SM), f) DOPE, g) cholesterol (chol), and h) diacylglycerol (DG), and the exact lipid
compositions are described in Table 6.9. At 0 µM (in blue) lipid concentration, H0 A3
is unstructured as depicted by the single minimum at ~200 nm. As lipid concentration
increases, the H0 A3 peptide undergoes a conformational change to an α-helical
structure indicated by two minima at 208 and 222 nm and a positive ellipticity at < 200
nm. A single isodichroic point is observed at ~203 nm for each lipid composition,
indicating a random coil state and an α-helical state.
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Figure 6.18. Titrations of specific organelle lipids into the H0 B1 peptide measured by
CD to evaluate lipid specificity.
Different compositions of the following specific lipids studied in organelle-membrane
mimics were evaluated: a) phosphatidylinositol (PI), b) cardiolipin (CL), c)
bis(monoacylglycerol)phosphate (BMP), d) phosphatidic acid (PA), e) sphingomyelin
(SM), f) DOPE, g) cholesterol (chol), and h) diacylglycerol (DG), and the exact lipid
compositions are described in Table 6.9. At 0 µM (in blue) lipid concentration, H0 B1
is an unstructured random coil as depicted by the single minimum at ~200 nm. As lipid
concentration increases, the H0 B1 peptide undergoes a conformational change to an
α-helical structure indicated by two minima at 208 and 222 nm and a positive ellipticity
at < 200 nm. A single isodichroic point is observed at ~203 nm for each lipid
composition, indicating a random coil state and an α-helical state.
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Figure 6.19. Titrations of specific organelle lipids into the H0 B2 peptide measured by
CD to evaluate lipid specificity.
Different compositions of the following specific lipids studied in organelle-membrane
mimics were evaluated: a) phosphatidylinositol (PI), b) cardiolipin (CL), c)
bis(monoacylglycerol)phosphate (BMP), d) phosphatidic acid (PA), e) sphingomyelin
(SM), f) DOPE, g) cholesterol (chol), and h) diacylglycerol (DG), and the exact lipid
compositions are described in Table 6.9. At 0 µM (in blue) lipid concentration, H0 B2
is disordered as depicted by the single minimum at ~200 nm. As lipid concentration
increases, the H0 B2 peptide undergoes a conformational change to an α-helical
structure indicated by two minima at 208 and 222 nm and a positive ellipticity at < 200
nm. A single isodichroic point is observed at ~203 nm for each lipid composition,
indicating a random coil state and an α-helical state.
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Figure 6.20. Partitioning of all H0 helices into specific lipids (found in organellemembrane mimics) is sensitive to overall negative charge.
The molar ellipticity at 222 nm from lipid titrations into a) A1, b) A2, c) A3, d) B1,
and e) B2 was plotted as a function of lipid concentration for all individual lipid
components established in organelle-membranes (compositions shown in Table 6.9),
where PI is blue, CL is red, BMP is green, PA is purple, SM is orange, DOPE is black,
Chol is brown, and DG is dark pink. CD spectra from the corresponding lipid titrations
are shown in Figures 6.15-6.19. f) The experimentally determined partition coefficients
for all H0 helices and specific-lipid membrane compositions were determined by fitting
the data shown in a-e with equation 2.14. Error bars are standard errors determined by
fitting data in GraphPad Prism software. Strong partitioning into the membrane
generally occurs for all H0 peptides when the negative charge/100 lipids is less than
˗25 (PI/CL/BMP/PA). Among the A subfamily, H0 A1 peptide displays the weakest
membrane partitioning, meanwhile the H0 B2 peptide is the weaker membrane binder
of the B subfamily.
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The A subfamily only displays strong partitioning into the membrane when the net
membrane charge is less than ˗25/100 lipids. The fractional helicity (Table 6.11) increases
~two-fold in the presence of PI, CL, BMP, and PA (membranes where the net charge is
less than ˗25/100) when compared to the 25% DOPS membrane baseline. Likewise, we
observe increased stability in the presence of PI, CL, BMP, and PA as the [θ]222nm: [θ]208nm
ratio (Table 6.12) increases from the baseline measurement. Conversely, each H0 A peptide
displayed similar fractional helicities and a generally lower [θ]222nm: [θ]208nm ratio than the
baseline with the addition of zwitterionic lipids (SM, DOPE, cholesterol, and DG),
consistent with weak partitioning into low anionic membranes. In agreement with a
previous report of H0-NBAR

membrane interactions47, the H0 A peptides weakly

associate with zwitterionic lipids and strongly partition into anionic lipids. We conclude
that electrostatic contributions define H0 A peptide-membrane interactions, where
variations among A subfamily binding are influenced by their different hydrophobicmembrane binding interface.
Table 6.11. Experimentally Determined Fractional Helicity (𝑓H) of the H0 Helices of
Endophilin in the Presence of Specified Lipids in Organelle-Mimicking Membranes
25% DOPS
PI
CL
BMP
PA
SM
DOPE
Chol
DG

A1
23.2
48.6
46.3
33.6
47.3
14.9
19.3
19.1
24.9

A2
22.9
54.3
56.8
51.9
53.9
23.0
25.2
19.3
26.8

A3
26.5
65.1
70.2
66.6
68.1
34.5
30.7
25.9
32.2

B1
33.8
68.3
47.9
45.4
29.0*
30.6
23.6
19.8
23.8

B2
18.7
62.4
36.0
33.5
30.7
9.4
25.9
14.7
20.5

𝑓H is calculated from θ222nm (at 1 mM lipid, 1:20 peptide: lipid ratio) as θobs from Figures 6.15-6.19.
*
indicates 𝑓H is calculated at maximum lipid concentration titrated (0.75 mM)
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Table 6.12. [θ]222nm: [θ]208nm ratio of the H0 Helices of Endophilin in the Presence of
Specified Lipids in Organelle-Mimicking Membranes
25% DOPS
PI
CL
BMP
PA
SM
DOPE
Chol
DG

A1
0.61
0.81
0.81
0.75
0.82
0.57
0.63
0.58
0.68

A2
0.64
0.77
0.79
0.76
0.76
0.57
0.69
0.63
0.64

A3
0.75
0.87
0.89
0.85
0.84
0.73
0.80
0.75
0.69

B1
0.89
1.03
1.00
0.99
1.00*
0.88
0.84
0.78
1.01

B2
0.81
1.14
1.07
1.03
1.01
0.60
0.95
0.76
0.87

[θ]222nm: [θ]208 nm is determined from 1 mM lipid (1:20 peptide: lipid ratio) from Figures 6.15-6.19.
*
indicates [θ]222: [θ]208 nm is calculated at maximum lipid concentration titrated (0.75 mM)

Table 6.13. Experimentally determined ΔG of the H0 Helices of Endophilin in the
Presence of Specified Lipids in Organelle-Mimicking Membranes
25% DOPS
PI
CL
BMP
PA
SM
DOPE
Chol
DG

A1
˗6.47
˗7.06
˗6.70
˗6.94
˗6.64
˗5.98
˗5.95
˗5.76
˗5.54

A2
˗6.59
˗7.29
˗7.23
˗7.10
˗7.16
˗6.61
˗6.43
˗6.17
˗5.89

A3
˗6.22
˗7.27
˗7.32
˗6.99
˗7.31
˗6.30
˗6.19
˗5.94
˗5.56

B1
˗6.92
˗7.63
˗7.97
˗7.84
˗7.81
˗7.40
˗6.45
˗6.45
˗6.26

B2
˗6.76
˗7.75
˗6.55
˗7.07
˗6.65
˗6.69
˗5.85
˗6.21
˗5.64

ΔG was calculated from fitting parameter Kp (Figure 6.20) using ΔG = ˗RTlnKp

The H0 B subfamily displays significantly different binding trends than the H0 A
peptides, resulting from contributions of both electrostatic and hydrophobic interactions.
The H0 B1 peptide exhibits the strongest partitioning to all individual organelle lipids when
compared with all H0 peptides, and H0 B1 strongly partitioning into the most negatively
charged membrane, CL, along with all other membranes where the net charge is less than
˗25/100 lipids. Additionally, zwitterionic, cylindrical SM induced favorable partitioning
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into the membrane for the H0 B1 peptide as evidenced by a partition coefficient twice as
strong as the reference composition (75/25 = DOPC/DOPS). Therefore, strong partitioning
for SM and weaker partitioning into zwitterionic, conical lipids (DOPE, cholesterol, and
DG) suggest that the lipid geometry can influence H0 B1 membrane interactions. The
promiscuous and strong partitioning of H0 B1 supports its proposed cellular function of
interacting with many different membrane-bound organelles207, 257-259. Meanwhile, the H0
B2 peptide displays drastically different lipid binding preferences compared to the H0 B1
peptide, only showing favorable partitioning into PI and BMP-containing membranes,
linking the H0 B2 helix to its selectivity for OMM and LE membranes (Figure 6.20f) and
to its cellular function in mitochondrial maintenance205 and endosome maturation260.
6.6

Analysis of TFE-titration curves for the H0 helices of endophilin
The addition of TFE to the H0 helices of endophilin induces a disordered-to-helix

transition, while the H0 peptide remains monomeric. The fractional helicity substantially
increases from aqueous buffer (a disordered state) to high TFE concentrations. The
measured transfer free energy change for the A peptides are overall similar. Since this
peptide subfamily has closely related amino acid sequences, we did not expect significant
differences in the ΔG ��� values (Table 6.3). The ΔG ��� and fractional helicity at high

TFE for the B subfamily differs greatly between the two peptides, where the ΔG ��� for the

H0 B1 peptide is 2-fold smaller and helicity is 2.5 times greater.
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6.7

Evaluation of Physicochemical Parameters
We measured binding of the conserved H0 helix of each endophilin subfamily to

lipid bilayers of increasingly complex lipid compositions. The peptides studied differ in
amino acid sequence as well as physicochemical properties, such as net charge,
hydrophobicity, hydrophobic moment, helicity, and subtended angle. Previous studies
indicate that these physicochemical parameters effect the binding and specificity of
amphipathic helical peptides on membranes.73, 209, 261 We demonstrate that H0 peptidemembrane binding is dependent on anionic lipids, and that membrane binding is sensitive
to variations in lipid compositions.
Overall, the H0 peptides displayed strong membrane partitioning. The magnitude
of H0 peptide-membrane partition coefficients ranged from 104 – 106 in the presence of
anionic membranes while other well-studied membrane-active peptides, including melittin
and magainin, have partition coefficients ranging from 103 – 105.262-265 Overall, our Kp
values are in agreement with previously measured membrane partition coefficient of the
closely related H0 helix of N-BAR amphiphysin into POPS membranes, with a Kp value
of (4.2 ± 1.0) x 104.47 Comparing the Kp of amphiphysin H0 helix to our Kp values into
DOPS vesicles, partitioning of both endophilin subfamilies displayed greater membrane
partitioning by a factor of 2- to 20-fold. This discrepancy can be explain by the difference
in ionic strength, since peptide binding is known to decrease as the salt concentration
increases.253, 266
The degree of helicity is closely linked to membrane binding for each of the H0
helices. There are many different methods to evaluate and gauge the helicity of peptides
173

from CD spectra, including spectral decomposition tools230, 238, 267, the [θ]222nm: [θ]208nm
ratio268, and fractional helicity. Evaluation of the lipid titration spectra with all H0 peptides
with BeStSel237, 238 (online spectral decomposition webtool) as well as the [θ]222nm: [θ]208nm
ratio indicate an increase in α˗helicity and stability, and hence membrane partitioning, as
the lipid concentration is increased.
Fractional helicity can be calculated using θ222nm from titration measurements that
is dependent on the peptide-to-lipid ratio. A closer look at the fractional helicity at high
lipid concentrations (0.75–2 mM, Table 6.4, 6.7, & 6.11) across all membrane
compositions indicate that high helicity (≥ 50%269) is not always linked to strong partition
coefficients for each of the H0 peptides. In cases where strong binding but weaker helicity
is observed, the [θ]222nm: [θ]208nm ratio is usually ≥ 1. Therefore, the membrane binding
energetics is not completely determined by the degree of helicity. It is likely determined
by the stabilizing side chain interactions255 of the unique H0 peptide sequences with
specific membrane compositions. Furthermore, the [θ]222nm: [θ]208nm ratio was often found
to be ≥ 1 for the H0 B peptides. The self-oligomerization tendency of the H0 B peptides
indicates that the endophilin B subfamily may form higher-order oligomers, resulting in a
critical role for the H0 helix to promote efficient BAR domain membrane association.207,
270

Many hydrophobicity scales have been determined and are often used to predict
secondary structure.220, 271 The WW-IF hydrophobicity scale is specifically determined to
describe the interfacial partitioning and folding of membrane proteins.213 This scale
emphasizes the importance of aromatic residues as highly favorable in membrane
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partitioning and deemphasizes the overall influence of charged residues (Lys, Arg), which
have been proposed to favorably partition into the bilayer due to side chain snorkeling.272275

The WW whole-residue scale213 indicates that the H0 helices of endophilin-membrane

partitioning into POPC membranes is unfavorable (positive kcal/mol), which is likely due
to the measurement of transfer free energy into a zwitterionic (POPC) bilayer as opposed
to a negatively charged membrane. However, the MPEx215 Totalizer tool allows the user
to adjust the helicity and membrane charge. Application of 50% α-helicity and an increase
in anionic charge to ˗100 mV using the WW-IF scale results in a closer prediction of
hydrophobicities when compared with experimental ΔG shown in Tables 6.4, 6.8, & 6.13.
Meanwhile, the Fauchere and Pliska hydrophobicity scale is experimentally determined
from octanol/water partitioning of N-acetyl-amino-acids.217 Overall, the summation of side
chain hydrophobicities from the Fauchere and Pliska scale (HeliQuest) indicates that the
H0 B subfamily is more hydrophobic than the A subfamily.
Traditionally, the hydrophobic moment is used to evaluate the amphiphilicity of a
helix.218 However, a recent report argues that the hydrophobic moment is a poor predictor
of helicity and membrane binding, and rather, simply describes the degree of segregation
between the polar and hydrophobic faces.255 The hydrophobic moment does not account
for the spatial distribution of amino acids along the helical axis, potential intramolecular
salt bridges, or hydrogen bond formation.212, 276 The WW-IF scale predicts the H0 A3
peptide as having the greatest amphiphilicity, while the Eisenberg method calculates the
H0 B1 peptide. The H0 A3 peptide generally has a greater fractional helicity for both
organelle-mimicking membranes and specified-lipid membranes among all the H0
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peptides, while the H0 B1 has the strongest membrane partition coefficients. However,
looking at the both membrane partitioning and helicity, the hydrophobic moment
(calculated with either method) is not a reliable predictor for all the H0 peptides from the
endophilin subfamilies.255
6.8

Organelle Recognition
Endophilin has previously been shown to induce membrane remodeling through

BAR domain scaffolding20, and the role of H0 amphipathic insertion has been widely
debated25, 47, 208, 277-279. Here we evaluate the role of the H0 helix as an organelle recognition
sequence. At the subcellular level, isoforms A1 and A3 have been discovered to localize
to presynaptic boutons, where they are found on synaptic vesicles as well as in the
cytosol.280, 281 Subcellular fractionation studies determined A1 in mouse brains to be
associated with various membrane fractions including the ER, Golgi, endosomes,
lysosomes, and mitochondria, in addition to being found in the cytosol.282 Meanwhile, the
subcellular localization of endophilin B1 has been described as both diffuse203 and reticular
in the cytosol258, as well as enriched in the perinuclear region258. B1 localizes to
intracellular membrane compartments, such as the Golgi and mitochondria207, 257, 258, as
well as synaptic vesicles.259 The function and subcellular localization patterns for
endophilin B2 are the least well known. However, early studies indicate that low B2
expression levels correlate with a diffuse cytosolic pattern with enrichment in the
perinuclear space and some plasma membrane localization, while overexpression results
in dense filaments surrounding the nucleus.46
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In this study, we characterized the membrane binding and specificity of the H0
helices of endophilin for a more precise understanding regarding its membrane binding
specificity to specific organelles. H0 peptide binding to membranes results from
contributions of both hydrophobic and electrostatic free energies of favorable lipid
interactions.283 The partition coefficients of the H0 helices determined for organellemimicking membranes were weaker than its association with 25% and 100% DOPS
membranes. This weaker partitioning into the organelle-mimicking membranes is likely
due to weaker electrostatic interactions from the relatively low negative charge, ranging
from ˗13 to ˗37/ 100 lipids (Table 6.5).
Our results indicate that the H0 A peptides of endophilin weakly associate to a wide
range of organelle-mimicking compositions, similar to subcellular fractionation studies282,
and membrane association is dominated by electrostatic interactions. There is increasing
evidence for a complex lipid membrane, such as the plasma membrane, to form local
domains with different compositions and physical properties that are substantially different
from overall membrane content.284 Hence, although we do not observe increased
partitioning into the inner leaflet plasma membrane mimic in comparison with the other
organelles for the H0 A peptides, an interesting hypothesis to test in future studies is that
local increases in negative charge285 would enhance the H0 A peptide binding to the
membrane in vivo. Additionally, the H0 A peptides’ weak association with PM-mimicking
membranes could indicate that protein-protein interactions contribute to endophilin A’s
strong membrane recruitment. Our results support the proposed function that the H0 helix
aids in directing the BAR domain scaffold to the membrane interface.
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The specific lipid titrations indicate that organelle specificity may be influenced by
the strong association of key lipid components of the various membrane-bound organelles.
The H0 B1 peptide displayed the strongest membrane binding for most of the membrane
compositions evaluated in this study. This promiscuity of B1 supports its proposed cellular
function of interacting with various different membrane-bound organelles during
intracellular trafficking and autophagy.207, 257-259, 286 Similarly, the favorable partitioning of
H0 B2 into PI and BMP lipids, key components in the OMM and LE membrane mimics,
supports its cellular function of facilitating mitochondrial maintenance205 and endosome
maturation260. Unlike the A subfamily, endophilin B1 and B2 were previously found to
form heterodimers during mitophagy.205 It remains unclear the extent of regulation for
homo- and heterodimerization between the B subfamily (and whether it is present within
the A subfamily). We hypothesize the different physicochemical properties and membrane
affinities determined for the organelle-mimics and specified-lipid membranes may modify
the subcellular localization of endophilin B, since the presence of a heterodimer205 may
allow for fine tuning membrane targeting when co-mixing the two different H0 helices.
6.9

Conclusions
Accuracy of membrane trafficking is highly dependent on protein recognition of its

target membrane.287 Proteins must transverse the crowded cellular milieu and recognize
specific binding compartments for functionality and sustaining cell life. The H0 AH motif
of endophilins supports its in vivo function by contributing a favorable transfer free energy
upon association with its membranous binding partners. The H0 helices of endophilin
follows the disordered-to-helix transition in the presence of both helix inducer TFE and
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anionic membranes.

In agreement with previous studies288, the presence of more

hydrophobic residues generally promotes an increase in H0 membrane binding. Overall,
this study highlights that secondary structure prediction tools and physicochemical
parameters, such as large hydrophobic moments and high helicity, does not always
correlate with strong membrane partitioning. Therefore, evaluation of multiple tools and
parameters, such as the [θ]222nm: [θ]208nm ratio, will aid in understanding the peptidemembrane binding energies and the discrepancies between fractional helicity. The H0 helix
of endophilins weakly associates with organelle-membrane mimics, thereby priming the
membrane for BAR domain association. Further studies are needed to evaluate the second
AH of endophilin, the H1I helix, to understand the structural and functional role of both
AHs of endophilin.
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Chapter 7: Future Outlooks
7.1

Measuring the free energy of adhesion of α-synuclein to assess hemifusion
Lipid bilayers are considered multicomponent liquids, i.e. flexible surfaces, in two

dimensions289 with internal degrees of freedom allowing for interactions and redistribution
of components between the two leaflets290. Molecular mediators, including small
molecules and proteins, can induce contacts (adhesion) between two outer leaflet
monolayers.290 Adhesion between two monolayers can initiate hemifusion, or the merging
of the two contacting leaflets, which is often dependent upon membrane
composition.290 Hemifused Ω-like structures have emerged as a key intermediate in both
fusion and fission, critical to cellar processes such as endo- and exocytosis.291, 292

Figure 7.1. α-Synuclein tether formation results from relatively strong adhesion energy.
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GUVs, with composition 45/30/24.7/0.3 = DOPS/DOPE/DOPS/Texas RedTM-DHPE,
were incubated with N-acetylated α-synuclein E130C conjugated with Alexa Fluor®
488 for 10 minutes. Two GUVs were aspirated and held under tension (~0.2 mN/m),
and buffer conditions were 117 mM sucrose, 117 mM glucose, 50 mM NaCl, 7 mM
HEPES, 0.3 mM TCEP, pH 7.4. The two vesicles were gently pushed together. The
contact site between the two vesicles shown in a) the 488 nm (α-synuclein) channel and
b) the 561 nm (Texas RedTM-DHPE lipid) channel highlights the enrichment of αsynuclein (white box) at the junction site. After the two GUVs were pushed together,
the vesicles were incubated for ~2 minutes and then moved apart. c) A tether was
formed connecting the two GUVs by slowly moving one GUV away from the other.
α-Synuclein is an intrinsically disordered protein abundantly found in synaptic
boutons.51 Although the exact function of α-synuclein remains elusive, its ability to
associate with membranes is hypothesized to be critical to its function.293 Membrane
bound α-synuclein is implicated in aiding membrane remodeling during cellular
trafficking294, synaptic vesicle fusion295, and regulation of mitochondria296 through
unknown mechanisms. α-Synuclein oligomers, composed of ~30 monomers, have been
previously shown to induce hemifusion in the presence of anionic membranes.293
Since the mechanism of α-synuclein membrane remodeling remains unclear,
evaluation of the adhesion energy between monomeric α-synuclein and membranes can be
studied to further understand α-synuclein’s role in hemifusion. Preliminary experiments,
shown in Figure 7.1a, indicate that α-synuclein is enriched at the contact site where two
GUVs are pushed together. Furthermore, this interaction between α-synuclein monomers
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is strong enough to form a tether between the two outer leaflets, and it is enriched in αsynuclein (Figure 7.1c). This tether is stable under relatively high membrane tensions
(~0.60 mN/m) and physiological salt conditions (~137 mM NaCl, 7 mM HEPES, 0.3 mM
TCEP, pH 7.4).
Figure 7.2 shows a schematic depiction of micropipette aspiration experiments in
the case of weak and strong binding. Confocal microscopy and GUV aspiration allow us
to simultaneously control membrane tension and measure membrane area. Adhesion
energy can be evaluated while changing factors such as lipid composition, i.e. anionic lipid
content, membrane tension, and salt concentration. Additionally, assessment of the
presence of Ca2+ ions and proteins involved in the soluble N-ethylmaleimide-sensitive
factor attachment protein receptor (SNARE) complex, both critical factors in exocytosis
and cellular hemifusion events291, on α-synuclein adhesion energy can lead to better
biophysical understanding of monomeric α-synuclein’s role in hemifusion.

Figure 7.2. Measuring weak and strong adhesion energy between two aspirated GUVs.
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a) Weak adhesion between one tense GUV (left) and a flaccid GUV (right). b) Strong
adhesion between two tense GUVs, which has a flat contact zone (thick black line).
Figure is adapted from Sun et al.290
7.2

Phase separation between different BAR-domain proteins
A recent study investigating the initial steps of endocytosis suggests that membrane

remodeling can be driven by phase separation through large liquid droplets (which function
as membrane-less organelles) assembled near the plasma membrane.297 Phase separation
is defined by the spontaneous separation into two phases of a well-mixed
solution.298 Theoretical studies suggest segregation on the membrane can occur based on
a protein’s intrinsic curvature.299 Membrane curvature induced phase separation has
previously been observed in vitro for IRSp53 inverse-BAR, or I-BAR, proteins on proteincoated membrane tethers (high curvature) pulled from GUVs (low curvature).300
Additionally, the spontaneous segregation of F-BAR and N-BAR proteins has been shown
both in cells as well as in in vitro liposome reconstitution assays.27
One driver of protein phase separation is the presence of intrinsically disordered
regions (IDRs).298 As previously mentioned in Chapter 4, one isoform of FBP17 contains
an (~90 amino acids) IDR145 whereas endophilin (Chapters 5 & 6) contains a variable linker
region175 with low complexity. The membrane recruitment dynamics of FBP17 is
significantly different from other BAR proteins, in that it is observed at the membrane both
before and after vesicle scission.170 Detection of phase separation between these two
different BAR domain classes on anionic membranes with different curvatures (i.e. a
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relatively flat GUV and a highly curved membrane tether) may contribute to better
understanding BAR protein recruitment dynamics during clathrin-mediated endocytosis.
7.3

Opto-chemical control of protein recruitment to the plasma membrane
Photoactivatable proteins with chemically-induced dimerization (CID) is an

experimental technique (shown in Figure 7.3) that can be used to study dynamic biological
processes with spatiotemporal precision.301 By using a novel chemical inducer of protein
dimerization (CNTH), protein-protein interactions and protein localization to the
membrane can be reversibly turned on and off with light pulses in a cellular
environment.301 CNTH is a light-activated protein dimerizer that contains a coumarin
photocage, a caged trimethoprim ligand (TMP), a photocleavable nitroveratryl linker, and
a noncaged chlorohexane (HaloTag) ligand.301 TMP is the ligand for Escherichia coli
dihydrofolate reductase (eDHFR) while the chlorohexane ligand binds to the
HaloTag.301 The HaloTag fusion protein can also contain a CAAX box, which is a
sequence that signals for post-translational modifications resulting in plasma membrane
recruitment through palmitoylation.302 Recent work demonstrated a proof-of-principle
experiment by showing successful light-induced spatiotemporal control of positive and
negative membrane curvature generation initiated by F-BAR FBP17 and I-BAR IRSp53,
respectively.303 Employment of the light-inducible CID technique can enable subcellular
investigation of a number of different dynamic cellular processes, such as endo- and
exocytosis, lamellipodia formation and cell migration, and actin driven cell-dynamics.301,
303
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Figure 7.3. Schematic of reversible, light-controlled protein dimerization.
The CNTH dimerizer has four modules: 1) a coumarin photocage (purple); 2) a caged
trimethoprim (TMP) ligand (red); 3) a photocleavable linker (blue); and 4) a noncaged
HaloTag ligand (green). Once the CNTH molecule is incubated and taken up by
mammalian cells, the HaloTag ligand will bind to the HaloTag fusion protein (fused
with a protein of interest). The HaloTag fusion protein may also be designed with a
CAAX box, which facilitates post-translational palmitoylation resulting in plasma
membrane localization. The coumarin photocage can then be selectively removed with
444 nm light, which allows the TMP ligand to bind the eDHFR fusion protein (fused
with a second protein of interest); thereby turning on dimerization. Dimerization can
then be turned off by light activation with a 405 nm light pulse, which cleaves the TMP
ligand from the linker and HaloTag ligand. Figure is adapted from Aonbangkhen et
al.301
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CID is an advantageous method to protein-protein interactions since these
interactions can be rapidly activated and deactivated with high spatiotemporal
resolution.301 Here, we propose to use the photoactivable and CID tools to understand fast
endophilin-mediated endocytosis (FEME). Lamellipodin (Lpd) is recruited to the plasma
membrane through its pleckstrin homology (PH) domain that specifically binds to the
signaling lipid PI(3,4)P2.304

Lpd promotes lamellipodia formation304, regulates actin

filament assembly305, and cooperates with endophilin to regulate EGF-receptor
endocytosis306. Recent studies indicate that endophilin is pre-enriched at the membrane
due to Lpd recruitment by F-BARs FBP17 and CIP4, which ultimately results in a primed
membrane for FEME.18 For FEME to occur, receptors must first be activated to become
cargo.17 By using a Lpd-HaloTag-eGFP-CAAX fusion protein with an endophilin
A1/A2/A3-eDHFR-mCherry fusion protein, we can spatiotemporally control endophilin
membrane recruitment via Lpd membrane association with various cell receptors, and then
examine the downstream effects of dimerization by photo-inducing a small subset of
molecules at the plasma membrane. Preliminary ex vivo experiments show that the LpdHaloTag-eGFP-CAAX fusion protein associates with the plasma membrane (Figure 7.4).
Further experiments are needed to optimize protein expression levels during
cotransfections

of

both

fusion

proteins

prior

to

chemical

dimerization

studies. Additionally, we can evaluate differences, if any, of the recruitment dynamics of
the three endophilin A isoforms. Interestingly, CIP4, Lpd, and endophilin are all
overexpressed in many cancers.18 Therefore, investigating the receptor recruitment

186

mechanisms based on cell-type or cargo will aid in a broader understanding of a potential
role for FEME in tumorigenesis.

Figure 7.4. Preliminary cell transfection with lamellipodin-HaloTag and endophilin A1eDHFR fusion proteins with chemically induced dimerization using CNTH.
HeLa cells were transfected with i) Lpd-HaloTag-eGFP, ii) Lpd-HaloTag-CAAXeGFP, and iii) cotransfected with ii) and endophilin A1-eDHFR-mCherry with
Lipofectamine 3000 reagent (Invitrogen). The plasmids were custom synthesized from
GenScript (Piscataway, NJ). Lpd without the CAAX box has a cytosolic distribution
(left panel) while Lpd is associated with the cell membranes with the CAAX box
(middle panel). The right panel shows a cotransfection with Lpd and endophilin A1
fusion constructs, where the yellow intensity indicates colocalization. Cellular
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expression levels of the endophilin A1-eDHFR-mCherry fusion protein were relatively
low in comparison to Lpd, and transfection conditions must be optimized before we
induced chemical dimerization. Cells were imaged with a Nikon Eclipse Ti2 Inverted
spinning disk confocal microscope (Tokyo, Japan) with a CFI APO 100X Oil TIRF
NA 1.49 WD 0.12 mm objective lens with Daniel Wu in the David Chenoweth lab,
University of Pennsylvania. Scale bars are 10 μm.
7.4

Subcellular localization of the N-terminal H0 helix of endophilin ex vivo
In chapter 6, we evaluated the H0 helix membrane binding preferences and

energetics to various organelle-membrane mimicking compositions by monitoring lipid
titrations via CD spectroscopy. To complement the in vitro assessment of the N-terminal
H0 helix of endophilins, we aim to evaluate if the N-terminal H0 helix alone is sufficient
to enable specific organelle targeting in cells. Additionally, our objective is to understand
where the different domains of endophilin function subcellularly since very little is known
about the targeting mechanisms of the protein-membrane dynamics of endophilin.
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Table 7.1. Overview of Endophilin Gene Constructs for Mammalian Cell Expression

Using a variety of molecular biology techniques including ligation independent
cloning (LIC), we generated each domain of endophilin along with domain combinations
(Table 7.1) of each isoform in a mammalian cell vector with a C-terminal eGFP (see
Chapter 2.12 for primers). In vitro and ex vivo experiments have shown a positive
correlation between the number of amphipathic helices and vesiculation by creating Δ H0
deletion and double H0 helix (DAH) mutants of endophilin.208 Here, we also constructed
double H0 mutants in addition to single H0 versions to study this amplifying effect of the
H0 helix.208 Furthermore, we created a library of chimeric endophilins (shown in Figure
7.5), where the H0 helix of each isoform is swapped with each endophilin isoform by first
PCR amplifying the BAR-Linker-SH3 domains of each endophilin, and then the new H0
helix is constructed by multi-step elongation PCR (Chapter 2.12, Tables 2.9 & 2.10). For
example, the chimeric protein construct termed H0B1-A1FL, indicates that the H0 helix of
endophilin A1 (full length-FL) is replaced with the H0 helix of B1.
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Figure 7.5. Design of chimeric endophilin A1 with swapped H0 helices with the four
other endophilin isoforms.
Each endophilin isoform’s H0 helix was swapped with the remaining four isoforms to
create a chimeric gene construct, resulting in 20 chimeric gene constructs. The
terminology H0B1-A1FL indicates that the H0 helix of A1 has been molecularly edited
to the H0 helix of B1 while the BAR domain, linker, and SH3 domain is from
endophilin A1.
We preliminarily investigated the subcellular localization patterns of endophilin
isoforms through transiently transfected HeLa cells to study the overexpression and
subcellular colocalization of different endophilin domains and endophilin chimeras. The
overall goal of this study is to gain better insights into the membrane sensing and
subcellular localization of endophilin by using the constructs from Table 7.1 and Figure
7.5.
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Figure 7.6. Representative images of HeLa cell transient transfection of different
endophilin constructs.
Representative images of HeLa cell transient transfection with endophilin isoforms and
subsequent fixation with 4% paraformaldehyde. Transfection with the different
endophilin constructs include H0-eGFP, double H0-eGFP (D-H0), N-BAR-eGFP, and
full-length-eGFP (FL). Blue arrows indicate puncta, red arrows indicate filament
formation, and white arrows indicate accumulation near the cell edge. Scale bars are
10 µm.
Firstly, we are interested in studying the specificity with respect to organelle
targeting of the amphipathic helices outside their native protein context in a cellular
191

environment. The images in Figure 7.6 show that the full-length constructs of all
endophilins contain many puncta (blue arrows), or small vesicles as has been previously
reported207, 257, 258, 280, 281. Additionally, the overexpression of the H0s and double-H0s (DH0s) generally results in enrichment at the membrane (white arrow), puncta formation
(blue arrow), and even fibril-like structures for A1 (red arrow). Furthermore, the H0
helices of A2, B1, and B2 along with their corresponding full-length constructs appear to
be enriched at or near lamellipodia, or thin-cellular protrusions composed of branched actin
filaments307. However, this cellular phenomenon must be rigorously quantified by cellular
markers to distinguish it between cellular ruffling, which gives a similar appearance to
lamellipodia. Cellular markers for lamellipodia/cellular ruffling include anti-ARPC2
antibody

(lamellipodia:

actin-binding

component)308,

anti-cortactin

antibody

(lamellipodia: width marker)309, and anti-WAVE2 antibodies (ruffling marker)308.

Early

colocalization studies through specific organelle staining and colocalization analysis,
indicate that the H0 helices of B1 and B2 have a greater tendency to localize with
mitochondria and early endosomes than the A subfamily (Figure 7.7).

Figure 7.7. Colocalization of the Double-H0-eGFP constructs with mitochondria and
early endosome markers in HeLa cells.
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Colocalization with a) mitochondria marker MitotrackerTM Red and b) early endosomal
antibody Anti-EEA1 with the double H0 (D-H0) helices in HeLa cells using Pearson’s
correlation coefficient (PCC). The double H0 helix of the B subfamily colocalizes with
mitochondria with statistical significance. Meanwhile, colocalization of the D-H0 of
the B subfamily with early endosomes displays a similar tendency, where the
colocalization between the D-H0s of A1 and B2 with Anti-EEA1 was determined as
statistically significant. P values were calculated using an unpaired, two-tailed
Student’s t-test, where P ≤ 0.05 is indicated by *, P ≤ 0.001 is ***.
Since the relatively small domains of the H0 helix and double H0 helix are tagged
with the larger eGFP protein (33kD), these constructs tend to be highly localized in the
nucleus, which is a common observation with eGFP transfections.310 Therefore, we can
also evaluate chimeric endophilin constructs (Figure 7.5) to further study the H0 helix
subcellular localization by swapping the helix of the A subfamily with the B
subfamily. Figure 7.8a shows representative images of transient transfections comparing
the full-length A3 with chimeric A3-FL with its H0 swapped for the H0 of B2 (H0B2A3FL). In the right most image, we observe colocalization of the H0B2-A3FL construct
with a mitochondrial marker. Endophilin A3 is known to primarily associate with the
plasma membrane281 while endophilin B2 associates with intracellular membranes46, 205,
260

. Colocalization with mitochondria increases with chimeric H0B2-A3FL as compared

to wild-type endophilin A3 full length, which is quantified in 7.8b. This colocalization,
due to swapping of the H0 helix, suggests that the H0 helix may have a critical role in the
subcellular localization pattern of endophilins. Future studies should include a rigorous
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evaluation of all chimeric endophilins, more specifically, swapping the A and B subfamily,
with specific organelle markers to determine the precise role of the H0 helix in organelle
targeting.

Figure 7.8. HeLa cell transient transfection of a chimeric endophilin construct.
a) Representative images of HeLa cell transient transfection and subsequent fixation
with 4% paraformaldehyde with different endophilin constructs of A3-FL-eGFP (left)
and chimeric A3 with H0 B2 denoted H0 B2-A2FL-eGFP (middle and right
image). The middle image shows a merged picture of a cell membrane marker (Cell
BriteTM Blue from Biotium) in red and the chimeric endophilin in green. The right
image shows a merged picture of mitochondria marker, MitotrackerTM Red, in red
overlain with green chimeric endophilin.

The yellow intensity indicates

colocalization. Scale bars are 10 µm. b) Colocalization of chimera H0 B2-A3-eGFP
with MitotrackerTM Red is greater than A3-FL-eGFP evaluated by Mander’s fractional
overlap coefficient.
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7.5

Membrane sensing and curvature generation of chimeric endophilins
The chimeric endophilins shown in Figure 7.5 were also subcloned into a bacterial

expression vector. Our lab has extensively studied endophilin A1’s capacity to sense and
generate membrane curvature.25, 45, 87 Therefore, we can employ our GUV instability and
Langmuir binding isotherm assays to the chimeric endophilins of A1 with the swapped H0
helices of A2, A3, B1, and B2. These set of experiments will provide new insights into
how membrane physical properties such as membrane tension and lipid composition
regulate curvature coupling with membrane sensing and remodeling. We can then evaluate
the influence of different H0 helices on endophilin A1’s membrane sensing and curvature
generation capacity. Similar H0 helices of A2 and A3 will likely have a minimal effect on
endophilin A1’s transition density. However, the H0 helices of B1 and B2 have critically
different physicochemical parameters and will likely influence endophilin A1’s transition
density by regulating its curvature sensing ability.
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